10-Q

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2022

o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from _______ to _______

SEC File No. 001-37954

SHIFTPIXY, INC.

(Exact name of registrant as specified in its charter)

Wyoming	47-4211438
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
501 Brickell Key Drive, Suite 300, Miami, FL	33131
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number: (888) 798-9100

N/A

(Former name, former address and former three months, if changed since last report)

Securities registered under Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001 per share	PIXY	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “non-accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	x	Smaller reporting company	x
Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

The number of shares of the registrant’s only class of common stock issued and outstanding as of April 14, 2022, was 33,661,552.

TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Financial Statements (unaudited)	2
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	31
Item 3.	Quantitative and Qualitative Disclosure about Market Risk	45
Item 4.	Controls and Procedures	45
PART II — OTHER INFORMATION
Item 1.	Legal Proceedings and Risk Factors	47
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	47
Item 3.	Defaults Upon Senior Securities	47
Item 4.	Mine Safety Disclosures	47
Item 5.	Other Information	48
Item 6.	Exhibits	48
Signatures		49

PART I — FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

ShiftPixy, Inc. 

Condensed Consolidated Balance Sheets

	February 28, 2022		August 31, 2021
	(Unaudited)
ASSETS
Current assets
Cash	$	3,349,000	$	1,199,000
Accounts receivable	381,000		498,000
Unbilled accounts receivable	2,615,000		2,741,000
Deposit – workers’ compensation	36,000		155,000
Prepaid expenses	1,172,000		605,000
Other current assets	132,000		126,000
Current assets of discontinued operations	92,000		356,000
Total current assets	7,777,000		5,680,000
Cash and marketable securities held in Trust Account (See Notes 2 and 5)	116,732,000		—
Fixed assets, net	2,992,000		2,784,000
ROU operating lease	7,225,000		—
Note receivable, net	4,004,000		4,004,000
Deposits – workers’ compensation	91,000		386,000
Deposits and other assets	944,000		944,000
Deferred offering costs – SPACs (See Note 5)	—		48,261,000
Non-current assets of discontinued operations	232,000		883,000
Total assets	$	139,997,000	$	62,942,000
LIABILITIES AND EQUITY (DEFICIT)
Current liabilities
Accounts payable and other accrued liabilities	$	9,618,000	$	6,553,000
Payroll related liabilities	11,173,000		7,876,000
Accrued workers’ compensation costs	597,000		663,000
Current liabilities of discontinued operations	1,291,000		1,516,000
Total current liabilities	22,679,000		16,608,000
Non-current liabilities
Operating lease liability, non-current	6,834,000		—
Accrued workers’ compensation costs	1,260,000		1,646,000
Non-current liabilities of discontinued operations	3,226,000		3,765,000
Total liabilities	33,999,000		22,019,000
Commitments and contingencies
Class A common shares subject to possible redemption 11,500,000 and no shares at $10.00 per share redemption value as of February 28, 2022 and August 31, 2021 (See Notes 2 and 5)	116,725,000		—
Stockholders’ equity (deficit)
Preferred stock, 50,000,000 authorized shares; $0.0001 par value	—		—
Common stock, 750,000,000 authorized shares; $0.0001 par value; 33,661,552 and 25,863,099 shares issued as of February 28, 2022 and August 31, 2021	3,000		3,000
Additional paid-in capital	146,716,000		142,786,000
Accumulated deficit	(166,940,000)		(149,338,000)
Total ShiftPixy, Inc Stockholders' deficit	(20,221,000)		(6,549,000)
Non-controlling interest in consolidated subsidiaries (See Note 5)	$	9,494,000	$	47,472,000
Total Equity (Deficit)	$	(10,727,000)	$	40,923,000
Total liabilities and equity deficit	$	139,997,000	$	62,942,000

See accompanying notes to the unaudited interim condensed consolidated financial statements.

2

ShiftPixy Inc. 

Condensed Consolidated Statements of Operations 

(Unaudited)

	For the Three Months Ended				For the Six Months Ended
	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
Revenues (See Note 2)	$	10,437,000	$	2,419,000	$	19,378,000	$	4,922,000
Cost of revenue	10,498,000		2,056,000		18,743,000		4,046,000
Gross profit  (loss)	(61,000)		363,000		635,000		876,000
Operating expenses:
Salaries, wages, and payroll taxes	3,653,000		2,592,000		7,543,000		4,785,000
Stock-based compensation – general and administrative	339,000		423,000		747,000		919,000
Commissions	28,000		49,000		56,000		87,000
Professional fees	1,677,000		1,006,000		3,414,000		1,713,000
Software development	1,073,000		786,000		2,234,000		1,663,000
Depreciation and amortization	130,000		86,000		253,000		148,000
General and administrative	2,014,000		1,380,000		3,946,000		3,139,000
Total operating expenses	8,915,000		6,322,000		18,193,000		12,454,000
Operating Loss	(8,976,000)		(5,959,000)		(17,558,000)		(11,578,000)
Other (expense) income:
Interest expense	(1,000)		(3,000)		(2,000)		(6,000)
Other income	13,000		—		16,000		—
Expensed SPAC offering costs	(515,000)		—		(515,000)		—
Total other expense	(503,000)		(3,000)		(501,000)		(6,000)
Loss from continuing operations	(9,479,000)		(5,962,000)		(18,059,000)		(11,584,000)
Total (loss) income from discontinued operations, net of tax	(18,000)		(221,000)		(151,000)		(1,535,000)
Net loss attributable to Shiftpixy Inc. shareholders	$	(9,497,000)	$	(6,183,000)	$	(18,210,000)	$	(13,119,000)
Deemed dividend from change in fair value from warrants modification	(7,731,000)		—		(7,731,000)		—
Net loss attributable to common shareholders	$	(17,228,000)	$	(6,183,000)	$	(25,941,000)	$	(13,119,000)
Net loss  per share, Basic and diluted
Continuing operations	$	(0.55)	$	(0.18)	$	(0.77)	($ 0.36)
Discontinued operations	—		(0.01)		—		(0.05)
Net  loss per common share – Basic and diluted	$	(0.55)	$	(0.19)	$	(0.77)	($ 0.41)
Weighted average common shares outstanding – Basic and diluted	31,215,495		32,746,660		33,593,393		31,772,050

See accompanying notes to the unaudited interim condensed consolidated financial statements.

3

ShiftPixy Inc. 

Condensed Consolidated Statements of Equity (Deficit) 

For the Six Months Ended February 28, 2022

(Unaudited)

	Preferred Stock Issued			Common Stock Issued			Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ Deficit ShiftPixy, Inc		Noncontrolling interest		Total Equity (Deficit)
	Shares	Amount		Shares	Amount
Balance, September 1, 2021	—	$	—	25,863,099	$	3,000	$	142,786,000	$	(149,338,000)	$	(6,549,000)	$	47,472,000	$	40,923,000
Cumulative effect adjustment for ASC 842 lease accounting adoption	—	—		—	—		—		608,000		608,000		—		$	608,000
Common stock issued for private placement, net of offering cost	—	—		2,850,000	—		4,183,000		—		4,183,000		—		$	4,183,000
Common stock issued on exercised warrants, net of offering costs	—	—		4,948,453	—		5,409,000		—		5,409,000		—		$	5,409,000
Prefunded warrants from private placement, net of offering costs	—	—		—	—		6,861,000		—		6,861,000		—		$	6,861,000
Stock-based compensation expense	—	—		—	—		747,000		—		747,000		—		$	747,000
Excess of proceeds from the sale of private placement warrants to Sponsor	—	—		—	—		(13,270,000)		—		(13,270,000)		—		$	(13,270,000)
Withdrawal of SPAC registrations under Form S-1	—	—		—	—						—		(37,978,000)		$	(37,978,000)
Net Loss	—	—		—	—		—		(18,210,000)		(18,210,000)				$	(18,210,000)
Balance, February 28, 2022	—	$	—	33,661,552	$	3,000	$	146,716,000	$	(166,940,000)	$	(20,221,000)	$	9,494,000	$	(10,727,000)

ShiftPixy Inc.

Condensed Consolidated Statements of Equity (Deficit) 

For the Three Months Ended February 28, 2022

(Unaudited)

	Preferred Stock Issued			Common Stock Issued			Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ Deficit ShiftPixy, Inc		Noncontrolling interest		Total Equity (Deficit)
	Shares	Amount		Shares	Amount
Balance, December 1, 2021	—	$	—	28,713,099	$	3,000	$	140,968,000	$	(158,051,000)	$	(17,080,000)	$	47,472,000	$	30,392,000
Cumulative effect adjustment for ASC 842 lease accounting adoption	—	—		—	—		—		608,000		$	608,000	—		$	608,000
Common stock issued on exercised warrants, net of offering costs	—	—		4,948,453	—		5,409,000		—		$	5,409,000	—		$	5,409,000
Stock-based compensation expense	—	—		—	—		339,000		—		339,000		—		$	339,000
Withdrawal of SPAC registrations under Form S-1	—	—		—	—		—		—		—		$	(37,978,000)	$	(37,978,000)
Net Loss	—	—		—	—		—		(9,497,000)		(9,497,000)		—		$	(9,497,000)
Balance, February 28, 2022	—	$	—	33,661,552	$	3,000	$	146,716,000	$	(166,940,000)	$	(20,221,000)	$	9,494,000	$	(10,727,000)

See accompanying notes to the unaudited interim condensed consolidated financial statements.

4

ShiftPixy Inc. 

Condensed Consolidated Statements of Equity (Deficit) 

For the Six Months Ended February 28, 2021

(Unaudited)

	Preferred Stock Issued			Common Stock Issued			Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ Equity (Deficit)
	Shares	Amount		Shares	Amount
Balance, September 1, 2020	—	$	—	16,902,146	$	2,000	$	119,430,000	$	(119,462,000)	$	(30,000)
Common stock issued for private placement, net of offering costs	—	—		4,000,000	—		10,701,000		—		10,701,000
Stock-based compensation expense	—	—		—	—		863,000		—		863,000
Preferred stock issued for preferred option exercised	12,500	—		—	—		—		—		—
Common stock issued on preferred stock conversion	(12,500)	—		12,500	—		—		—		—
Net Loss	—	—		—	—		—		(13,119,000)		(13,119,000)
Balance, February 28, 2021	—	$	—	20,914,646	$	2,000	$	130,994,000	$	(132,581,000)	$	(1,585,000)

ShiftPixy Inc.

Condensed Consolidated Statements of Equity (Deficit) 

For the Three Months Ended February 28, 2021

(Unaudited)

	Preferred Stock Issued			Common Stock Issued			Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ Equity (Deficit)
	Shares	Amount		Shares	Amount
Balance, December 1, 2020	—	$	—	20,902,146	$	2,000	$	130,552,000	$	(126,398,000)	$	4,156,000
Common stock issued for private placement, net of offering costs	—	—		—	—		—		—		—
Stock-based compensation expense	—	—		—	—		442,000		—		442,000
Preferred stock issued for preferred option exercised	12,500	—		—	—		—		—		—
Common stock issued on preferred stock conversion	(12,500)			12,500	—		—		—		—
Net Loss	—	—		—	—		—		(6,183,000)		(6,183,000)
Balance, February 28, 2021	—	$	—	20,914,646	$	2,000	$	130,994,000	$	(132,581,000)	$	(1,585,000)

See accompanying notes to the unaudited interim condensed consolidated financial statements.

5

ShiftPixy, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	For the Six Months Ended
	February 28, 2022		February 28, 2021
OPERATING ACTIVITIES
Net loss	$	(18,210,000)	($ 13,119,000)
Loss from discontinued operations	(151,000)		(1,535,000)
Net loss from continuing operations	(18,059,000)		(11,584,000)
Adjustments to reconcile net loss from continuing operations to net cash used in continuing operating activities:
Depreciation and amortization	253,000		148,000
Stock-based compensation	747,000		863,000
Expensed SPAC offering costs	515,000		—
Non-cash lease expense	217,000		—
Changes in operating assets and liabilities:
Accounts receivable	117,000		(108,000)
Unbilled accounts receivable	126,000		261,000
Prepaid expenses and other current assets	(573,000)		(163,000)
Deposits – workers’ compensation	414,000		150,000
Deposits and other assets	—		(458,000)
Accounts payable and other accrued liabilities	3,065,000		421,000
Payroll related liabilities	3,297,000		1,243,000
Accrued workers’ compensation costs	(452,000)		(11,000)
Total Adjustments	7,726,000		2,346,000
Net cash used in continuing operating activities	(10,333,000)		(9,238,000)
Net cash used in discontinued operating activities	—		(1,192,000)
Net cash used in operating activities	(10,333,000)		(10,430,000)
INVESTING ACTIVITIES
Investment of IHC IPO proceeds into Trust Account	(116,732,000)		—
Purchase of fixed assets	(461,000)		(1,095,000)
Disposal of fixed assets	—		—
Net cash (used in) provided by investing activities	(117,193,000)		(1,095,000)
FINANCING ACTIVITIES
SPAC related offering costs paid	(3,502,000)		—
Proceeds from initial public offering of IHC	116,725,000		—
Proceeds from exercised warrants, net of offering costs	5,409,000		10,701,000
Proceeds from private placement, net of offering costs	4,183,000		—
Proceeds from private placement prefunded warrants, net of offering costs	6,861,000		—
Net cash provided by financing activities	129,676,000		10,701,000
Net increase in cash	2,150,000		(824,000)
Cash - Beginning of Period	1,199,000		4,303,000
Cash -End of Period	$	3,349,000	$	3,479,000
Supplemental Disclosure of Cash Flows Information:
Cash paid for interest	$	2,000	$	6,000
Cash paid for income taxes	—		—
Non-cash Investing and Financing Activities:
Deferred offering costs SPACs	$	37,978,000	$	—
Change in fair value due to warrants modification	13,728,000		$	—
Operating lease assets and liabilities from ASC 842 adoption	$	7,687,000

See accompanying notes to the unaudited interim condensed consolidated financial statements.

6

ShiftPixy, Inc. 

Notes to the Condensed Consolidated Financial Statements 

(Unaudited)

Note 1: Nature of Operations

ShiftPixy, Inc. was incorporated on June 3, 2015, in the State of Wyoming. The Company is a specialized Human Capital service provider that provides solutions for large contingent part-time workforce demands, primarily in the restaurant and hospitality service trades. The Company’s historic focus has been on the quick service restaurant industry in Southern California, but has begun to expand into other geographic areas and industries employing temporary or part-time labor sources.

The Company functions as an employment administrative services (“EAS”) provider primarily through its wholly-owned subsidiary, ReThink Human Capital Management, Inc. (“HCM”), as well as a staffing provider through another of its wholly-owned subsidiaries, ShiftPixy Staffing, Inc (“Staffing”). These subsidiaries provide a variety of services to our clients, (as a co-employer through HCM and a direct employer through Staffing), including the following: administrative services, payroll processing, human resources consulting, and workers’ compensation administration and coverage (as permitted and/or required by state law). The Company has built a human resources information systems (“HRIS”) platform to assist in customer acquisition that simplifies the onboarding of new clients into the Company’s closed proprietary operating and processing information system (the “ShiftPixy Ecosystem”). This HRIS platform is expected to facilitate additional value-added services in future reporting periods.

In January 2020, the Company sold the assets of Shift Human Capital Management Inc. (“SHCM”), a wholly-owned subsidiary of the Company, pursuant to which it assigned the majority of the Company’s billable clients at the time of the sale to a third party for cash. The continuing impact of this transaction on the Company’s financial statements is described below in Note 3, Discontinued Operations.

Note 2: Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim reports of companies filing as a small reporting company. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results of operations for the three and six months ended February 28, 2022 are not necessarily indicative of the results that may be expected for the full year ending August 31, 2022.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K and 10-K/A for the fiscal year ended August 31, 2021 (“Fiscal 2021”), filed with the SEC on December 3, 2021 and February 28, 2022, respectively.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of ShiftPixy Inc, and its wholly-owned subsidiaries. The condensed consolidated financial statements also include the accounts of (a) Industrial Human Capital, Inc. ("IHC"), which is a special purpose acquisition company, or "SPAC", for which we serve as the financial sponsor (as described below), and which is deemed to be controlled by us as a result of our 15% equity ownership stake, the overlap of three of our executive officers as executive officers of IHC, and significant influence that we currently exercise over the funding and acquisition of new operations for an initial business combination ("IBC"). (See Note 2, Variable Interest Entity). All intercompany balances have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:

•Liability for legal contingencies;

7

•Useful lives of property and equipment;

•Deferred income taxes and related valuation allowance;

•Valuation of illiquid non-controlling interest in SPAC shares transferred;

•Valuation of long-lived assets including long term notes receivable prior to January 1, 2021; and

•Projected development of workers’ compensation claims.

Revenue and Direct Cost Recognition

For the year ended August 31, 2021 ("Fiscal 2021"), we adopted Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), using the modified retrospective approach. Under this method, the guidance is applied only to the most current period presented in the financial statements. ASU No. 2014-09 outlines a single comprehensive revenue recognition model for revenue arising from contracts with customers and superseded most of the previous revenue recognition guidance, including industry-specific guidance. Under ASU No. 2014-09, an entity recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. Our revenue recognition policies remained substantially unchanged as a result of the adoption of ASU No. 2014-09 and we did not have any significant changes in our business processes or systems.

The Company’s revenues are primarily disaggregated into fees for providing staffing solutions and EAS/HCM services. The Company enters into contracts with its clients for Staffing or EAS based on a stated rate and price in the contract. Contracts generally have a term of 12 months but are cancellable at any time by either party with 30 days’ written notice. The performance obligations in the agreements are generally combined into one performance obligation, as they are considered a series of distinct services, and are satisfied over time because the client simultaneously receives and consumes the benefits provided as the Company performs the services. Payments for the Company’s services are typically made in advance of, or at the time that the services are provided. The Company does not have significant financing components or significant payment terms for its customers and consequently has no material credit losses. The Company uses the output method based on a stated rate and price over the payroll processed to recognize revenue, as the value to the client of the goods or services transferred to date appropriately depicts our performance towards complete satisfaction of the performance obligation.

Staffing Solutions

The Company records gross billings as revenues for its staffing solutions clients. The Company is primarily responsible for fulfilling the staffing solutions services and has discretion in establishing price. The Company includes the payroll costs in revenues with a corresponding increase to cost of revenues for payroll costs associated with these services. As a result, we are the principal in this arrangement for revenue recognition purposes. For the three months ended February 28, 2021, the Company recognized no revenues that should have been evaluated under a staffing solutions model.

EAS Solutions

EAS solutions revenue is primarily derived from the Company’s gross billings, which are based on (i) the payroll cost of the Company’s worksite employees (“WSEs”) and (ii) a mark-up computed as a percentage of payroll costs for payroll taxes and workers’ compensation premiums.

Gross billings are invoiced to each EAS client concurrently with each periodic payroll of the Company’s WSEs, which coincides with the services provided and which is typically a fixed percentage of the payroll processed. Revenues, which exclude the payroll cost component of gross billings and therefore consist solely of markup, are recognized ratably over the payroll period as WSEs perform their services at the client worksite. Although the Company assumes responsibility for processing and remitting payroll and payroll related obligations, it does not assume employment-related responsibilities such as determining the amount of the payroll and related payroll obligations. As a result, the Company records revenue on a “net” basis in this arrangement for revenue recognition purposes. Revenues that have been recognized but not invoiced for EAS clients are included in unbilled accounts receivable on the Company’s consolidated balance sheets, and were $2,615,000 and $2,741,000, as of February 28, 2022 and August 31, 2021, respectively.

Consistent with the Company’s revenue recognition policy for EAS clients, direct costs do not include the payroll cost of its WSEs. The cost of revenue associated with the Company’s revenue generating activities is primarily comprised of all other

8

costs related to its WSEs, such as the employer portion of payroll-related taxes, employee benefit plan premiums and workers’ compensation insurance costs.

The fees collected from the worksite employers for benefits (i.e. zero-margin benefits pass-through), workers’ compensation and state unemployment taxes are presented in revenues and the associated costs of benefits, workers’ compensation and state unemployment taxes are included in operating expenses for EAS clients, as the Company does retain risk and acts as a principal with respect to this aspect of the arrangement. With respect to these fees, the Company is primarily responsible for fulfilling the service and has discretion in establishing price.

Disaggregation of Revenue

The Company’s primary revenue streams include HCM and staffing services. The Company’s disaggregated revenues for the three and six months ended February 28, 2022 and February 28, 2021 were as follows:

	For the Three Months Ended				For the Six Months Ended
Revenue (in millions):	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
HCM1	$	1.6	2.4		$	3.3	4.9
Staffing	8.8		—		16.1		—
	$	10.4	$	2.4	$	19.4	$	4.9

1 HCM revenue is presented net, $12.6 million and $25.5 million gross billings less WSE payroll costs of $11.0 million and $22.2 million for the three and six months ended February 28, 2022, respectively and $17.9 million and $37.6 million gross less WSE payroll cost of $15.5 and $32.7 million for the three and six months ended February 28, 2021, respectively.

During Fiscal 2021 the Company announced the launch of ShiftPixy Labs. We generated no revenue from this initiative during the three or six months ended February 28, 2022.

For the three and six months ended February 28, 2022 and February 28, 2021, the following geographical regions represented more than 10% of total revenues:

	For the Three Months Ended				For the Six Months Ended
Region:	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
California	53	%	67	%	54	%	68	%
Washington	13	%	10	%	13	%	10	%

Incremental Cost of Obtaining a Contract

Pursuant to the “practical expedients” provided under ASU No 2014-09, the Company expenses sales commissions when incurred because the terms of its contracts are cancellable by either party upon 30 days' notice. These costs are recorded in commissions in the Company’s Consolidated Statements of Operations.

Segment Reporting

Prior to Fiscal 2021, the Company operated as one reportable segment under ASC 280, Segment Reporting. The chief operating decision maker regularly reviews the financial information of the Company at a consolidated level in deciding how to allocate resources and in assessing performance. During Fiscal 2021, the Company entered into new business lines and geographic areas that, to date, are not material. However, with the migration to Staffing during the fiscal quarter ending May 31, 2021, the Company is beginning to manage the business on a segmented basis and therefore intends to report such information once systems and processes are updated accordingly. Reporting and monitoring activities on a segment basis will allow the chief operating decision maker to evaluate operating performance more effectively. See also Disaggregation of Revenue, above.

9

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased as cash equivalents. The Company had no such investments as of February 28, 2022 or August 31, 2021.

Marketable Securities Held in Trust Account

At February 28, 2022, substantially all of the assets held in the Trust Account were invested in U.S. Treasury securities with maturities of 180 days or less. These funds are restricted for use and may only be used for purposes of completing an IBC or redemption of the public common shares of IHC.

Concentration of Credit Risk

The Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of February 28, 2022, there was $3,507,000 of cash on deposit in excess of the amounts insured by the FDIC.

No individual clients represented more than 10% of revenues for the three and six months ended February 28, 2022. However, four clients represented 100% of total accounts receivable as of February 28, 2022.

Fixed Assets

Fixed assets are recorded at cost, less accumulated depreciation and amortization. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When fixed assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Leasehold improvements are amortized over the shorter of the useful life or the initial lease term.

Fixed assets are recorded at cost and are depreciated over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives of property and equipment for purposes of computing depreciation are as follows:

Equipment:	5 years
Furnitures & Fixtures:	5 - 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

The amortization of these assets is included in depreciation expense on the condensed consolidated statements of operations.

Internal Use Software

Software development costs relate primarily to software coding, systems interfaces and testing of the Company’s proprietary employer information systems and are accounted for in accordance with ASC 350-40, Internal Use Software.

Internal software development costs are capitalized from the time the internal use software is considered probable of completion until the software is ready for use. Business analysis, system evaluation and software maintenance costs are expensed as incurred. The capitalized computer software development costs are reported under the section fixed assets, net in the condensed consolidated balance sheets.

The Company determined that there were no material capitalized internal software development costs for the three and six months ended February 28, 2022. All capitalized software recorded was purchased from third party vendors. Capitalized software development costs are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company incurred research and development costs for the three and six months ended February 28, 2022 and February 28, 2021, of approximately $1.9 and $3.9 million and $1.4 and $2.8 million, respectively. All costs were related to internally developed or externally contracted software and related technology for the Company’s HRIS platform and related mobile application. In addition, no software costs were capitalized for the three months ended February 28, 2022 and February 28, 2021, respectively.

10

Lease Recognition

In February 2016, the FASB established Topic 842, Leases, by issuing ASU No. 2016-02 (“ASC 842”), which required lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The standard established a right-of-use model (“ROU”) that required a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the Condensed Statement of Operations.

The Company adopted the standard on December 1, 2021 with an effective date of September 1, 2021. A modified retrospective transition approach was required, applying the standard to all leases existing at the date of initial application. An entity could choose to use either (1) the effective date of the standard or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chose the second option, the transition requirements for existing leases also applied to leases entered into between the date of initial application and the effective date. The entity had to also recast its comparative period financial statements and provide the disclosures required by the standard for the comparative periods. The Company elected to use the effective date as its date of initial application. Consequently, financial information was not updated and the disclosures required under the standard were not provided for dates and periods prior to September 1, 2021.

The standard provided a number of optional practical expedients as part of transition accounting. The Company elected the “package of practical expedients”, which allowed the Company to avoid reassessing its prior conclusions about lease identification, lease classification and initial direct costs under the standard. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements as these were not applicable to the Company.

The standard had a material effect on the Company’s Condensed Consolidated Financial Statements. The most significant changes related to (1) the recognition of ROU assets and lease liabilities on the Condensed Consolidated Balance Sheet for its office equipment and real estate operating leases and (2) providing significant disclosures about the Company’s leasing activities.

Upon adoption, the Company recognized additional operating liabilities of approximately $7.7 million, with corresponding ROU operating lease asset, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The Company determined if an arrangement was a lease at inception. The Company used an incremental borrowing rate based on the information available at the commencement date of the lease to determine the present value of lease payments. In determining the ROU asset and lease liability at lease inception, the lease terms could include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

The standard also provided practical expedients for an entity’s ongoing accounting for leases. The Company elected the short-term lease recognition exemption for office equipment leases. For those current and prospective leases that qualify as short-term, the Company will not recognize ROU assets or lease liabilities. The Company also elected the practical expedient to not separate lease and non-lease components for all of its real estate leases.

Impairment and Disposal of Long-Lived Assets

The Company periodically evaluates its long-lived assets for impairment in accordance with ASC 360-10, Property, Plant, and Equipment. ASC 360-10 requires that an impairment loss be recognized for assets to be disposed of or held-for-use when the carrying amount of an asset is deemed not to be recoverable. If events or circumstances were to indicate that any of our long-lived assets might be impaired, the Company would assess recoverability based on the estimated undiscounted future cash flows to be generated from the applicable asset. In addition, the Company may record an impairment loss to the extent that the carrying value of the asset exceeds the fair value of the asset. Fair value is generally determined using an estimate of discounted future net cash flows from operating activities or upon disposal of the asset. There were no indicators noted of impairments during the periods ended February 28, 2022 or February 28, 2021.

11

Workers’ Compensation

Everest Program

Until July 2018, a portion of the Company’s workers’ compensation risk was covered by a retrospective rated policy, which calculates the final policy premium based on the Company’s loss experience during the term of the policy and the stipulated formula set forth in the policy. The Company funds the policy premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. During the policy term and thereafter, periodic adjustments may involve either a return of previously paid premiums or a payment of additional premiums by the Company or a combination of both. If the Company’s losses exceed the expected losses under that policy, then the Company could receive a demand for additional premium payments. The Company is currently engaged in litigation regarding such a demand for additional premium payments, which we believe to be without merit, as discussed at Note 11, Contingencies, Everest Litigation, below.

Sunz Program

From July 2018 through February 28, 2021, the Company’s workers’ compensation program for its WSEs was provided primarily through an arrangement with United Wisconsin Insurance Company and administered by Sunz Insurance Solutions, LLC (“Sunz”). Under this program, the Company has financial responsibility for the first $0.5 million of claims per occurrence. The Company provides and maintains a loss fund that is earmarked to pay claims and claims related expenses. The workers’ compensation insurance carrier establishes monthly funding requirements comprised of premium costs and funds to be set aside for payment of future claims (“claim loss funds”). The level of claim loss funds is primarily based upon anticipated WSE payroll levels and expected workers’ compensation loss rates, as determined by the insurance carrier. Monies funded into the program for incurred claims expected to be paid within one year are recorded as Deposit - workers’ compensation, a short-term asset, while the remainder of claim funds are included in Deposit- workers’ compensation, a long-term asset in its consolidated balance sheets. The Company is currently engaged in litigation regarding demands by Sunz for additional claims loss funds, which we believe to be without merit, as discussed at Note 11, Contingencies, Sunz Litigation, below.

Current Program

Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program. Under this program, the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria.

Under the Everest and Sunz programs, the Company utilized a third party to estimate its loss development rate, which was based primarily upon the nature of WSEs’ job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates.

As of February 28, 2022 and August 31, 2021, the Company had $0.04 million and $0.2 million, in Deposit – workers’ compensation classified as a short-term asset and $0.1 million and $0.4 million, classified as a long-term asset, respectively.

The Company’s estimate of incurred claim costs expected to be paid within one year is included in short-term liabilities, while its estimate of incurred claim costs expected to be paid beyond one year is included in long-term liabilities on its consolidated balance sheets. As of February 28, 2022 and August 31, 2021, the Company had short term accrued workers’ compensation costs of $0.6 million and $0.7 million, and long term accrued workers’ compensation costs of $1.3 million and $1.6 million, respectively.

The Company retained workers’ compensation asset reserves and workers’ compensation related liabilities for former WSEs of clients transferred to Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure Employer Services, Inc. (“Vensure”), in connection with the Vensure Asset Sale described in Note 3, Discontinued Operations, below. As of February 28, 2022, the retained workers’ compensation assets and liabilities are presented as a discontinued operation net asset or liability. As of February 28, 2022, the Company had $0.1 million in short term assets and $1.3 million of short term liabilities, and had $0.2 million of long term assets and $3.2 million of long term liabilities.

Because the Company bears the financial responsibility for claims up to the level noted above, such claims, which are the primary component of its workers’ compensation costs, are recorded in the period incurred. Workers’ compensation insurance

12

includes ongoing health care and indemnity coverage whereby claims are paid over numerous years following the date of injury. Accordingly, the accrual of related incurred costs in each reporting period includes estimates, which take into account the ongoing development of claims and therefore requires a significant level of judgment. In estimating ultimate loss rates, the Company utilizes historical loss experience, exposure data, and actuarial judgment, together with a range of inputs that are primarily based upon the WSE’s job responsibilities, their location, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. For each reporting period, changes in the actuarial assumptions resulting from changes in actual claims experience and other trends are incorporated into the Company’s workers’ compensation claims cost estimates. The estimated incurred claims are based upon: (i) the level of claims processed during each quarter; (ii) estimated completion rates based upon recent claim development patterns under the plan; and (iii) the number of participants in the plan.

The Company has had very limited and immaterial COVID-19 related claims between March 2020 through the date of this Quarterly Report, although there is a possibility of additional workers’ compensation claims being made by furloughed WSEs as a result of the employment downturn caused by the pandemic. On May 4, 2020, the State of California indicated that workers who become ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. There is a possibility that additional workers’ compensation claims could be made by employees required to work by their employers during the COVID-19 pandemic, which could have a material impact on our workers’ compensation liability estimates. While the Company has not seen significant additional expenses as a result of any such potential claims to date, which would include claims for reporting periods after February 28, 2022, we continue to monitor closely all workers’ compensation claims made as the COVID-19 pandemic continues.

Fair Value of Financial Instruments

ASC 820, Fair Value Measurement, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practical to estimate fair value. ASC 820 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. At February 28, 2022 and August 31, 2021, the carrying value of certain financial instruments (cash, accounts receivable and payable) approximated fair value due to the short-term nature of the instruments. Notes Receivable is valued at estimated fair value as described below.

The Company measures fair value under a framework that utilizes a hierarchy prioritizing the inputs to relevant valuation techniques. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used in measuring fair value are:

•Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

•Level 2: Inputs to the valuation methodology include:

◦Quoted prices for similar assets or liabilities in active markets;

◦Quoted prices for identical or similar assets or liabilities in inactive markets;

◦Inputs other than quoted prices that are observable for the asset or liability;

◦Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

◦If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

•Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

Funds held in trust represent U.S. treasury bills that were purchased with funds raised through the initial public offering of IHC. The funds raised from SPACs are held in trust accounts that are restricted for use and may only be used for purposes of completing an IBC or redemption of the public shares of common stock of the SPACs as set forth in their respective trust agreements. The funds held in trust are included within Level 1 of the fair value hierarchy and included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheets.

13

The Company did not have other Level 1 or Level 2 assets or liabilities at February 28, 2022 or August 31, 2021. We recorded the fair value of the SPAC founder shares that the Company transferred to the underwriters using non-recurring Level 3 assumptions, including quoted asset prices for SPAC shares and warrants and estimates of the likelihood of the IPOs and IBCs of our sponsored SPACs being consummated. See also Note 5, Deferred Offering Costs – SPACS, below.

The valuation of the Note Receivable from the Vensure Asset Sale (as defined below), is a Level 3 fair value measurement as of August 31, 2020 and through December 31, 2020 (end of the earn-out period as defined under the terms of the Note Receivable).

The Note Receivable, as described in Note 3, Discontinued Operations, below, was estimated using a discounted cash flow technique based on expected contingent payments identified in the Vensure Asset Sale contract and with significant inputs that are not observable in the market and thus represents a Level 3 fair value measurement as defined in ASC 820. The Company valued the Note Receivable on the January 1, 2020 transaction date using a 10% discount rate, and on August 31, 2020 and through December 31, 2020 using a 15% discount rate, which contemplates the risk and probability assessments of the expected future cash flows. The significant inputs in the Level 3 measurement not supported by market activity include the probability assessments of expected future cash flows related to the Vensure Asset Sale, appropriately discounted considering the

uncertainties associated with the obligation, and as calculated in accordance with the terms of the Vensure Asset Sale agreement. For our fiscal year ended August 31, 2020 ("Fiscal 2020"), the expected cash payments from the Note Receivable were based on estimated gross wages billed for the clients transferred to Vensure pursuant to the Vensure Asset Sale as of the measurement date.

The Company used the following assumptions to value the Note Receivable as of August 31, 2020:

•Discount rate of 15%

•Actual monthly wages billed to the extent available to the Company

For interim reporting periods after December 31, 2020, including as of February 28, 2022 and August 31, 2021, the Company valued the Note Receivable as discussed in Note 3, Discontinued Operations, below.

The development and determination of the unobservable inputs for Level 3 fair value measurements and the fair value calculations are the responsibility of the Company’s chief financial officer and are approved by the chief executive officer. There were no transfers out of Level 3 for the three or six months ended February 28, 2022.

Advertising Costs

The Company expenses all advertising as incurred. The Company incurred advertising costs totaling $435,000 and $897,000 for the three and six months ended February 28, 2022 and $719,000 and $921,000 for the three and six months ended February 28, 2021, respectively.

Income Taxes

The Company accounts for income taxes pursuant to ASC 740, Income Taxes. Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority.

Earnings (Loss) Per Share

The Company utilizes ASC 260, Earnings per Share. Basic Net Income (Net Loss) per common share is computed by dividing Net Income (Net Loss) attributable to common shareholders by the weighted-average number of shares of common stock outstanding during the reporting period. Common stock outstanding for purposes of Net Income (Net Loss) per share calculations include unexercised Preferred Options and unexercised prefunded warrants, as described in Note 7, Stockholders' Equity, below. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the

14

denominator is increased to include additional common stock equivalents available upon exercise of stock options and warrants using the treasury stock method. Dilutive common stock equivalents include the dilutive effect of in-the-money stock equivalents, which are calculated based on the average share price for each period using the treasury stock method, excluding any common stock equivalents if their effect would be anti-dilutive. In periods in which a net loss has been incurred, all potentially dilutive common stock shares are considered anti-dilutive and thus are excluded from the calculation. Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

	For the Three Months Ended		For the Six Months Ended
	February 28, 2022	February 28, 2021	February 28, 2022	February 28, 2021
Options (See Note 8)	1,769,497	1,822,173	1,769,497	1,822,173
Warrants (See Note 7)	27,113,736	4,396,209	22,440,225	4,396,209
Total potentially dilutive shares	28,883,233	6,218,382	28,883,233	6,218,382

For the table above, “Options” represent all options granted under the Company’s 2017 Stock Option/Stock Issuance Plan (the "Plan"), as described in Note 8, Stock Based Compensation, below.

Stock-Based Compensation

At February 28, 2022, the Company had one stock-based compensation plan under which the Company may issue awards, as described in Note 8, Stock Based Compensation, below. The Company accounts for the Plan under the recognition and measurement principles of ASC 718, Compensation- Stock Compensation, which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the condensed consolidated statements of operations at their fair values.

The grant date fair value is determined using the Black-Scholes-Merton (“Black-Scholes”) pricing model. For all employee stock options, the Company recognizes expense on an accelerated basis over the employee’s requisite service period (generally the vesting period of the equity grant).

The Company’s option pricing model requires the input of highly subjective assumptions, including the expected stock price volatility and expected term. The expected volatility is based on the historical volatility of the Company’s common stock since our initial public offering. Any changes in these highly subjective assumptions significantly impact stock-based compensation expense.

The Company elects to account for forfeitures as they occur. As such, compensation cost previously recognized for an unvested award that is forfeited because of the failure to satisfy a service condition is revised in the period of forfeiture.

The methods and assumptions used in the determination of the fair value of stock-based awards are consistent with those described in the Company's Annual Report on Form 10-K and 10-K/A for Fiscal 2021, filed with the SEC on December 3, 2021 and on February 28, 2022, respectively, which includes a detailed description of the Company's stock-based compensation awards, including information related to vesting terms, service and performance conditions, payout percentages, and process for estimating the fair value of stock options granted.

Recent Accounting Standards

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This standard requires an impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces multiple existing impairment models in current U.S. GAAP, which generally requires a loss to be incurred before it is recognized. The new standard applies to trade receivables arising from revenue transactions such as contract assets and accounts receivable. Under ASC 606, revenue is recognized when, among other criteria, it is probable that an entity will collect the consideration it is entitled to when goods or services are transferred to a customer. When trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. This guidance is effective for smaller reporting companies for annual periods beginning after December 15, 2022, including the interim periods in the year. Early adoption is permitted. The Company will adopt the guidance when it becomes effective.

15

On December 31, 2019, the FASB issued ASC 2019-12 “Income Taxes: Simplifying the Accounting for Income Taxes” (“Topic 740”). The amendments in this update simplify the accounting for income taxes by removing certain exceptions. For public business entities, the amendments in this update are effective for fiscal years, and interim periods

within those fiscal years, beginning after December 15, 2020. Early adoption of the amendments is permitted, including adoption in any interim period for (1) public business entities for periods for which financial statements have not yet been issued and (2) all other entities for periods for which financial statements have not yet been made available for issuance. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The Company will adopt the guidance when it becomes effective.

Variable Interest Entity

The Company is involved in the formation of various entities considered to be Variable Interest Entities (“VIEs”). The Company evaluates the consolidation of these entities as required pursuant to ASC Topic 810 relating to the consolidation of VIEs. These VIEs are primarily formed to sponsor the related SPACs.

The Company’s determination of whether it is the primary beneficiary of VIE is based in part on an assessment of whether or not the Company and its related parties are exposed to the majority of the risks and rewards of the entity. Typically, the Company is entitled to substantially all or portion of the economics of these VIEs. The Company is the primary beneficiary of the VIE entities.

During the six months ended February 28, 2022, our sponsored SPAC, IHC, completed its IPO, selling 11,500,000 units (the "IHC Units") pursuant to a registration statement and prospectus, as described below. The IPO closed on October 22, 2021, raising gross proceeds of $115 million. These proceeds were deposited in a trust account established for the benefit of the IHC public shareholders and, along with an additional $1.675 million deposited in trust by the Company reserved for interest payments for future possible redemptions by IHC stockholders, are included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheet at February 28, 2022. These proceeds are invested only in U.S. treasury securities in accordance with the governing documents of IHC.

Each IHC Unit had an offering price of $10.00 and consisted of one share of IHC common stock and one redeemable warrant. Each warrant entitles the holder thereof to purchase one share of IHC common stock at a price of $11.50 per share. The IHC public stockholders have a right to redeem all or a portion of their shares of IHC common stock upon the completion of its IBC, subject to certain limitations. Under the terms of the registration statement and prospectus, IHC is required to consummate its IBC within 12 months of the completion of the IPO. If IHC is unable to meet this deadline, and no extension is granted, then IHC will redeem 100% of the public shares of common stock outstanding for cash, subject to applicable law and certain conditions.

In connection with the IPO, we purchased, through investments, 4,639,102 private placement warrants ("Placement Warrants") at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102, and we currently own 2,110,000 Founder Shares of IHC common stock, representing approximately 15% of the issued and outstanding common stock of IHC. Before the closing of the IPO, the Sponsor transferred 15,000 Founder Shares to IHC's independent directors, reducing its shareholdings from 2,125,000 to 2,110,000. Each Placement Warrant is identical to the warrants sold in the IPO, except as described in the IPO registration statement and prospectus. Following the completion of the IHC IPO, we determined that IHC is a Variable Interest Entity ("VIE") in which we have a variable interest because IHC does not have enough equity at risk to finance its activities without additional subordinated financial support. We have also determined that IHC's public stockholders do not have substantive rights, and their equity interest constitutes temporary equity, outside of permanent equity, in accordance with ASC 480-10-S99-3A. As such, we have concluded that we are currently the primary beneficiary of IHC as a VIE, as we have the right to receive benefits or the obligation to absorb losses of the entity, as well as the power to direct a majority of the activities that significantly impact IHC's economic performance. Since we are the primary beneficiary, IHC is consolidated into our condensed consolidated financial statements.

Shares Subject to Possible Redemption

The Company accounts for its common stock holdings in its sponsored SPACs, (which are consolidated in our condensed consolidated financial statements), that are subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of common stock are classified as shareholders’ equity. Each sponsored SPAC's shares of common stock feature certain

16

redemption rights that are considered to be outside of the SPAC's control and subject to occurrence of uncertain future events. Accordingly, as of February 28, 2022, shares of common stock subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.

The Company recognizes changes in redemption value of these shares immediately as they occur and adjusts the carrying value of redeemable shares of common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of the redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. As of February 28, 2022, the carrying amount of the sponsored SPAC shares of IHC common stock subject to redemption was recorded at their redemption value of $116.7 million. The remeasurement of the redemption value of the redeemable shares of common stock is recorded in equity. The remeasurement in equity comprised of offering cost incurred in connection with the sale of public shares of the SPACs was $13 million, consisting of approximately $9.5 million of offering costs related to the Founder Shares transferred to the SPACs’ underwriter representative as described in Note 5, Deferred Offering Costs, and $3.5 million in other offering costs related to the IPO paid at closing in cash.

Note 3: Discontinued Operations

On January 3, 2020, the Company executed an asset purchase agreement assigning client contracts comprising approximately 88% of its quarterly revenue through the date of the transaction, including 100% of its existing professional employer organization (“PEO”) business effective as of December 31, 2019, and transferring $1.5 million of working capital assets, including cash balances and certain operating assets associated with the assigned client contracts included in the agreement, to a wholly owned subsidiary of Vensure (the “Vensure Asset Sale”). Gross proceeds from the Vensure Asset Sale were $19.2 million, of which $9.7 million was received at closing and $9.5 million was scheduled to be paid out in equal monthly payments over the four years following the closing of the transaction (the “Note Receivable”), subject to adjustments for working capital and customer retention, (as measured by a gross wage guarantee included in the governing agreement), over the twelve month period following the Vensure Asset Sale.

For Fiscal 2020, the Company estimated the value of the Note Receivable at fair value as discussed in Note 2, Summary of Significant Accounting Policies, above. For the three months ended February 28, 2022, the Company recorded the Note Receivable based on our estimate of expected collections which, in turn, was based on additional information obtained through discussions with Vensure and evaluation of our records. On March 12, 2021, the Company received correspondence from Vensure proposing approximately $10.7 million of working capital adjustments under the terms of the Vensure Asset Sale agreement which, if accepted, would have had the impact of eliminating any sums owed to the Company under the Note Receivable. As indicated in the reconciliation table below, the Company has recorded $2.6 million of working capital adjustments, subject to final review and acceptance, and has provided for an additional reserve of $2.9 million for potential claims. By letter dated April 6, 2021, the Company disputed Vensure’s proposed adjustments.The disputes between the Company and Vensure regarding working capital adjustments under the Vensure Asset Sale agreement are currently the subject of litigation pending in the Delaware Chancery Court, as discussed at Note 11, Contingencies, Vensure Litigation, below.

The following is a reconciliation of the gross proceeds to the net proceeds from the Vensure Asset Sale as presented in the balance sheet for the period ended February 28, 2022.

Gross proceeds	$	19,166,000
Cash received at closing – asset sale	(9,500,000)
Cash received at closing – working capital	(166,000)
Gross note receivable	$	9,500,000
Less:  Transaction reconciliation – estimated working capital adjustments	(2,604,000)
Adjusted Note Receivable	6,896,000
Reserve for estimated potential claims	(2,892,000)
Long-term note receivable, estimated net realizable value	$	4,004,000

The entire Note Receivable is recorded as a long term note receivable as of February 28, 2022. Any adjustments to the Note Receivable are applied against payments in the order they are due to be paid.

17

The Vensure Asset Sale generated a gain of $15.6 million for Fiscal 2020. The Company expected a minimal tax impact from the Vensure Asset Sale as it utilized its net operating losses accumulated since inception to offset the gain resulting from discontinued operations tax provision with a corresponding offset to the valuation allowance.

The Vensure Asset Sale met the criteria of discontinued operations set forth in ASC 205 and as such the Company has reclassified its discontinued operations for all periods presented and has excluded the results of its discontinued operations from continuing operations for all periods presented.

The terms of the Vensure Asset Sale call for adjustments to the Note Receivable either for: (i) working capital adjustments or (ii) in the event that the gross wages of the business transferred is less than the required amount.

(i) Working capital adjustments: Through February 28, 2022, the Company has identified $2.6 million of likely working capital adjustments, including $88,000 related to lower net assets transferred at closing, and $2.5 million of cash remitted to the Company’s bank accounts, net of cash remitted to Vensure’s bank accounts. Under the terms of the Vensure Asset Sale, a reconciliation of the working capital was to have been completed by April 15, 2020. Due to operational difficulties and quarantined staff caused by the outbreak of COVID-19, Vensure requested a postponement of the working capital reconciliation that was due in Fiscal 2020. Although Vensure provided the Company with its working capital reconciliation on March 12, 2021, it failed to provide adequate documentation to support its calculations. Accordingly, the working capital adjustment recorded as of February 28, 2022, represents the Company’s estimate of the reconciliation adjustment by using Vensure’s claims and the limited supporting information Vensure provided as a starting point, and then making adjustments for amounts in dispute based upon our internal records and best estimates. There is no assurance that the working capital change identified as of February 28, 2022 represents the final working capital adjustment.

(ii) Gross billings adjustment: Under the terms of the Vensure Asset Sale, the proceeds of the transaction are reduced if the actual gross wages of customers transferred for Calendar 2020 are less than 90% of those customers’ Calendar 2019 gross wages. The Company has prepared an estimate of the Calendar 2020 gross wages based on a combination of factors including reports of actual transferred client billings in early Calendar 2020, actual gross wages of continuing customers of the Company, publicly available unemployment reports for the Southern California markets and the relevant COVID-19 impacts on employment levels, and other information. Based on the information available, the Company estimated that it would receive additional consideration below the required threshold and reduced the contingent consideration by $1.4 million. Vensure has not identified any such adjustments to date. Based on the information available, the Company reclassified the previously recorded gross wages claim to a general potential claims reserve during Fiscal 2021. No additional adjustment was made during the three months ended February 28, 2022.

The carrying amounts of the classes of assets and liabilities from the Vensure Asset Sale included in discontinued operations are as follows:

18

	February 28, 2022		August 31, 2021
Cash	$	—	$	—
Accounts receivable and unbilled account receivable	—		—
Prepaid expenses and other current assets	—		—
Deposits – workers’ compensation	92,000		356,000
Total current assets	92,000		356,000
Fixed assets, net	—		—
Deposits – workers’ compensation	232,000		883,000
Total assets	$	324,000	$	1,239,000
Accounts payable and other current liabilities	$	—	$	—
Payroll related liabilities	—		—
Accrued workers’ compensation cost	—		1,516,000
Total current liabilities	—		1,516,000
Accrued workers’ compensation cost	—		3,765,000
Total liabilities	—		5,281,000
Net liability	$	324,000	$	(4,042,000)

Reported results for the discontinued operations by period were as follows:

	For the Three Months Ended				For the Six Months Ended
	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
Revenues	$	—	$	—	$	—	$	—
Cost of revenue	18,000		221,000		151,000		1,535,000
Gross profit	(18,000)		(221,000)		(151,000)		(1,535,000)
Operating expenses:
Salaries, wages and payroll taxes	—		—		—		—
Commissions	—		—		—		—
Total operating expenses	—		—		—		—
(Loss) income from discontinued operations	$	(18,000)	$	(221,000)	$	(151,000)	$	(1,535,000)

Note 4: Special Purpose Acquisition Company ("SPAC") Sponsorship

On April 29, 2021, we announced our sponsorship, through our wholly-owned subsidiary, ShiftPixy Investments, Inc. ("Investments"), of four SPACs.

Each SPAC was seeking to raise approximately $150 million in capital investment, through an IPO, to acquire companies in the healthcare and technology segments of the staffing industry, as well as one or more insurance entities, while IHC has completed its IPO and is seeking to acquire companies in the light industrial segment of the staffing industry, as described below. We anticipated that, through our wholly-owned subsidiary, we would own approximately 15% of the issued and outstanding stock in each entity upon their IPOs being consummated, and that each would operate as a separately managed, publicly traded entity following the completion of their respective IBCs. We also anticipated entering into service agreements with each of the staffing entities that would allow them to participate in our HRIS platform. We also expected to facilitate the procurement of workers’ compensation, personal liability, and other similar insurance products for these staffing entities through our anticipated relationship with the insurance SPAC after it completed its IBC. For the three and six month periods ended

19

February 28, 2022, the sponsorship operations for all of these entities, with the exception of IHC, are consolidated in the accompanying financial statements as they were being conducted under a wholly-owned subsidiary. The operations of IHC have been consolidated in the accompanying financial statements for the reasons set forth above.

The registration statement and prospectus covering the IPO of IHC was declared effective by the SEC on October 19, 2021, and IHC Units, consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the New York Stock Exchange (“NYSE”) on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, we purchased, through our wholly-owned subsidiary, 4,639,102 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102.

Following the closing of the IPO, the sum of $116,725,000 was placed in a trust account (the “Trust Account”), and has been invested in U.S. government securities within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the "ICA"), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the ICA, as determined by the Company, until the earlier of: (i) the completion of the IBC and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The $116,725,000 consisted of the $115,000,000 of gross proceeds from the sale of the IHC Units in the IPO and $1,725,000 funded by the Company, as the corporate parent of the Sponsor, representing guaranteed interest for future redemptions and calculated as one year's interest at 1.5%. With the completion of the IPO, the Company recorded approximately $38.0 million of deferred costs in APIC as of February 28, 2022, and $274,000 of offering costs paid on behalf of IHC. During the six months ended February 28, 2022, IHC incurred approximately $3.5 million in offering costs. No other offering costs have been incurred during the three month period ended February 28, 2022, for the other SPACs. The Trust Account generated interest income for the six month period ended February 28, 2022 of approximately $7,000.

On March 18, 2022, we announced the withdrawal of the IPO registration statements related to Vital Human Capital, Inc. ("Vital"), TechStackery, Inc. ("TechStackery"), and Firemark Global Capital, Inc. ("Firemark"), in order to focus on the growth and expansion of our Company and to completing IHC's IBC. See Note 12, Subsequent Events.

Note 5: Deferred Offering Costs - SPACs

During Fiscal 2021, the Company incurred professional fees related to the filing of registration statements for the IPOs of four SPACs. The Company also transferred certain Founder Shares of those SPACs to a third party which created a non-controlling interest in those entities. These Founder Shares of common stock were transferred to the SPACs’ underwriter representative (the “Representative”) at below fair market value, resulting in compensation and therefore deferred offering costs for the SPACs, and the creation of a minority interest. The non-controlling interest is recorded as a minority interest on the Balance Sheet and the Statement of Equity.

As of August 31, 2021, Deferred offering costs - SPACs totaled $48,261,000, consisting of $789,000 of legal and accounting fees related to the SPACs’ IPOs and $47,472,000 related to the non-controlling interest in consolidated subsidiaries.

The non-controlling interest – deferred offering costs represents the estimated value of the portion of our Founder Shares in each of the following SPACs that we received as a result of our sponsorship, and which we transferred to the Representative on April 22, 2021, at a price below the fair market value of the shares, as follows: (i) 2,000,000 shares of IHC common stock; (ii) 2,000,000 shares of TechStackery common stock; (iii) 2,000,000 shares of Vital common stock; and (iv) 4,000,000 shares of Firemark common stock. We estimate the total value of the 10,000,000 shares transferred, which represents deferred compensation to the Representative, to be $47,472,000, or $4.7472 per share. We arrived at this valuation by reference to similar SPAC IPO transactions, as set forth below:

1.Consistent with most SPAC IPOs, the market price of units (consisting of some combination of common stock and warrants) sold to the public in a SPAC IPO is $10 per unit.

2.We have valued the warrant portion of each Unit at $0.75. Deducting this value from the Unit yields a value of $9.25 per share of common stock at the time of the IPO, which we have applied to the value of each of the Founder Shares that we issued to the Representative.

3.We have applied a further discount of 48.8%, which is a blended discount designed to reflect the following contingencies and uncertainties: (a) 20% probability that the SPAC IPOs are never consummated; (b) 20% probability that none of our sponsored SPACs successfully complete their IBC; and (c) 21% additional discounts to account for future sponsor and Representative concessions, as well as the possibility of decrease in the value of the common stock of each SPAC.

20

One of the Company's sponsored SPACs, IHC, completed its IPO on October 22, 2021, resulting in the recognition of approximately $13 million of offering costs, including $9.8 million that had been deferred as of August 31, 2021. No offering costs were incurred for TechStackery, Vital, or Firemark during the quarter ended February 28, 2022.

As discussed in Note 4, Special Purpose Acquisition Company ("SPAC") Sponsorship , and Note 12, Subsequent Events, the Company has announced its withdrawal of registration statements on Form S-1 previously filed with the SEC relating to three of its Sponsored SPACs — Vital, TechStackery, and Firemark -- to devote its resources to completing IHC's IBC. The abandonment of these SPAC IPOs, resulted in our recognition of approximately $38.5 million of deferred offering costs against $38 million in non-controlling interest and $0.5 million in the other expenses in our Condensed Consolidated Statement of Operations.

Note 6: Going Concern

The accompanying financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. As of February 28, 2022, the Company had cash of $3.3 million and a working capital deficit of $14.9 million. During this same period, the Company used approximately $10.33 million of cash from its continuing operations and incurred recurring losses, resulting in an accumulated deficit of $166.9 million as of February 28, 2022.

Historically, our principal source of financing has come through the sale of our common stock and issuance of convertible notes. In May 2020, we successfully completed an underwritten public offering, raising a total of $12 million ($10.3 million net of costs), and closed an additional $1.35 million ($1.24 million net of costs) between June 1, 2020 and July 7, 2020 pursuant to the underwriter’s over-allotment. In October 2020, we closed an additional $12 million equity offering ($10.7 million net of costs). In May 2021, we raised approximately $12 million ($11.1 million net of costs) in connection with the sale of common stock and warrants. More recently, in September 2021, we raised approximately $12 million ($11.1 million net of costs) in connection with the sale of common stock and warrants, and in January 2022, we entered into a warrant exercise agreement that raised approximately $5.9 million ($5.4 million net of costs).

The recurring losses, negative working capital and cash used in the Company’s operations are indicators of substantial doubt as to the Company’s ability to continue as going concern for at least one year from issuance of these financial statements. Our plans and expectations for the next twelve months include raising additional capital to help fund expansion of our operations, including the continued development and support of our information technology (“IT”) and HRIS platform, as well as our activities in connection with our sponsorship of IHC described above. We expect to continue to invest in our HRIS platform, ShiftPixy Labs, our sponsorship of IHC and other growth initiatives, all of which have required and will continue to require significant cash expenditures.

The Company believes that IHC has the potential to generate additional payroll billings revenue during the fiscal year ending August 31, 2022 ("Fiscal 2022"), provided that IHC successfully completes its IBC and the Company is able to enter into one or more client services agreements with IHC on favorable terms.

The Company also expects its ShiftPixy Labs growth initiative to generate cash flow once launched, by functioning as an incubator of food service and restaurant concepts through collaboration and partnerships with local innovative chefs. If successful, the Company believes that this initiative will produce sound businesses that provide recurring revenue through direct sales, as well as through utilization of the ShiftPixy Ecosystem, HRIS platform, and other human capital services that the Company provides. To the extent that this business model is successful and can be replicated in other locations, the Company believes that it has the potential to contribute significant revenue to ShiftPixy in the future. The Company may also take equity stakes in various branded restaurants that it develops and operates with its partners through ShiftPixy Labs. Such ownership interests will be held to the extent that it is consistent with the Company’s continued existence as an operating company, and to the extent that the Company believes such ownership interests have the potential to create significant value for its shareholders.

The Company expects to engage in additional sales of its securities during Fiscal 2022, either through registered public offerings or private placements, the proceeds of which the Company intends to use to fund its operations and growth initiatives.

The Company’s management believes that its current cash position, (including the proceeds of the January 2022 warrant exercise described above), along with its anticipated revenue growth and proceeds from future sales of its securities, when combined with prudent expense management, will be sufficient to alleviate substantial doubt about its ability to continue as a going concern and to fund its operations for at least one year from the date these financials are available (especially when considering the absence of any funded debt outstanding on its balance sheet). If these sources do not provide the capital necessary to fund the Company’s operations during the next twelve months, it may need to curtail certain aspects of its operations or expansion activities, consider the sale of additional assets, or consider other means of financing. The Company

21

can give no assurance that it will be successful in implementing its business plan and obtaining financing on advantageous terms, or that any such additional financing will be available. These consolidated financial statements do not include any adjustments for this uncertainty.

Note 7: Stockholders’ Equity

Preferred Stock

Preferred Stock

As previously disclosed, in September 2016, the founding shareholders of the Company were granted options to acquire preferred stock of the Company (the “Preferred Options”). The number of Preferred Options granted was based upon the number of shares held at the time of the grant. These Preferred Options are nontransferable and forfeited upon the sale of the related founding shares of common stock held by the option holder. Upon the occurrence of certain specified events, such founding shareholders can exercise each Preferred Option to purchase one share of preferred stock of the Company at an exercise price of $0.0001 per share. The preferred stock underlying the Preferred Options does not include any rights to dividends or preference upon liquidation of the Company and is convertible into shares of the Company’s common stock on a one-for-one basis. Upon consummation of the Vensure Asset Sale in January 2020, a total of 24,634,560 Preferred Options became exercisable and exchangeable into an equal number of shares of our common stock.

On June 4, 2020, Scott W. Absher, the Company’s Chief Executive Officer, exercised 12,500,000 Preferred Options to purchase 12,500,000 shares of our preferred stock for an aggregate purchase price of $1,250. Immediately following the exercise of the Preferred Options described above, Mr. Absher elected to convert the 12,500,000 shares of preferred stock into 12,500,000 shares of common stock, which are subject to a 24-month lock-up period during which such shares may not be traded. Between July 20, 2020 and November 30, 2020, an additional 294,490 Preferred Options were exercised and converted into 294,490 shares of common stock, which were subject to a six-month lock up period at the time they were issued, during which such shares could not be traded on the open market. As of February 28, 2022, the restrictions on all of these shares have been lifted, rendering them freely tradeable.

On October 22, 2021, the Company’s board of directors canceled 11,790,000 of these Preferred Options previously issued to its co-founder, J. Stephen Holmes. Accordingly, these Preferred Options are no longer exercisable. A total of 37,570 Preferred Options issued pursuant to the September 2016 grant and triggered by the Vensure Asset Sale remain unexercised.

The amount of Preferred Options, and the number of shares of preferred stock issuable upon exercise of such options, is based upon the number of shares of common stock held by the option holders at the time the Preferred Options were issued in September 2016. Accordingly, in order to confirm the original intent of the granting of up to 25,000,000 Preferred Options to Mr. Absher, it has always been the Company’s intent to adopt a second grant of an additional 12,500,000 Preferred Options to Mr. Absher, whereby each option permits the holder to acquire one share of the Company’s preferred stock for $0.0001 per share. On August 13, 2021, consistent with this intent, the Company granted 12,500,000 Preferred Options to Mr. Absher to purchase shares of Preferred Stock, par value $0.0001 per share, for consideration of $0.0001 per share. Each Preferred Option is exercisable for a period of twenty-four months upon (i) the acquisition of a Controlling Interest (as defined below) in the Company by any single shareholder or group of shareholders acting in concert, (other than Mr. Absher), or (ii) the announcement of (x) any proposed merger, consolidation, or business combination in which the Company’s Common Stock is changed or exchanged, or (y) any sale or distribution of at least 50% of the Company’s assets or earning power, other than through a reincorporation. Each share of Preferred Stock is convertible into Common Stock on a one-for-one basis. “Controlling Interest” means the ownership or control of outstanding voting shares of the Company sufficient to enable the acquiring person, directly or indirectly and individually or in concert with others, to exercise one-fifth or more of all the voting power of the Company in the election of directors or any other business matter on which shareholders have the right to vote under the Wyoming Business Corporation Act. As of February 28, 2022, no events have occurred that would trigger the exercise of the Preferred Options issued to Mr. Absher in August 2021.

Common Stock and Warrants

During the six months ended February 28, 2022, the Company closed the following transactions:

January 2022 Warrant Exercise Agreement

On May 17, 2021, we issued warrants to purchase up to an aggregate of 4,948,453 shares of our common stock, par value $0.0001 per share, with an exercise price of $2.425 (the "Existing Warrants"). The Existing Warrants were immediately exercisable and expire on June 15, 2026. On January 26, 2022, we entered into a Warrant Exercise Agreement ("the Exercise Agreement") with the holder of the Existing Warrants (the "Exercising Holder"). Pursuant to the Exercise Agreement, the

22

Exercise Holder and the Company agreed that, subject to any applicable beneficial ownership limitations, the Exercising Holder would cash exercise up to 4,948,453 of its Existing Warrants (the "Investor Warrants") into shares of our common stock underlying such Existing Warrants (the "Exercised Shares"). To induce the Exercising Holder to exercise the Investor Warrants, the Exercise Agreement (i) amended the Investor Warrants to reduce their exercise price per share to $1.20 and (ii) provided for the issuance of a new warrant to purchase up to an aggregate of approximately 9,896,906 shares of our common stock (the “January 2022 Common Warrant”), with such January 2022 Common Warrant being issued on the basis of two January 2022 Common Warrant shares for each share of the Existing Warrant that was exercised for cash. The January 2022 Common Warrant is exercisable commencing on July 28, 2022, terminates on July 28, 2027, and has an exercise price per share of $1.55. The Exercise Agreement generated aggregate proceeds to the Company of approximately $5.9 million, prior to the deduction of $461,000 of costs consisting of placement agent commissions and offering expenses payable by the Company. As a result of the warrant modification, which reduced the exercise price of the Existing Warrants, as well as the issuance of the January 2022 Common Warrants, the Company recorded approximately (i) $639,000 for the increased fair value of the modified warrants; and (ii) $12,590,000 as the fair value of the January 2022 Common Warrants on the date of issuance. We recorded approximately $5,477,000 as issuance costs that offset the $5.5 million of additional paid-in capital the Company received for the cash exercise of the Existing Warrants at the reduced exercise price, while the remaining $7,731,000 was recorded as a deemed dividend on the Condensed Consolidated Statements of Operations, resulting in a reduction of income available to common shareholders in our basic earnings per share calculation.

September 2021 Private Placement

In September 2021, the Company entered into a $12 million private placement transaction, inclusive of $0.9 million of placement agent fees and costs, with a large institutional investor pursuant to which the Company sold to the investor an aggregate of (i) 2,850,000 shares of Common Stock, together with warrants (the “September 2021 Common Warrants”) to purchase up to 2,850,000 shares of Common Stock, with each September 2021 Common Warrant exercisable for one share of Common Stock at a price per share of $1.595, and (ii) 4,673,511 prefunded warrants (the “September 2021 Prefunded Warrants”), together with the September 2021 Common Warrants to purchase up to 7,523,511 shares of Common Stock, with each September 2021 Prefunded Warrant exercisable for one share of Common Stock at a price per share of $0.0001. Each share of Common Stock and accompanying September 2021 Common Warrant were sold together at a combined offering price of $1.595 and each September 2021 Prefunded Warrant and accompanying September 2021 Common Warrant were sold together at a combined offering price of $1.5949.

The September 2021 Prefunded Warrants are immediately exercisable, at a nominal exercise price of $0.0001, and may be exercised at any time until all of the September 2021 Prefunded Warrants are exercised in full. The September 2021 Common Warrants have an exercise price of $1.595 per share, are immediately exercisable, and will expire five years from the date that the registration statement covering the resale of the shares underlying the September 2021 Common Warrants is declared effective (which has not yet occurred). The private placement generated gross proceeds of approximately $12.0 million, prior to deducting $0.9 million of costs consisting of placement agent commissions and offering expenses payable by the Company. In addition to the seven percent (7%) of the aggregate gross proceeds cash fee, the Company issued to the placement agent warrants to purchase 376,176 shares of our common stock issuable upon exercise of the September 2021 Prefunded Warrants sold in the offering (the “September Placement Agent Warrants”). The September Placement Agent Warrants are exercisable for a period commencing on March 3, 2022 (six months after issuance) and expire four years from the effective date (which has not yet occurred) of a registration statement for the resale of the underlying shares, and have an initial exercise price per share of $1.7545.

23

The following table summarizes the changes in the Company’s common stock and Prefunded  Warrants from August 31, 2021 to February 28, 2022.

	Number of shares	Weighted average remaining life (years)	Weighted average exercise price
Warrants outstanding, August 31, 2021	9,592,085	4.7	$	3.87
Issued	22,470,104	4.7	1.58
(Cancelled)	—	—	—
(Exercised)	(4,948,453)	4.3	1.2
Warrants outstanding, February 28, 2022	27,113,736	4.7	2.83
Warrants exercisable, February 28, 2022	16,840,654	4.2	$	0.95

The following table summarizes the Company’s warrants outstanding as of February 28, 2022:

	Warrants Outstanding	Weighted average Life of Outstanding Warrants in years	Exercise price
Jan 2022 Common Warrants(1)	9,896,906	5.4	$	1.55
Sep 2021 Common Warrants	7,523,511	4.5	1.60
Sep 2021 Prefunded Warrants(2)	4,673,511	4.5	N/A
Sep 2021Underwriter Warrants (3)	376,176	4.5	1.75
May 2021Underwriter Warrants	247,423	4.2	2.43
October 2020 Common Warrants	2,300,000	3.6	3.30
October 2020 Underwriter Warrants	200,000	3.6	3.30
February 2021 Common Warrants	1,277,580	3.2	5.40
February 2021 Underwriter Warrants	111,108	3.2	5.40
March 2020 Exchange Warrants	423,669	3.6	10.17
Amended March 2019 Warrants	66,288	2.0	40.00
March 2019 Services Warrants	3,366	2.0	70.00
June 2018 Warrants	6,276	1.8	40.00
June 2018 Services Warrants	5,422	1.8	99.60
2017 PIPE Warrants	2,500	0.3	276.00
	27,113,736	4.7	$	2.22

(1)The January 2022 Common Warrants are exercisable commencing on July 28, 2022 and terminate on July 28, 2027..

(2)The September 2021 Prefunded Warrants were sold as part of a Prefunded Warrant Unit as described above at a nominal price of $0.0001 per share.

(3)The September 2021 Placement Agent Warrants become exercisable six months from issuance and expire four years from the effective date (which has not yet occurred) of the registration statement covering the resale of the underlying shares.

Note 8: Stock Based Compensation

Employee Stock Option Plan Increase

In March 2017, the Company adopted its 2017 Stock Option/Stock Issuance Plan (the “Plan”). The Plan provides incentives to eligible employees, officers, directors and consultants in the form of incentive stock options (“ISOs”), non-qualified stock options (“NQs”), (each of which is exercisable into shares of common stock), (collectively, “Options”) or shares of common stock (“Share Grants”).

24

On July 1, 2020, the Company's board of directors unanimously approved an increase in the number of shares of common stock issuable under the Plan from 250,000 to 3,000,000. On March 31, 2021, the Company’s shareholders approved the increase in the number of shares of common stock issuable under the Plan as well as any contingent grant awards under the Plan on or subsequent to July 1, 2020. On June 4, 2021, the Company registered an aggregate of 3,000,000 shares, par value $0.0001 per share, reserved for issuance under the Plan.

For all options granted prior to July 1, 2020, each option has a term of service vesting provision over a period of time as follows: 25% vest after a 12-month service period following the award, with the balance vesting in equal monthly installments over the succeeding 36 months. Options granted on or after July 1, 2020 typically vest over four years, with 25% of the grant vesting one year from the grant date, and the remainder in equal quarterly installments over the succeeding 12 quarters. All options granted to date have a stated ten-year term and, as of February 28, 2022, all options granted to date are exercisable.

Stock grants are issued at fair value, considered to be the market price on the grant date. The fair value of option awards is estimated on the grant date using the Black-Scholes stock option pricing model.

Following its adoption of ASU 2016-9, the Company elected to account for forfeitures under the Plan as they occur. Any compensation cost previously recognized for an unvested award that is forfeited because of a failure to satisfy a service condition is reversed in the period of the forfeiture.

The Company recognized approximately $339,000 and $747,000 of compensation expense for the three and six months ended February 28, 2022, respectively.

The Company compensates its board members through grants of common stock for services performed. These services have been accrued within the accounts payable and other accrued liabilities on the condensed consolidated balance sheet. The Company has incurred $81,000 and $205,000 for the three and six months ended February 28, 2022, respectively.

The following table summarizes option activity during the six months ended February 28, 2022:

	Options Outstanding and Exercisable
	Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance Outstanding, August 31, 2021	1,776,115	8.90	$	6.80
Granted	120,000	9.76	0.76
Exercised	—	—	—
Forfeited	(126,618)	8.66	(3.70)
Balance Outstanding at February 28, 2022	1,769,497	8.61	$	6.98
Balance Exercisable at February 28, 2022	1,769,497

 

Options outstanding as of February 28, 2022 had aggregate intrinsic value of $1,415. 

25

At February 28, 2022, the total unrecognized deferred share-based compensation expected to be recognized over the remaining weighted average vesting periods of 2.77 years for outstanding grants was $3,002,000. Option vesting activity from August 31, 2021, through February 28, 2022 was as follows:

Options Vested	Number of Options	Weighted Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance, August 31, 2021	309,257	8.63	$	16.92
Vested	218,077	8.57	4.88
Exercised	—	—	—
Forfeited	(8,011)	7.87	7.97
Balance, February 28, 2022	519,323	8.28	$	12.14

The following table summarizes information about stock options outstanding and vested at February 28, 2022: 

	Options Outstanding				Options Vested
Exercise Prices	Number of Options Exercisable	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In Years)				(In Years)
$0.75 - 10.00	1,730,808	8.6	$	4.27	483,756	8.4	$	4.93
$10.01 - $40.00	2,000	7.3	18.95		1,453	7.3	19.01
$40.01 - $80.00	13,100	7.1	51.21		11,066	7.1	51.21
$80.01 - $120.00	10,271	6.2	102.91		9,862	6.2	102.93
$120.01 - $160.00	12,193	5.5	155.36		12,060	5.5	155.39
$160.01 - $391.60	1,125	5.4	391.60		1,125	5.4	391.60
	1,769,497	8.6	$	6.64	519,322	8.3	$	12.14

 

Note 9: Related Parties

Director Compensation

On February 10, 2020, Amanda Murphy was appointed to our Board. Ms. Murphy was our Director of Operations at the time of her appointment. Ms. Murphy received approximately $240,000 in Fiscal 2021 and on October 22, 2021, our Board approved the promotion of Ms. Murphy to the position of Chief Operating Officer, as well as an increase in her annual salary to $500,000, all of which were effective January 1, 2022. As of February 28, 2022, Ms. Murphy has deferred payment of her salary increase. Nevertheless, Ms. Murphy's base pay increase is recorded in accrued liabilities on the condensed balance sheets.

During Fiscal 2021, in connection with her relocation to Miami, Florida as part of the relocation of our principal executive offices, Ms. Murphy received a one-time incentive payment of approximately $80,000 in addition to reimbursement of her expenses associated with her relocation.

Scott W. Absher, our CEO and Chair of our Board, received compensation in the form of salary of approximately $750,000 for Fiscal 2021. On October 22, 2021, our Board approved raising Mr. Absher’s annual salary to $1,000,000, effective January 1, 2022, and also approved the payment of a $500,000 bonus to Mr. Absher, 50% of which was payable upon Board approval, and the remainder of which was payable on January 1, 2022. As of February 28, 2022, Mr. Absher had not received any bonus payments and has deferred payment of his salary increase and bonus. Nevertheless, the bonuses and the incremental base salary for Mr. Absher's base pay increase are recorded in accrued liabilities in the condensed consolidated balance sheets. Further, the Company paid Mr. Absher 50% of his bonus, or $250,000, in March 2022.

26

In addition, Mr. Absher received the following additional payments during Fiscal 2021: (i) a one-time incentive payment of approximately $170,000 in connection with his relocation to Miami, Florida as part of the relocation of our principal executive offices, in addition to reimbursement of his expenses associated with his relocation; and (ii) a one-time bonus payment in the amount of $240,000 in recognition of his efforts on behalf of the Company.

J. Stephen Holmes

J. Stephen Holmes formerly served as a non-employee sales manager advisor to and was a significant shareholder of the Company. The Company incurred $750,000 in professional fees for services provided by Mr. Holmes during each of Fiscal 2021. For the six months ended February 28, 2022, Mr. Holmes was compensated $120,000 for his services.

On or about October 22, 2021, we severed all ties with Mr. Holmes, effective immediately, and cancelled Preferred Options that had previously been issued to him but had not been exercised. As a result of these actions, the Company no longer has any financial obligation to Mr. Holmes, and believes that he is no longer a significant shareholder of the Company. See Note 7, Stockholders Equity.

Related Persons to Scott Absher

Mark Absher, the brother of Scott Absher, was previously employed as our Registered In-House Counsel, Director and Secretary. Mr. Absher resigned from his positions with the Company on February 6, 2019 and received compensation of $276,951 in Fiscal 2019. On November 18, 2021, Mr. Absher rejoined the Company as Deputy General Counsel – Special Projects, for an annual salary of $240,000 for Fiscal 2022. Based on his re-hire date, Mr. Absher did not receive any compensation from the Company in Fiscal 2021 or Fiscal 2020.

David May, a member of our business development team, is the son-in-law of Scott Absher. Mr. May received compensation of approximately $125,000 in Fiscal 2021. In addition, in connection with his relocation to Miami, Florida, as part of the relocation of our principal executive offices, Mr. May received a one-time incentive payment of approximately $103,000 during Fiscal 2021, in addition to reimbursement for expenses associated with his relocation.

Jason Absher, a member of our business development team, is the nephew of Scott Absher and the son of Mark Absher. Mr. Absher was hired on February 22, 2021 at an annual salary of $75,000, which was subsequently raised to $120,000, effective August 1, 2021.

Phil Eastvold, the Executive Producer of ShiftPixy Labs, is the son-in-law of Scott Absher. Mr. Eastvold was hired on September 1, 2020. Mr. Eastvold received compensation for Fiscal 2021 of approximately $200,000. In addition, in connection with his relocation to Miami, Florida as part of the relocation of our principal executive offices, Mr. Eastvold received a one-time incentive payment of approximately $111,000 during Fiscal 2021, in addition to reimbursement for expenses associated with his relocation.

Connie Absher, (the spouse of Scott Absher), Elizabeth Eastvold, (the daughter of Scott Absher and spouse of Mr. Eastvold), and Hannah Absher, (the daughter of Scott Absher), are also employed by the Company. These individuals, as a group, received aggregate compensation of $183,000 in Fiscal 2021. In addition, in connection with her relocation to Miami, Florida as part of the relocation of our principal executive offices, Hannah Absher received a one-time incentive payment of approximately $18,000 during Fiscal 2021, in addition to reimbursement for expenses associated with her relocation. Connie Absher and Elizabeth Eastvold did not receive any such relocation bonus.

Note 10: Commitments

Operating Leases & License Agreements

Effective April 15, 2016, the Company entered into a non-cancelable five-year operating lease for its Irvine facility. On July 25, 2017, the Company entered into a non-cancelable operating lease for expansion space at its Irvine offices with a termination date that coincides with the termination date of the prior lease and extended the terms of the original lease until 2022. The leases for certain facilities contain escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $35,000.

Effective August 13, 2020, the Company entered into a non-cancelable seven-year lease for 13,246 square feet of office space located in Miami, Florida to house its principal executive offices commencing October 2020, and continuing through September 2027. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $57,000.

27

Effective October 1, 2020, the Company entered into a non-cancelable 64-month lease for 23,500 square feet of primarily industrial space located in Miami, Florida, to house ghost kitchens, production facilities, and certain marketing and technical functions, including those associated with ShiftPixy Labs. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $34,000.

Effective June 7, 2021, the Company entered into a non-cancelable sublease agreement with Verifone, Inc. to sublease premises consisting of approximately 8,000 square feet of office space located in Miami, Florida, that the Company anticipates using for its sales and operations workforce. The lease has a term of three years expiring on May 31, 2024. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the sublease. Monthly rent expense under this lease is approximately $26,000.

Effective June 21, 2021, the Company entered into a non-cancelable 77-month lease, with an anticipated possession date of March 1, 2022, for premises consisting of approximately 13,418 square feet of office space located in Sunrise, Florida, that the Company anticipates using primarily to house its operations personnel and other elements of its workforce. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the lease. Monthly rent expense under this lease is approximately $27,000.

The components of lease expense is as follows:

	Three Months ended February 28, 2022		Six Months ended on February 28, 2022
Operating Lease Cost	$	334,251	$	788,203

Future minimum lease and licensing payments under non-cancelable operating leases at February 28, 2022, are as follows:

	Minimum lease commitments
2022	$	731,000
2023	1,739,000
2024	1,737,000
2025	1,532,000
2026	1,275,000
Thereafter	1,515,000
Total minimum payments	$	8,529,000
Less: present value discount	1,164,000
Lease Liability	$	7,365,000
Weighted-average remaining lease term - operating leases (months)	54
Weighted-average discount rate	5.54		%

The Company has a finance lease for a copier located in our Irvine office totaling $33,030 with a monthly minimum lease payment of $756, which began on April 1, 2020 and continues through March 2, 2025. The principal balance of the finance lease was $23,391 and $26,260 as of February 28, 2022 and August 31, 2021, respectively, and is included within our accounts payable and other accrued liabilities in our Condensed Consolidated Balance Sheets.

Non-contributory 401(k) Plan

The Company has a non-contributory 401(k) Plan (the “401(k) Plan”). The 401(k) Plan covers all non-union employees who are at least 21 years of age and have completed 3 months of service. There were no employer contributions to the 401(k) Plan for the three or six months ended February 28, 2022 and February 28, 2021.

28

Special Purpose Acquisition Company Sponsorship

On April 29, 2021, the Company announced its sponsorship, through a wholly-owned subsidiary, of four SPAC IPOs. The Company purchased founder shares in each SPAC (the "Founder Shares"), through its wholly-owned subsidiary, for an aggregate purchase price of $25,000 per SPAC. The number of Founder Shares issued was determined based on the expectation that such Founder Shares would represent 15% of the outstanding shares of each SPAC after its IPO (excluding the private placement warrants described below and their underlying securities).

The registration statement and prospectus covering the IPO of one of these SPACs, IHC, was declared effective by the SEC on October 19, 2021, and IHC units (the “IHC Units”), consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the NYSE on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, the Company purchased, through its wholly-owned subsidiary, 4,639,102 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102. Each private placement warrant is exercisable to purchase one whole share of common stock in IHC at $11.50 per share. The private placement warrants will be worthless to the extent that IHC does not complete an initial business combination.

The investment amounts set forth above do not include loans that the Company may extend to each SPAC in an amount not to exceed $500,000 individually (or $2 million in the aggregate), in its role as sponsor. As of February 28, 2022, the Company had advanced, through its wholly owned subsidiary, an aggregate of approximately $820,000 to the SPACs for payment of various expenses in connection with the SPAC IPOs, principally consisting of SEC registration, legal and auditing fees.

The Company previously disclosed that it anticipates that each of the SPACs will repay these advanced expenses from the proceeds of their respective SPAC IPOs. On March 18, 2022, however, we announced the withdrawal of registration statements on Form S-1 previously filed with the SEC relating to the following three SPACs for which we had served as Sponsor through our wholly-owned subsidiary: Firemark, TechStackery and Vital. Accordingly, the Company does not anticipate receiving repayment of any advanced expenses on behalf of these three SPACs, which total $625,000 as of February 28, 2022. During the six month period ended February 28, 2022, the Company received approximately $183,000 from IHC, as repayment of advances provided by the sponsor.

Note 11: Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will be resolved only when one or more future events occur or fail to occur. The Company’s management, in consultation with its legal counsel as appropriate, assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

During the ordinary course of business, the Company is subject to various claims and litigation. Management believes that after consulting legal counsel the outcome of such claims or litigation will not have a material adverse effect on the Company’s financial position, results of operations or cash flow.

Kadima Litigation

The Company is in a dispute with its former software developer, Kadima Ventures (“Kadima”), over incomplete but paid for software development work. In May 2016, the Company entered into a contract with Kadima for the development and deployment of user features that were proposed by Kadima for an original build cost of $2.2 million to complete. This proposal was later revised upward to approximately $7.2 million to add certain features to the original proposal. As of February 28, 2022, the Company has paid approximately $11 million to Kadima, but has never been provided access to the majority of the promised software. Kadima has refused to continue development work, denied access to developed software, and refused to surrender to the Company any software that it has developed unless the Company pays an additional $12.0 million above the $11.0 million already paid. In April 2019, Kadima filed a complaint against the Company in the Superior Court of the State of Arizona, Maricopa County, alleging claims for breach of contract, promissory estoppel and unjust enrichment, and seeking damages in excess of $11.0 million. The Company vigorously disputes and denies each of Kadima’s claims, including that it owes any sums to Kadima, and further believes that it is entitled, at a minimum, to a refund of a substantial portion of the sums that it has already paid, along with the release of the software modules currently being withheld. In June 2020, the Company engaged in a mediation with Kadima in an attempt to resolve the matter, which was unsuccessful. On July 14, 2020 the Company filed an answer to Kadima’s complaint, which denied Kadima’s claims and asserted counter-claims for breach of contract and fraud. Discovery is complete, and the Court has set a trial date of September 12, 2022.

29

Splond Litigation

On April 8, 2019, claimant, Corey Splond, filed a class action lawsuit, on behalf of himself and other similarly situated individuals in the Eighth Judicial District Court for the State of Nevada, Clark County, naming the Company and its client as defendants, and alleging violations of certain wage and hour laws. This lawsuit is in the initial stages, and the Company denies any liability. Even if the plaintiff ultimately prevails, the potential damages recoverable will depend substantially upon whether the Court determines in the future that this lawsuit may appropriately be maintained as a class action. Further, in the event that the Court ultimately enters a judgment in favor of plaintiff, the Company believes that it would be contractually entitled to be indemnified by its client against at least a portion of any damage award.

Radaro Litigation

On July 9, 2020, the Company was served with a complaint filed by one of its former software vendors, Radaro Inc., in the United States District Court for the Central District of California, alleging damages arising from claims sounding in breach of contract and fraud. By Order filed October 21, 2020, the Court dismissed plaintiff’s claims for fraud and for punitive damages, with leave to replead. The Company denies plaintiff’s claims and is defending the lawsuit vigorously. Discovery is underway, and the Court has set a trial date of September 6, 2022.

Everest Litigation

On December 18, 2020, the Company was served with a Complaint filed in the United States District Court for the Central District of California by its former workers’ compensation insurance carrier, Everest National Insurance Company. The Complaint asserts claims for breach of contract, alleging that the Company owes certain premium payments to plaintiff under a retrospective rated policy, and seeks damages of approximately $600,000. On February 5, 2021, the Company filed an Answer to Plaintiff’s Complaint denying its claims for relief, and also filed a cross-claim against the third party claims administrator, Gallagher Bassett Services, Inc., for claims sounding in breach of contract and negligence based upon its administration of claims arising under the policy. By order dated April 7, 2021, the Court dismissed the Company’s complaint against Gallagher Bassett without prejudice to re-filing in another forum. On May 17, 2021, the Company refiled its complaint against Gallagher Basset in the Circuit Court of Cook County, Illinois, and the Court substantially denied Gallagher Basset's motion to dismiss the complaint by order dated January 31, 2022. Discovery is underway in both cases, and the California Court has set a trial date in the Everest case of February 7, 2023, while no trial date has been set in the Illinois case.

Sunz Litigation

On March 19, 2021, the Company was served with a Complaint filed in the Circuit Court for the 11th Judicial Circuit, Manatee County, Florida, by its former workers’ compensation insurance carrier, Sunz Insurance Solutions, LLC. The Complaint asserts claims for breach of contract, alleging that the Company owes payments for loss reserve funds totaling approximately $10 million. The Company denies plaintiff’s allegations and is defending the lawsuit vigorously. On May 12, 2021, the Company filed a motion to dismiss the complaint, and Sunz filed an amended complaint in response. Discovery is proceeding in the matter and no trial date has been set.

Vensure Litigation

On September 7, 2021, Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure, filed a complaint against the Company in the Court of Chancery of the State of Delaware asserting claims arising from the Asset Purchase Agreement (the “APA”) governing the Vensure Asset Sale described above. The APA provided for Vensure to purchase, through its wholly-owned subsidiary, certain of the Company’s assets for total consideration of $19 million in cash, with $9.5 million to be paid at closing, and the remainder to be paid in 48 equal monthly installments (the “Installment Sum”). The Installment Sum was subject to certain adjustments to account for various post-closing payments made by the parties, and the APA provided for the following procedure to determine the final amount of the Installment Sum: (i) Within 90 days of the effective date, Vensure was required to provide the Company with a “Proposed Closing Statement”, which must detail any adjustments; (ii) Within 30 days of its receipt of Vensure’s Proposed Closing Statement, the Company had the right to challenge any of the proposed adjustments contained therein; and (iii) If the Company disputed Vensure’s Proposed Closing Statement, a 30-day period ensued for the parties to attempt to resolve the dispute, with the Company entitled to examine “such Books and Records of [Vensure] as relate to the specific items of dispute . . .”

30

Vensure resisted the Company’s repeated efforts to obtain the Proposed Closing Statement for over one year after the closing of the transaction. Finally, on March 12, 2021, under threat of legal action by the Company, Vensure provided its Proposed Closing Statement, in which it contended for the first time that it owes nothing to the Company, and that the Company actually owes Vensure the sum of $1,519,991. By letter dated April 6, 2021, the Company provided Vensure with its objections to the Proposed Closing Statement, which included Vensure’s gross overstatement of payments it purportedly made on the Company’s behalf, as well as its bad faith actions in obstructing the Company’s efforts to make these payments.

From April 2021 through August 2021, Vensure and the Company engaged in the “30-day negotiation period” referred to above, which was extended multiple times at Vensure’s request to provide Vensure an opportunity to provide evidence supporting its assertions. Over the course of these negotiations, Vensure withdrew its claim for approximately $1.5 million from the Company, and acknowledged that Vensure owed ShiftPixy some portion of the Installment Fund. Nevertheless, in early September 2021, without warning and contrary to the dispute resolution provisions of the APA, Vensure filed suit against the Company in Delaware Chancery Court for breach of contract and declaratory judgment, seeking unspecified damages. The Company vigorously disputes and denies each of Vensure’s claims. Accordingly, on November 4, 2021, the Company filed its Answer and Counterclaim to Vensure’s Complaint, in which it not only denied Vensure’s claims, but also asserted counterclaims for breach of contract and tortious interference with contract. The counterclaim seeks damages from Vensure totaling approximately $9.5 million – the full amount due under the APA - plus an award of attorneys’ fees and expenses. Discovery is expected to commence shortly.

Note 12: Subsequent Events

Management has evaluated events that have occurred subsequent to the date of these consolidated financial statements and has determined that, other than those listed below, no such reportable subsequent events exist through the date the financial statements were issued in accordance with FASB ASC Topic 855, "Subsequent Events."

Withdrawal of Certain SPAC Sponsorships

On March 18, 2022, the Company announced the withdrawal of registration statements on Form S-1 previously filed with the SEC relating to three SPACs for which its wholly owned subsidiary, ShiftPixy Investments, Inc., had previously been identified as the Sponsor: Vital, TechStackery, and Firemark. We noted in a press release accompanying this announcement that we had decided to devote our resources to assisting our other sponsored SPAC, IHC, which previously consummated its IPO, to completing its IBC as quickly as possible.

Nasdaq Listing Notification

On April 4, 2022, we received a letter from the staff of the Listing Qualifications Department (the "Staff") of Nasdaq notifying us that for the previous 30 consecutive business days, the bid price for our common stock had closed below the minimum $1.00 per share requirement for continued listing under Nasdaq's Listing Rule 5550(a)(2) (the "Minimum Bid Requirement"). This notification has no immediate effect on the listing or trading of our common stock on Nasdaq. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), if during the 180 calendar days following the notification, or prior to October 3, 2022, the closing bid price of our common stock is at or above $1.00 per share for a minimum of ten consecutive business days, the Staff will provide us with written confirmation of compliance. If we do not achieve the Minimum Bid Price Requirement by October 3, 2022, we may be eligible for an additional 180 calendar days compliance period if we meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for Nasdaq, with the exception of the Minimum Bid Price Requirement, and we provide written notice of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. However, if it appears to the Staff that we will not be able to cure the deficiency, or if we are otherwise not eligible, then the Staff would notify us that our securities would be subject to delisting. In the event of such notification, we may appeal the Staff's determination to delist our securities, but the Staff may refuse to grant our request for continued listing.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes, and other financial information included in this Quarterly Report, as well as the information contained in our Annual Report on Form 10-K and 10-K/A for the fiscal year ended August 31, 2021 (“Fiscal 2021”), filed with the SEC on December 3, 2021 and February 28, 2022, respectively.

31

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS AND INFORMATION

This Quarterly Report, the other reports, statements, and information that we have previously filed or that we may subsequently file with the SEC, and public announcements that we have previously made or may subsequently make, contain “forward-looking statements” within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, which statements involve substantial risks and uncertainties. Unless the context is otherwise, the forward-looking statements included or incorporated by reference in this Quarterly Report and those reports, statements, information and announcements address activities, events or developments that we expect or anticipate will or may occur in the future. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements contained in this Quarterly Report include, but are not limited to, statements about:

• our future financial performance, including our revenue, costs of revenue and operating expenses;

• our ability to achieve and grow profitability;

• the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs;

• our predictions about industry and market trends;

• our ability to expand successfully internationally;

• our ability to manage effectively our growth and future expenses, including our growth and expenses associated with our sponsorship of various special purpose acquisition companies;

• our estimated total addressable market;

• our ability to maintain, protect and enhance our intellectual property;

• our ability to comply with modified or new laws and regulations applying to our business;

• the attraction and retention of qualified employees and key personnel;

• the effect that the novel coronavirus disease (“COVID-19”) or other public health issues could have on our business, financial condition and the economy in general;

• our ability to be successful in defending litigation brought against us; and

• our ability to continue to meet the listing requirements of Nasdaq.

We caution you that the forward-looking statements highlighted above do not encompass all of the forward-looking statements made in this Quarterly Report.

We have based the forward-looking statements contained in this Quarterly Report primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section entitled “Risk Factors” in our Annual Report on Form 10-K for Fiscal 2021 filed with the SEC on December 3, 2021, which is expressly incorporated herein by reference, and elsewhere in this Quarterly Report. Moreover, we operate in a very competitive and challenging environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report. We cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

The forward-looking statements made in this Quarterly Report relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made herein to reflect events or circumstances after the date of this Quarterly Report or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, other strategic transactions or investments we may make or enter into.

32

The risks and uncertainties we currently face are not the only ones we face. New factors emerge from time to time, and it is not possible for us to predict which will arise. There may be additional risks not presently known to us or that we currently believe are immaterial to our business. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. If any such risks occur, our business, operating results, liquidity and financial condition could be materially affected in an adverse manner.

The industry and market data contained in this Quarterly Report are based either on our management’s own estimates or, where indicated, independent industry publications, reports by governmental agencies or market research firms or other published independent sources and, in each case, are believed by our management to be reasonable estimates. However, industry and market data are subject to change and cannot always be verified with complete certainty due to limits on the availability and reliability of raw data, the voluntary nature of the data gathering process and other limitations and uncertainties inherent in any statistical survey of market shares. We have not independently verified market and industry data from third-party sources. In addition, consumption patterns and customer preferences can and do change. As a result, you should be aware that market share, ranking and other similar data set forth herein, and estimates and beliefs based on such data, may not be verifiable or reliable.

Overview

Our current business, and the primary source of our revenues to date, has been under a human capital fee-based SAAS business model. We have developed a comprehensive HRIS platform designed to provide real-time, agile business intelligence information for our clients as well as an employment marketplace designed to match client opportunities with a large workforce under a digital umbrella. Our market focus is to use this traditional approach, coupled with developed technology, to address underserved markets containing predominately lower wage employees with high turnover, beginning with light industrial, services, and food and hospitality markets. We provide human resources, employment compliance, insurance-related, payroll, and operational employment services solutions for our clients and shift work or gig opportunities for WSEs (or shifters). As consideration for providing these services, we receive administrative or processing fees, typically as a percentage of a client’s gross payroll, process and file payroll taxes and payroll tax returns, provide workers’ compensation insurance, and provide employee benefits. We have built a substantial business on a recurring revenue model since our inception in 2015. For the three and six months ended February 28, 2022 , we processed approximately $21.4 million and $42.6 million of payroll billings, respectively, our primary operating metric, and incurred approximately $9.5 million and $18.2 million in operating losses for the three and six months ended February 28, 2022, which were driven primarily by substantial investments in our technology platform, our SPAC sponsorships and our ShiftPixy Labs growth initiative, as well as by necessary upgrades to our back-office operations to facilitate servicing a large WSE base under a traditional staffing model.

For most of Fiscal 2021 and continuing into the second quarter of Fiscal 2022, our primary focus was on clients in the restaurant and hospitality industries, (market segments typically characterized by high employee turnover and low pay rates), and healthcare industries typically employing specialized personnel that command higher pay rates. We believe that these industries are better served by our HRIS platform and related mobile application, which provide payroll and human resources tracking for our clients and which we believe result in lower operating costs, improved customer experience and revenue growth acceleration. California continued to be our largest market during the second quarter of Fiscal 2022, accounting for approximately 53% of our gross billings. Washington and New Mexico represented our other significant markets during the second quarter of Fiscal 2022, representing approximately 21% of our total revenues. (Our other locations did not contribute revenue to a material degree.) All of our clients enter into client services agreements ("CSAs") with us or one of our wholly owned subsidiaries.

Our business focus during Fiscal 2021 and continuing into the second quarter of Fiscal 2022 was to complete our HRIS platform and to expand that platform to position the Company for rapid billings growth as well as to expand our product offerings to increase our monetization of our payroll billings. To that end, we identified and began to execute on various growth strategies, including our sponsorship of our IHC SPAC and our ShiftPixy Labs initiative. We expect that our execution of these strategies, if successful, will yield significant customer growth driven by widespread adoption of our technology offerings, which we believe represents a substantial value proposition to our clients as a valuable source of agile human capital business intelligence.

Our revenues for the second quarter of Fiscal 2022 consisted of: i) staffing solutions revenues equal to gross billings for staffing solutions clients; and ii) EAS solutions revenues which consist of administrative fees calculated as a percentage of gross payroll processed, payroll taxes due on WSEs billed to the client and remitted to the taxation authority, and workers’ compensation premiums billed to the client for which we facilitate coverage for our clients. Our costs of revenues for EAS solutions revenues consist of the accrued and paid payroll taxes and our costs to provide the workers’ compensation coverage

33

and administration related services, including premiums and loss reserves. For staffing solutions revenues our cost of revenues also included the gross payroll paid to staffing solutions employees. A significant portion of our assets and liabilities is for our workers’ compensation reserves, carried as cash balances, and our estimates of projected workers’ compensation claims, carried as liabilities. We provided a self-funded workers’ compensation policy up to $500,000 and purchased reinsurance for claims in excess of that limit through February 28, 2021, after which we changed to a direct cost premium only workers’ compensation program.

We believe that our customer value proposition is to provide a combination of overall net cost savings to our clients, for which they are willing to pay increased administrative fees, as follows:

•Payroll tax compliance and management services;

•Governmental HR compliance services, such as compliance with the Affordable Care Act (“ACA”);

•Reduced client workers’ compensation premiums or enhanced coverage; and

•Access to an employee pool of potential applicants to reduce turnover costs.

We have invested heavily in a robust, cloud-based HRIS platform (the ShiftPixy “Ecosystem”) in order to:

•reduce WSE management costs;

•automate new WSE and client onboarding; and

•provide value-added services for our business clients resulting in additional revenue streams to the Company.

Our cloud-based HRIS platform captures, holds, and processes HR and payroll information for clients and WSEs through an easy-to-use customized front-end interface coupled with a secure, remotely hosted database. The HRIS platform can be accessed by either a desktop computer or an easy to use smartphone application designed with legally binding HR workflows in mind. Once fully implemented, we expect to reduce the time, expense, and error rate for on-boarding WSEs into our ecosystem. This allows our HRIS platform to serve as a “gig” marketplace for WSEs and clients and for client businesses to better manage their human capital needs.

We see our technology platform as a key competitive advantage and differentiator to our market competitors and one that will allow us to expand our human capital business beyond our current focus of low-wage employees and healthcare workers. We believe that providing this baseline business, coupled with a technology solution to address additional concerns such as employee scheduling and turnover, will provide a unique, cost effective solution to the HR compliance, staffing, and scheduling problems that these businesses face. We are completing additional features that we expect to generate additional revenue streams, enhance and expand our product offering, increase our client customer and WSE counts, and increase our revenues and profit per existing WSE.

COVID-19 Pandemic Impact

The COVID-19 pandemic continues to provide both business setbacks and business opportunities. Our growth trajectory has been muted by the economic impacts of the COVID-19 pandemic on our core business clients, primarily restaurants and nurse staffing organizations supplying health services not related to COVID-19.

The COVID-19 pandemic has significantly impacted and delayed our expected growth, which we saw initially through a decrease in our billed customers and WSEs beginning in mid-March 2020, when the State of California first implemented “lockdown” measures. Substantially all of our billed WSEs as of February 29, 2020 worked for clients located in Southern California, and were primarily in the QSR industry. Many of these clients were required to furlough or lay off employees or, in some cases, completely shutter their operations. For our clients serviced prior to the March 2020 pandemic lockdown, we experienced an approximate 30% reduction in business levels within six weeks after the first lockdown commenced. Early in the pandemic, the combination of our sales efforts and the tools that our services provide to businesses impacted by the COVID-19 pandemic resulted in additional business opportunities for new client location additions, as did the fact that many of our clients received Payroll Protection Plan loans ("PPP Loans") under the CARES Act, which supported their businesses and payroll payments during in-store lockdowns. Nevertheless, during the quarter ended May 31, 2020, our WSE billings per client location decreased as many of our clients were forced to cease operations or reduce staffing. On July 13, 2020, the Governor of the State of California re-implemented certain COVID-19 related lockdown restrictions in most of the counties in the state, including those located in Southern California where most of our clients were located. The mercurial nature of the pandemic led to recurring lockdowns through the issuance of additional orders by state and county health authorities that yielded uneven

34

patterns of business openings and closings throughout our clients’ markets, which also experienced significant lockdowns beginning in late November 2020 and through the year-end holiday season as a spike in COVID-19 cases was observed.

The negative impact of these lockdowns on our business and operations continued through our third quarter of Fiscal 2021 in a see-saw pattern, with some improvement observed after the removal of many restrictions in California and elsewhere from March through June 2021, only to be followed by the reimplementation of restrictions in the face of the pandemic resurgence fueled by the spread of the Delta variant of the virus. While the availability of PPP Loans to our clients mitigated the negative impact on our business during the initial stages of the pandemic, we believe that the failure of the government to renew this program exacerbated the deleterious impact of subsequent restrictions and lockdowns on our financial results for Fiscal 2021. We have observed some degree of business recovery as these lockdowns have relaxed and vaccination efforts have accelerated, and we believe that, to the extent that COVID-19 infection rates continue to decrease, and vaccination rates increase, governmental authorities will continue to remove restrictions, which will fuel our clients’ business recoveries. Nevertheless, we believe that the recent resurgence of the virus, in the form of the Omicron variant, had a material negative impact on our business and results of operations, and that the emergence of additional variants of the virus could have a similarly material negative impact on us in the future.

We have also experienced increases in our workers’ compensation reserve requirements, and we expect additional workers’ compensation claims to be made by furloughed employees. We also expect additional workers’ compensation claims to be made by WSEs required to work by their employers during the COVID-19 pandemic. On May 4, 2020, the State of California indicated that workers who became ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. These additional claims, to the extent they materialize, could have a material impact on our workers’ compensation liability estimates.

Significant Developments in the Three Months Ended February 28, 2022.

Financing Activities

January 2022 Warrant Exercise Agreement

On May 17, 2021, we issued warrants to purchase up to an aggregate of 4,948,453 shares of our common stock, par value $0.0001 per share, with an exercise price of $2.425 (the "Existing Warrants") The Existing Warrants were immediately exercisable and expire on June 15, 2026.

On January 26, 2022, we entered into a Warrant Exercise Agreement ("the Exercise Agreement") with the holder of the Existing Warrants (the "Exercising Holder"). Pursuant to the Exercise Agreement, the Exercise Holder and the Company agreed that, subject to any applicable beneficial ownership limitations, the Exercising Holder would cash exercise up to 4,948,453 of its Existing Warrants (the "Investor Warrants") into shares of our common stock underlying such Existing Warrants (the "Exercised Shares"). To induce the Exercising Holder to exercise the Investor Warrants, the Exercise Agreement (i) amended the Investor Warrants to reduce their exercise price per share to $1.20 and (ii) provided for the issuance of a new warrant to purchase up to an aggregate of approximately 9,896,906 shares of our common stock (the “January 2022 Common Warrant”), with such January 2022 Common Warrant being issued on the basis of two January 2022 Common Warrant shares for each share of the Existing Warrant that was exercised for cash. The January 2022 Common Warrant is exercisable commencing on July 28, 2022, terminates on July 28, 2027, and has an exercise price per share of $1.55. The Exercise Agreement generated aggregate proceeds to the Company of approximately $5.9 million, prior to the deduction of $461,000 of costs consisting of placement agent commissions and offering expenses payable by the Company. As a result of the warrant modification, which reduced the exercise price of the Existing Warrants, as well as the issuance of the January 2022 Common Warrants, the Company recorded approximately (i) $639,000 for the increased fair value of the modified warrants; and (ii) $12,590,000 as the fair value of the January 2022 Common Warrants on the date of issuance. We recorded approximately $5,477,000 as issuance costs that offset the $5.5 million of additional paid-in capital the Company received for the cash exercise of the Existing Warrants at the reduced exercise price, while the remaining $7,731,000 was recorded as a deemed dividend on the Condensed Consolidated Statements of Operations, resulting in a reduction of income available to common shareholders in our basic earnings per share calculation.

September 2021 Private Placement

In September 2021, the Company entered into a $12 million private placement transaction, inclusive of $0.9 million of placement agent fees and costs, with a large institutional investor pursuant to which the Company sold to the investor an aggregate of (i) 2,850,000 shares of Common Stock, together with warrants (the “September 2021 Common Warrants”) to purchase up to 2,850,000 shares of Common Stock, with each September 2021 Common Warrant exercisable for one share of Common Stock at a price per share of $1.595, and (ii) 4,673,511 prefunded warrants (the “September 2021 Prefunded Warrants”), together with the September 2021 Common Warrants to purchase up to 7,523,511 shares of Common Stock, with

35

each September 2021 Prefunded Warrant exercisable for one share of Common Stock at a price per share of $0.0001. Each share of Common Stock and accompanying September 2021 Common Warrant were sold together at a combined offering price of $1.595 and each September 2021 Prefunded Warrant and accompanying September 2021 Common Warrant were sold together at a combined offering price of $1.5949.

The September 2021 Prefunded Warrants are immediately exercisable, at a nominal exercise price of $0.0001, and may be exercised at any time until all of the September 2021 Prefunded Warrants are exercised in full. The September 2021 Common Warrants have an exercise price of $1.595 per share, are immediately exercisable, and will expire five years from the date that the registration statement covering the resale of the shares underlying the September 2021 Common Warrants is declared effective (which has not yet occurred). The private placement generated gross proceeds of approximately $12.0 million, prior to deducting $0.9 million of costs consisting of placement agent commissions and offering expenses payable by the Company. In addition to the seven percent (7%) of the aggregate gross proceeds cash fee, the Company issued warrants to the placement agent to purchase an aggregate of 376,176 shares of our common stock issuable upon exercise of the September 2021 Prefunded Warrants sold in the offering (the “September Placement Agent Warrants”). The September Placement Agent Warrants are exercisable for a period commencing on March 3, 2022 (six months after issuance) and expire four years from the effective date (which has not yet occurred) of a registration statement for the resale of the underlying shares, and have an initial exercise price per share of $1.7545.

Growth Initiatives

During the second quarter of Fiscal 2022, we continued to execute on our two primary growth initiatives. Each growth initiative is designed to leverage our technology solution, knowledge, and expertise to provide for significant revenue growth for the human capital management services we provide to our clients.

Sponsorship of SPACs

On April 29, 2021, we announced our sponsorship of four SPAC IPOs. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million, which IHC currently intends to use to acquire companies primarily in the light industrial segment of the staffing industry. Immediately following the IHC IPO, IHC began to evaluate acquisition candidates. IHC’s goal is to complete its IBC within one year of consummation of the IHC IPO.

On March 18, 2022, we announced the withdrawal of registration statements on Form S-1 previously filed with the Securities and Exchange Commission relating to three SPACs for which our wholly owned subsidiary, ShiftPixy Investments, Inc., had previously been identified as the Sponsor: Vital, TechStackery, and Firemark. After considering our options and the current market environment, we concluded that we can best achieve our SPAC sponsorship goals, including expansion of our own footprint, by doing everything possible to ensure IHC’s ultimate success without distraction. We do not believe that our decision to withdraw our sponsorship from the other SPACs will have a material negative impact on our goal of building large national staffing clients to operate on the ShiftPixy technology platform, which remains unchanged and which we continues to work toward achieving.

We expect our sponsored SPAC, IHC, to operate as a separately managed, publicly-traded entity following the successful completion of its IBC or “De-SPAC”. Our goal is to enter into one or more CSAs with IHC that will allow it to participate in our HRIS platform. We believe that this initiative has the potential to generate significant revenues and earnings for us, while also supporting a favorable business model for IHC.

To date, we have incurred direct costs of $1 million to form the SPAC entities, primarily for legal and professional services related fees, which are included as operating expenses for the three and six months ended February 28, 2022.

ShiftPixy Labs

On July 29, 2020, we announced the launch of ShiftPixy Labs, which includes the development of ghost kitchens in conjunction with our wholly-owned subsidiary, ShiftPixy Ghost Kitchens, Inc. Through this initiative, we intend to bring various food delivery concepts to market that will combine with our HRIS platform to create an easily replicated, comprehensive food preparation and delivery solution. The initial phase of this initiative is being implemented in our dedicated kitchen facility located in close proximity to our Miami headquarters, which we are already showcasing through the distribution of video programming on social media produced and distributed by our wholly-owned subsidiary, ShiftPixy Productions, Inc. If successful, we intend to replicate this initiative in similarly constructed facilities throughout the United States and in selected international locations. We also intend to provide similar services via mobile kitchen concepts, all of which will be heavily

36

reliant on our HRIS platform and which we believe will capitalize on trends observed during the COVID-19 pandemic toward providing customers with a higher quality prepared food delivery product that is more responsive to their needs.

The idea of ShiftPixy Labs, (as described in more detail in Item 1 of our Annual Report on Form 10-K for Fiscal 2021, filed with the SEC on December 3, 2021), originated from discussions with our restaurant clients, combined with our observations of industry trends that appear to have accelerated during the pandemic. Beginning in Calendar 2020, we recognized a significant uptick in the use of mobile applications to order take-out food either for individual pickup or third-party delivery, which grew even more dramatically as the pandemic took hold. Not surprisingly, the establishment of fulfillment kitchens for third party delivery also spread rapidly during this time period, initially among national fast food franchise chains but then among smaller QSRs.

We believe that the restaurant industry is in the midst of a food fulfillment paradigm shift that will ultimately result in the widespread use of “ghost kitchens” in a shared environment. Similar to shared office work locations, a shared kitchen can provide significant cost efficiencies and savings compared to the cost of operating multiple retail restaurant locations. Coupled with ShiftPixy’s technology stack, which includes order delivery and dispatch, we believe that the ghost kitchen solutions that emerge from ShiftPixy Labs will provide a robust and effective delivery order fulfillment option for our clients.

We have also observed the growing impact of social media platforms over the past five years, a trend which has accelerated through the pandemic. As this trend has gained steam, many social media influencers have successfully capitalized on their popularity by establishing new business concepts in a variety of industries, including within the QSR space. Some of these QSRs are identified as “virtual” restaurants with delivery-only service fulfilled by centralized ghost kitchens. We intend to capitalize on this trend by creating an extensive social media presence for ShiftPixy Labs.

Many restaurant entrepreneurs have also become successful during the pandemic by moving outside through the use of mobile food trucks, which can be used as a launching point for restaurants and ultimately expanded to traditional indoor dining locations. We have researched this phenomenon and, coupled with our experience in the restaurant industry, believe a significant business opportunity exists to assist with the fulfillment of new restaurant ideas and rapidly expand those ideas across a broad geographic footprint utilizing centralized ghost kitchen fulfillment centers. Again, we believe that ShiftPixy Labs will provide solutions that will facilitate the rapid growth of these new businesses, through a combination of centralized ghost kitchens and an available pool of human capital resources provided through our HRIS platform, as well as through other business assistance provided by our management team.

During Fiscal 2021, we established an industrial facility in Miami that we expect to be fully operational shortly. We have installed ten standardized kitchen stations in both single and double kitchen configurations built within standard cargo container shells in this facility. We expect this facility, upon completion, to function as a state of the art ghost kitchen space that will be used to incubate restaurant ideas through collaboration and partnerships with local innovative chefs, resulting in sound businesses that provide recurring revenue to us in a variety of ways, both through direct sales and utilization of the ShiftPixy Ecosystem, our HRIS platform, and other human capital services that we provide. To the extent that this business model is successful and can be replicated in other locations, it has the potential to contribute significant revenue to us in the future.

We may also take equity stakes in various branded restaurants that we develop and operate with our partners through ShiftPixy Labs. Such ownership interests will be held to the extent that it is consistent with our continued existence as an operating company, and to the extent that we believe such ownership interests have the potential to create significant value for our shareholders.

Workers’ Compensation Insurance

During Fiscal 2021, the Company made a strategic decision to change its approach to securing workers’ compensation coverage for our clients. This was primarily due to rapidly increasing loss development factors stemming in part from the COVID-19 pandemic. The combination of increased claims from WSEs, the inability of WSEs to obtain employment quickly and return to work after injury claims, and increasing loss development factor rates from our insurance and reinsurance carriers resulted in significantly larger potential loss exposures, claims payments, and additional expense accruals. Starting on January 1, 2021, we began to migrate our clients to our new direct cost program, which we believe significantly limits our claims exposure. Effective March 1, 2021, all of our clients had migrated to the direct cost program.

For the second quarter of Fiscal 2022, included in our cost of sales was approximately $18,000 of expense for claims estimate increases relating to loss reserves activity for calendar 2021 for the legacy Sunz and Everest programs. These claims estimates are the subject of ongoing litigation with our former workers’ compensation insurance providers, Sunz and Everest, as

37

described in Note 11, Contingencies, above. We are currently re-evaluating our workers’ compensation liability estimates under our legacy Sunz and Everest programs.

Vensure Asset Sale Note Receivable Reconciliation

On January 3, 2020, we entered into an asset purchase agreement with Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure, pursuant to which we assigned client contracts representing approximately 88% of our quarterly revenue as of November 30, 2019, including 100% of our existing PEO business effective as of December 31, 2019, and we transferred $1.6 million of working capital assets, including cash balances and certain operating assets associated with the assigned client contracts included in the agreement. Gross proceeds from the Asset Sale were $19.2 million, of which $9.7 million was received at closing and $9.5 million was embodied in the Note Receivable described above, to be paid out in equal monthly payments for the next four years after certain transaction conditions were met. As of February 28, 2022, Vensure and the Company were engaged in litigation regarding the amount owed to the Company pursuant to the Note Receivable, as described in Note 11, Contingencies, above.

Quarterly Performance Highlights: Second Quarter Fiscal 2022 v. Second Quarter Fiscal 2021

•Served approximately 72 clients and an average of 3,000 WSEs. 

•Processed over $21.3 and $42 million in gross billings from continuing operations for the three and six months ended February 28, 2022, respectively, representing an increase of 19.6% and 13.1% from the same period, respectively, in Fiscal 2021 due to the easing of COVID-19 restrictions, which had a significant impact on our QSR customer base. Our continuing operations mix remained consistent for the three and six months ended February 28, 2022, with the same period in Fiscal 2021, primarily consisting of QSR WSEs. (For further information, please refer to the section entitled “Non-GAAP Financial Measures”, below.) Our revenues for the three and six months ended February 28, 2022 were 394.3% and 293.7%, respectively, higher than the same period in Fiscal 2021, due primarily to the our migration to a staffing revenue recognition model during the latter part of Fiscal 2021. Gross margin for the three and six months ended February 28, 2022 improved over the same period in Fiscal 2021, due primarily to higher billings driving greater margins from additional administrative fees and taxes.

•Gross margin slightly decreased for the three month period ended February 28, 2022 by $88,000 or 24%, compared to the same period in Fiscal 2021. For our six month period ended February 28, 2022, our gross margin increased by $95,000 or 10.7% compared to the same period in Fiscal 2021.

•Our operating loss for the three and six months ended February 28, 2022 increased by $2.7 and $4.4 million, respectively, compared to the same period in Fiscal 2021. The increase mainly reflects increased costs associated with our growth initiatives, (including payroll-related costs for the three and six months ended February 28, 2022 of $3.6 million and $7.5 million, professional costs of $1.7 million and $3.4 million, software development costs of $1.2 million and $2.2, and costs classified in our statement of operations as general and administrative expenses of $1.9 million and $3.7 million, respectively).

Our financial performance for the three and six months ended February 28, 2022, compared to the same period in Fiscal 2021, included the following significant items:

38

Results of Operations

The following table summarizes the unaudited condensed consolidated results of our operations for the three and six months ended February 28, 2022, and February 28, 2021.

	For the Three Months Ended				For the Six Months Ended
	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
Revenues (See Note 2)	$	10,437,000	$	2,419,000	$	19,378,000	$	4,922,000
Cost of revenue	10,498,000		2,056,000		18,743,000		4,046,000
Gross profit  (loss)	(61,000)		363,000		635,000		876,000
Operating expenses:
Salaries, wages, and payroll taxes	3,653,000		2,592,000		7,543,000		4,785,000
Stock-based compensation – general and administrative	339,000		423,000		747,000		919,000
Commissions	28,000		49,000		56,000		87,000
Professional fees	1,677,000		1,006,000		3,414,000		1,713,000
Software development	1,073,000		786,000		2,234,000		1,663,000
Depreciation and amortization	130,000		86,000		253,000		148,000
General and administrative	2,014,000		1,380,000		3,946,000		3,139,000
Total operating expenses	8,915,000		6,322,000		18,193,000		12,454,000
Operating Loss	(8,976,000)		(5,959,000)		(17,558,000)		(11,578,000)
Other (expense) income:
Interest expense	(1,000)		(3,000)		(2,000)		(6,000)
Other income	13,000		—		16,000		—
Expensed SPAC offering costs	(515,000)		—		(515,000)		—
Total other expense	(503,000)		(3,000)		(501,000)		(6,000)
Loss from continuing operations	(9,479,000)		(5,962,000)		(18,059,000)		(11,584,000)
Total (loss) income from discontinued operations, net of tax	(18,000)		(221,000)		(151,000)		(1,535,000)
Net loss attributable to Shiftpixy Inc. shareholders	$	(9,497,000)	$	(6,183,000)	$	(18,210,000)	$	(13,119,000)
Deemed dividend for triggering of warrant down round feature	(7,790,000)		—		(7,790,000)		—
Net loss attributable to common shareholders	$	(17,287,000)	$	(6,183,000)	$	(26,000,000)	$	(13,119,000)
Net loss  per share, Basic and diluted
Continuing operations	$	(0.30)	$	(0.18)	$	(0.54)	($ 0.36)
Discontinued operations	—		(0.01)		—		(0.05)
Net  loss per common share – Basic and diluted	$	(0.30)	$	(0.19)	$	(0.54)	($ 0.41)
Weighted average common shares outstanding – Basic and diluted	31,215,495		32,746,660		33,593,393		31,772,050

We report our revenues as gross billings, net of related direct labor costs for our EAS/HCM clients and revenues without reduction of labor costs for staffing services clients.

39

	For the Three Months Ended						For the Six Months Ended
	February 28, 2022			February 28, 2021			February 28, 2022			February 28, 2021
Gross Billings for HCM	$	12.6		$	17.9		25.5			37.6
Gross Wages for HCM	$	(11.0)		$	15.5		$	(22.2)		$	32.7
Total Net Revenue for HCM	$	1.6		2.4			$	3.3		4.9
Revenue for Staffing	8.8			—			16.1			—
Total Net Revenues (in millions)	$	10.4		$	2.4		19.4			4.9
Increase (Decrease), Quarter over Quarter (in millions)	8.0			0.4			14.5			0.7
Percentage Increase (Decrease), Quarter over Quarter	333.3		%	20.0		%	295.9		%	16.7		%
Cost of Revenues (in millions)	$	10.5		$	2.1		$	18.7		$	4.0
Increase (Decrease), Quarter over Quarter (in millions)	8.4			0.20			14.70			0.1
Percentage Increase (Decrease), Quarter over Quarter	400.0		%	10.5		%	367.5		%	2.6		%
Gross Profit (in millions)	$	(0.1)		$	0.4		$	0.6		$	0.9
Increase (Decrease), Quarter over Quarter (in millions)	(0.5)			0.3			(0.3)			0.6
Percentage Increase (Decrease), Quarter over Quarter	(125.0)		%	132.1		%	(33.3)		%	200.0		%
Gross Profit Percentage of Revenues	(1.0)		%	16.7		%	3.1		%	18		%

Three and six months ended February 28, 2022

Net revenue for our HCM services excludes the payroll cost component of gross billings. With respect to staffing services, employer payroll taxes, employee benefit programs, and workers’ compensation insurance, we believe that we are the primary obligor, and we have latitude in establishing price, selecting suppliers, and determining the service specifications. As such, the billings for those components are included as revenue. Revenues are recognized ratably over the payroll period as WSEs perform their services at the client worksite. In Fiscal 2021, we began to migrate our business clients to a staffing revenue recognition model during the later half of Fiscal 2021. As such, the net revenues for the three and six months ended February 28, 2021 are primarily HCM services while the net revenues for the Fiscal 2022 reporting period are under the staffing revenue recognition model. See also non-GAAP Financial Measures below.

Net Revenue increased approximately 333.3% and 295.9%, to $10.4 million and $19.4 million for the three and six months ended February 28, 2022, from $2.4 million and $4.9 million for the same period of Fiscal 2021, respectively. The increase for the three and six month periods is due to: i) the impact of the transition of some of our existing clients to a staffing revenue recognition model, which commenced during the latter part of Fiscal 2021 and ii) an increase in gross billings of $3.5 million or 19.6% to $21.3 million, from $17.9 million for the three months ended February 28, 2021 and an increase of $5.0 million or 13.1% to $$42.6 million from $37.6 million, for the six months ended February 28, 2021, along with Recurring WSE counts for the three and six months ended February 28, 2022, averaged approximately 3,000, consistent with a recovery to our pre-pandemic WSE levels.

Our gross billings from HCM and Staffing services totaled approximately $12.6 million and $8.8 million, representing 58.9% and 41.1% of our gross billings for the three months ended February 28, 2022 and $25.5 million and $16.1 million, representing 61.3% and 38.7% of our gross billings for the six months ended February 28, 2022.

Billings per WSE increased to $3,567 and $6,623 for the three and six month period ended February 28, 2022, due primarily to business recoveries achieved by our QSR clients as the pandemic subsided, combined with an increase in the placement of nursing WSEs who earn higher wages and generate higher billings.

For the three months ended February 28, 2022, our revenue associated with administrative fees increased by $132,000, or 38.4%, our tax revenues increased by $327,000 or 20.2%, consistent with our billed wages increase of 19.6%, and our revenue associated with workers’ compensation premiums decreased by $13,000, or 3.0%, due to the migration of our WSEs to a

40

guaranteed cost program during Fiscal 2021 and a change in our client mix that resulted in lower billed workers’ compensation rates per wage dollar, compared to the same comparative period in Fiscal 2021,. For the six months ended February 28, 2022, our revenue associated with administrative fees increased by $250,000 or 36.1%, our tax revenue increased by $528,000 or 16% and out workers compensation revenue decreased by $49,000 or 5.4%, compared to the same comparative period in Fiscal 2021

Cost of Revenues includes our costs associated with employer taxes, workers’ compensation insurance premiums, and the gross wages paid for our staffing clients. Cost of revenues for the three months ended February 28, 2022, increased by $8.4 million or 410.6% to $10.5 million from $2.1 million for the same period in Fiscal 2021. Cost of revenues for the six months ended February 28, 2022, increased by $14.7 million, or 363.2%, to $18.7 million from $4 million, respectively, for the same period in Fiscal 2021. The change in cost of revenues for the three and six months ended February 28, 2022 was due primarily to the conversion of certain existing clients to a staffing revenue recognition model during the latter part of Fiscal 2021. As discussed above, the staffing model includes the gross wages in the cost of sales as the Company is considered the employer. Other contributors to the increase in cost of sales are the slight increase in workers' compensation cost by approximately $300,000 for the three and six months ended in February 28, 2022, respectively, due to higher premiums from our participation in the direct guaranteed cost program, offset by the decrease in our claims accruals from our prior workers' compensation programs, and the increase by $211,000 and $310,000, or 13.6% and 10.2%, respectively, in taxes which is correlated to our increase in staffing services.

Gross Profit for the three months ended February 28, 2022 decreased by $423,000 or 116.5%, and decreased by approximately $241,000, or 27.5%, for the six months ended February 28, 2022, compared to the same periods in Fiscal 2021. The decrease for the three months ended February 28, 2022 was primarily driven by an increase in workers' compensation cost due to higher premiums from our participation in the direct guaranteed cost program, offset by an increase in our administrative fees and taxes billed, which is consistent with our 19.61% increase in gross billings compared to the same period in Fiscal 2021. The increase in gross profit for the six months ended February 28, 2022 was mainly driven by a $250,000 increase in our administrative fees and $218,000 increase in taxes billed, consistent with our 13.6% increase in gross billings, offset by an increase in workers' compensation cost of $342,000 and a decrease of $359,000 in gross wages, compared to the same period in Fiscal 2021.

Operating expenses for the three and six months ended February 28, 2022, increased by $2.6 million or 41% to $8.9 million from $6.3 million, and by $5.7 million or 46.1% to $18.2 million from $12.5 million, respectively, compared to the same period in Fiscal 2021. The increase in operating expenses for the three and six months ended February 28, 2022 is primarily due to increased costs associated with our growth initiatives. For the three months ended February 28, 2022 the $2.6 million increase is due to payroll-related cost increases of $1.0 million, professional fees increase of $0.7 million and software development costs of $0.3 million and general and administrative expenses increase of $0.6 million. The $5.7 million increase for the six months ended February 28, 2022 was due to $2.7 million of payroll related cost increases, professional fees increase of $1.7 million, software development costs of $0.6 million, and general and administrative cost increases of $0.8 million.

Payroll-related costs increased due primarily to hiring additional executive, operations, and software development personnel to support our growth initiatives and accrued executive bonuses. Professional fees increased due to litigation arising in the normal course of business and legal fees we paid on behalf of our sponsored SPACs. Software development costs were driven primarily by our continuing investment in our HRIS platform, while general and administrative expenses grew primarily due to rent cost increases from our entry into leases covering the following: (i) our principal executive offices in Miami, Florida; (ii) our ShiftPixy Labs facility in Miami, Florida; and (iii) our new office facility in Sunrise, Florida, which will house the majority of

41

our operations personnel and other elements of our workforce. Other contributors to the increase in general and administrative expenses include non-recurring costs to relocate certain employees, and marketing expenses related to our growth initiatives.

The following table presents certain information related to our operating expenses (unaudited):

	For the Three months Ended				For the Six Months Ended
	February 28, 2022		February 28, 2021		February 28, 2022	February 28, 2021
Operating expenses:
Salaries, wages, and payroll taxes	$	3,653,000	$	2,592,000	7,543,000	4,785,000
Stock-based compensation – general and admin	339,000		423,000		747,000	919,000
Commissions	28,000		49,000		56,000	87,000
Professional fees	1,677,000		1,006,000		3,414,000	1,713,000
Software development	1,073,000		786,000		2,234,000	1,663,000
Depreciation and amortization	130,000		86,000		253,000	148,000
General and administrative	2,014,000		1,380,000		3,946,000	3,139,000
Total operating expenses	$	8,915,000	$	6,322,000	18,193,000	12,454,000

Operating expenses increased for the three and six months ended February 28, 2022 by $2.6 million, or 41% and by $5.7 million or 46.1%, compared with the same period of Fiscal 2021. The components of operating expenses changed as follows:

Salaries, wages and payroll taxes increased for the three and six months ended February 28, 2022, by approximately $1 million, or 41%, and by $2.8 million or 57.6%, respectively, in comparison to the same period in Fiscal 2021. These costs consisted of gross salaries, benefits, and payroll taxes associated with our executive management team and corporate employees. Approximately $0.8 million of the increase was for accrued management bonuses and $0.2 million and $2 million was primarily attributable to hiring additional employees in the executive, operations, and software development ranks of our business to support our various growth initiatives, including our SPAC sponsorships and ShiftPixy Labs. Our corporate employee count increased from 56 employees as of February 28, 2021, to 83 employees as of February 28, 2022.

Share-Based compensation decreased by $0.1 million, or 19.9% and by $.2 million or 18.7%, for the three and six months ended February 28, 2022, compared to the same period in Fiscal 2021.

Commissions consist of commissions payments made to third party brokers and inside sales personnel, and remained consistent year over year, with a slight decrease based on the reduction of our sales force.

Professional fees consists of legal fees, accounting and public company costs, board fees, and consulting fees. Professional fees for the three and six months ended February 28, 2022, increased by 63.2% or $636,000 and by 97.3% or $1.7 million, respectively. The increase is primarily attributable to an increase in legal fees related to our current active litigation and IHC's IBC-related activities.

Software development consists of costs associated with research and development outsourced to third parties. Software development costs increased by 36.5%, or $287,000, and 34.3% or $571,000, for the three and six months ended February 28, 2022, respectively, compared to the same period in Fiscal 2021. The increased costs are due primarily to additional contracted developers to support our mobile application improvements.

Depreciation and amortization for the three and six months ended February 28, 2022, increased by $44,000, or 51% and $105,000 or 70.9%, respectively, as compared to the same period in Fiscal 2021, due to depreciation of the additional asset purchased during the period to support our growth initiatives.

General and administrative expenses consist of office rent and related overhead, software licenses, insurance, penalties, business taxes, travel and entertainment, and other general business expenses. General and administrative expenses for the three and six months ended February 28, 2022, increased by 45.9% or $634,000, and by 25.7% or $807,000, respectively, compared with the same period of Fiscal 2021. The increase was due primarily to approximately $1 million of general and administrative expenses incurred in connection with IHC, our sponsored SPAC, during the period. No such expenses were incurred during the same period of Fiscal 2021.

42

Net loss for the three and six months ended February 28, 2022, increased by $2.9 million, or 48.2%, from $6.2 million to $9.2 million, and 36.3%, from $13.1 million to $17.9 million, compared to the same period in Fiscal 2021. The increase is mainly due to increased costs associated with our growth initiatives, (including payroll-related costs for the three and six months ended February 28, 2022 of $3.6 million and $7.5 million, professional costs of $1.7 million and $3.4 million, software development costs of $1.2 million and $2.2 million, and costs classified in our statement of operations as general and administrative expenses of $2 million and $3.9 million, respectively). The increase in these cost is mainly related to the additional cost incurred in support to the Company's growth initiatives discussed above.

Other income (expense) for the three and six months ended February 28, 2022 increased by of $501,000 and $495,000, respectively, compared to the same period in Fiscal 2021. The increase is related to the expensing of deferred offering costs paid in cash and associated with the three SPACs for which our wholly-owned subsidiary has withdrawn its sponsorship, and which are not proceeding with their initial public offerings.

Loss from continuing operations for the three and six months ended February 28, 2022, increased by $3.2 million or 48.2% and by $6.1 million or 53%, respectively, due primarily to expenses associated with the Company's growth initiatives, as described above.

Gain/loss from discontinued operations. For the three and six months ended February 28, 2022, we recorded a loss primarily based upon our reassessment of our workers' compensation claims reserve associated with the clients that we transferred to Vensure in connection with the Vensure Asset Sale. For the three and six months ended February 28, 2022, the loss from discontinued operations decreased $203,000, or 91.9%, and $1.4 million, or 90.2%, respectively, compared with the same period in Fiscal 2021. The decrease was driven primarily by the phase out of the claims liability reserved, which trended downward during the period.

Liquidity and Capital Resources

For a discussion of our liquidity and capital resources, see Note 6, Going Concern, to the Notes to the Condensed Consolidated Financial Statements in “Part I, Item 1. Condensed Consolidated Financial Statements (Unaudited)” of this Quarterly Report.

Non-GAAP Financial Measures

In addition to financial measures presented in accordance with GAAP, we monitor other non-GAAP measures that we use to manage our business, make planning decisions and allocate resources. These key financial measures provide an additional view of our operational performance over the long term and provide useful information that we use to maintain and grow our business. The presentation of these non-GAAP financial measures is used to enhance the understanding of certain aspects of our financial performance. They are not meant to be considered in isolation, superior to, or as a substitute for the directly comparable financial measures presented in accordance with GAAP.

Our revenue recognition policy differs for our EAS/HCM and staffing clients and is dependent on the respective CSA applicable to each client. During Fiscal 2021, some of our EAS clients migrated to a staffing CSA. Our policy is to report revenues as gross billings, net of related direct labor costs, for our EAS/HCM clients, and revenues without reduction for labor costs for staffing clients. For the three months ended February 28, 2022, our gross billings from HCM and staffing services totaled approximately $12.6 million and $8.9 million (total of $21.5 million), representing 58.7% and 41.3% of our gross revenue, respectively. For the six months ended February 28, 2022, our gross billings from HCM and staffing services totaled approximately $25.6 million and $17.1 million (total of $42.7 million), representing 59.9% and 40.1% of our gross revenue, respectively. For the three and six months ended February 28, 2022, our gross billings were approximately $21.4 million and $42.6 million from our HCM services, respectively, and our gross billings generated from staffing were immaterial. (We had no revenues generated from technology services during the three or six months ended February 28, 2022 or February 28, 2021.

Gross billings represent billings to our business clients and include WSE gross wages, employer payroll taxes, and workers’ compensation premiums as well as administrative fees for our value-added services and other charges for workforce management support. Gross billings for our HCM services are a non-GAAP measurement that we believe to represent a key revenue-based operating metric, along with number of WSEs and number of clients. Active WSEs are defined as employees on our HRIS platform that have provided services for at least one of our clients for any reported period. Our primary profitability metrics are gross profit, and our primary driver of gross profit is administrative fees.

43

Reconciliation of GAAP to Non-GAAP Measure

Gross Billings to Net Revenues

The following table presents a reconciliation of our Gross Billings (unaudited) to Revenues:

	For the Three Months Ended February 28,			For the Six Months Ended February 28,
	2022		2021	2022		2021
Gross Billings in millions	$	21.4	17.9	$	42.6	37.6
Less: Adjustment to Gross Billings	$	10.9	15.5	$	23.2	32.7
Revenues, in millions	$	10.5	2.4	$	19.4	4.9

The following table provides the key revenue and our primary gross profit driver used by management.

	For the Three Months Ended February 28,						For the Six Months Ended February 28,
	2022			2021			2022			2021
Administrative Fees (in millions)	$	0.48		$	0.34		$	0.94		$	0.69
Increase (Decrease), Quarter over Quarter (in millions)	0.13			0.1			0.2			0.1
Percentage Increase (Decrease), Quarter over Quarter	38.4		%	34.9		%	36.0		%	15.9		%
Administrative Fee % of Gross Billings	2.2		%	1.9		%	2.2		%	1.8		%
Average WSEs by Quarter (unaudited)	3,000			3,000			3,000			3,000
Average Gross Billings per Average WSE	$	7,124		$	5,956		$	14,190		$	12,545

Our billed WSEs as of the end of:

	February 28, 2022	August 31, 2021	February 28, 2021
Active WSEs (unaudited)	3,000	2,800	3,000

Average Active WSEs totaled approximately 3,000, which is consistent with continuous growth and recovery to our pre-pandemic levels. The increase in administrative fees was consistent with our billings growth over the same time period. The increase in average gross billings per WSE was due primarily to growth in the higher wages commanded by our healthcare WSEs, as well as an increase in billings to our restaurant clients as their operations recovered from the worst effects of the COVID-19 pandemic.

Material Commitments

We do not have any contractual obligations for ongoing capital expenditures at this time. We do, however, purchase equipment and software necessary to conduct our operations on an as needed basis.

Contingencies

For a discussion of contingencies, see Note 11, Contingencies, to the Notes to the Condensed Consolidated Financial Statements in “Part I, Item 1. Condensed Consolidated Financial Statements (Unaudited)” of this Quarterly Report.

New and Recently Adopted Accounting Standards

For a listing of our new and recently adopted accounting standards, see Note 2, Summary of Significant Accounting Policies, to the Notes to the Condensed Consolidated Financial Statements in “Part I, Item 1. Condensed Consolidated Financial Statements (Unaudited)” of this Quarterly Report.

44

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not applicable.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer (Principal Executive Officer) and the Chief Financial Officer (Principal Financial Officer), to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, the Company recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

The Company carried out an evaluation under the supervision and with the participation of management, including the Principal Executive Officer and Principal Financial Officer, of the effectiveness of its disclosure controls and procedures at August 31, 2021, as defined in Rule 13a -15(e) and Rule 15d -15(e) under the Exchange Act. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, at February 28, 2022, our disclosure controls and procedures were not effective. A discussion of these findings is contained in our Annual Report on Form 10-K for Fiscal 2021, filed with the SEC on December 3, 2021.

Management’s Updated Report on Internal Control Over Financial Reporting

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an updated evaluation as of February 28, 2022 of the effectiveness of our internal control over financial reporting based on the framework stated by the Committee of Sponsoring Organizations of the Treadway Commission.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes, in accordance with GAAP. Because of inherent limitations, a system of internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate due to a change in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Based on its updated evaluation, our management concluded that our internal controls over financial reporting were not effective as of February 28, 2022. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

The material weaknesses detected at February 28, 2022, relate to the following:

Lack of Adequate Finance and Accounting Personnel

The Company’s current accounting staff is small, and we lack adequate written policies and procedures for accounting and financial reporting with respect to the requirements and application of GAAP and SEC disclosure requirements. Our relatively small staff creates inadequate segregation of duties, which makes the reporting process susceptible to errors, omissions, and inadequate review procedures. During Fiscal 2021, the Company began to implement a plan to develop its accounting and finance staff to meet the needs of its growing business, including but not limited to the hiring of new staff, departmental training and the development of entity level controls and mitigating activity level controls to reduce the risk of management override resulting from inadequate segregation of duties. That plan was not fully implemented during Fiscal 2021 and it will continue into Fiscal 2022. The Company is in the process of finalizing written policies and procedures to formalize the requirements of GAAP and SEC disclosure requirements.

The Company did not perform an effective risk assessment or monitor internal controls over financial reporting including completing the documentation and procedures surrounding its IT environment, controls over cut-off procedures, accounting for

45

capitalized software, discontinued operations, segregation of duties, and corporate oversight functions. The Company will continue its assessment on a quarterly basis.

During the period, the Company engaged outside experts to perform non-routine analyses for valuation of options and other derivative related expenses as well as to prepare the Company’s income tax provisions and to review the discontinued operations accounting and disclosures. The Company plans to continue hiring additional personnel and external resources to further mitigate these material weaknesses.

Once the remediation plan for each material weakness is fully implemented, the identified material weaknesses in internal control over financial reporting will be considered fully addressed when the relevant internal controls have been in operation for a sufficient period of time for management to conclude that the material weaknesses have been fully remediated and the internal controls over financial reporting are effective. The Company will work to design, implement and rigorously test these new controls in order to make these final determinations.

This Quarterly Report on Form 10-Q does not include an attestation report of the Company’s independent registered public accounting firm regarding internal controls over financial reporting because this is not required of the Company pursuant to Regulation S-K Item 308(b).

Changes in Internal Control Over Financial Reporting

Other than the changes to the internal controls over financial reporting discussed above, there were no changes that have occurred during the three or six months ended February 28, 2022, that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.

46

PART II — OTHER INFORMATION

Item 1. Legal Proceedings.

The Company is a party to various legal actions arising in the ordinary course of business which, in the opinion of the Company, are not material in that management either expects that the Company will be successful on the merits of the pending cases or that any liabilities resulting from such cases will be immaterial or substantially covered by insurance. While it is impossible to estimate with certainty the ultimate legal and financial liability with respect to these actions, management believes that the aggregate amount of such liabilities will not be material to the results of operations, financial position or cash flows of the Company. There have been no material developments to the litigation disclosed in our Annual Report on Form 10-K for Fiscal 2021, as filed with the SEC on December 3, 2021, except as noted in Note 11 Contingencies to the accompanying financial statements.

Item 1A. Risk Factors.

You should carefully review and consider the information regarding certain factors that could materially affect our business, financial condition or future results set forth under Part I, Item 1A, Risk Factors, contained in our Annual Report on Form 10-K for Fiscal 2021, as filed with the SEC on December 3, 2021, which is expressly incorporated herein by reference. Except as set forth below, there have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K and 10-K/A for Fiscal 2021, filed with the SEC on December 3, 2021 and February 28, 2022, respectively.

If we are unable to continue to meet the listing requirements of Nasdaq, our common stock will be delisted.

Our common stock currently trades on Nasdaq, where it is subject to various listing requirements including minimum per share prices. On April 4, 2022, we were notified by Nasdaq that we are not in compliance with certain of these listing requirements, and that failure to correct these deficiencies could result in delisting. See Note 12, Subsequent Events. We believe that we will be able to address Nasdaq’s concerns within the timeframe required for continued listing, and that we will then return to being in full compliance with all of its listing requirements. Nevertheless, if we are not able to meet Nasdaq’s listing standards in the future, we could be subject to suspension and delisting proceedings. A delisting of our common stock and our inability to list on another national securities market could negatively impact us by: (i) reducing the liquidity and market price of our common stock; (ii) reducing the number of investors willing to hold or acquire our common stock, which could negatively impact our ability to raise equity financing; (iii) limiting our ability to use a registration statement to offer and sell freely tradable securities, thereby preventing us from accessing the public capital markets; and (iv) impairing our ability to provide equity incentives to our employees.

Unfavorable global economic or political conditions could adversely affect our business, financial condition or results of

operations.

Our business is susceptible to general conditions in the global economy and in the global financial markets. Further, the impacts

of political unrest, including as a result geopolitical tension, such as a deterioration in the relationship between the U.S. and

China or escalation in conflict between Russia and Ukraine, including any additional sanctions, export controls or other

restrictive actions that may be imposed by the U.S. and/or other countries against governmental or other entities in, for example, Russia, also could lead to disruption, instability and volatility in the global markets, which may have an adverse impact on our business or ability to access the capital markets. A severe or prolonged economic downturn, including a recession or depression resulting from the ongoing COVID-19 pandemic, or political disruption could result in a variety of risks to our business and our ability to raise additional capital when needed on acceptable terms, if at all. A weak or declining economy or political disruption could also cause our customers to delay making payments for our services. Any of the foregoing could materially and adversely affect our business, financial condition, results of operations and prospects, and we cannot anticipate all of the ways in which the political or economic climate and financial market conditions could adversely impact our business.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

47

Item 5. Other Information.

Not applicable.

Item 6. Exhibits.

(a) Exhibits.

Exhibit No.	Document Description
4.1	Form of New Warrant (incorporated by reference from Exhibit 4.1 to our Current Report on Form 8-K, filed with the SEC on January 27, 2022).
4.2	Form of Warrant Exercise Agreement (incorporated by reference from Exhibit 10.1 to our Current Report on Form 8-K, filed with the SEC on January 27, 2022).
10.1	Form of Registration Rights Agreement (incorporated by reference from Exhibit 10.2 to our Current Report on Form 8-K, filed with the SEC on January 27, 2022).
31.1	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
31.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.
32.1*	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.
32.2*	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.
Exhibit 101	Interactive data files formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Cash Flows, and (iv) the Notes to the Condensed Consolidated Financial Statements.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

* This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 of the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

48

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this Quarterly Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ShiftPixy, Inc., a Wyoming corporation
DATE: April 14, 2022	By:	/s/ Scott W. Absher
		Scott W. Absher
		Principal Executive Officer

In accordance with the Exchange Act, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SIGNATURE	NAME	TITLE	DATE
/s/ Scott W. Absher	Scott W. Absher	Principal Executive Officer and Director	April 14, 2022
/s/ Domonic J. Carney	Domonic J. Carney	Principal Financial Officer	April 14, 2022

49

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Scott W. Absher, certify that:

1.	I have reviewed this report on Form 10-Q of ShiftPixy, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)	disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

	ShiftPixy, Inc.
DATE: April 14, 2022	By:	/s/ Scott W. Absher
		Scott W. Absher
		Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Domonic J. Carney, certify that:

1.	I have reviewed this report on Form 10-Q of ShiftPixy, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)	disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

DATE: April 14, 2022	By:	/s/ Domonic J. Carney
		Domonic J. Carney
		Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that the Quarterly Report on Form 10-Q for the period ended February 28, 2022, of ShiftPixy, Inc. (the "Company") fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	ShiftPixy, Inc.
DATE: April 14, 2022	By:	/s/ Scott W. Absher
		Scott W. Absher
		Chief Executive Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to ShiftPixy, Inc., and will be retained by ShiftPixy, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that the Quarterly Report on Form 10-Q for the period ended February 28, 2022, of ShiftPixy, Inc. (the "Company") fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

DATE: April 14, 2022	By:	/s/ Domonic J. Carney
		Domonic J. Carney
		Chief Financial Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to ShiftPixy, Inc. and will be retained by ShiftPixy, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	6 Months Ended
	Feb. 28, 2022	Apr. 14, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Feb. 28, 2022
Document Transition Report	false
Entity File Number	001-37954
Entity Registrant Name	SHIFTPIXY, INC.
Entity Incorporation, State or Country Code	WY
Entity Tax Identification Number	47-4211438
Entity Address, Address Line One	501 Brickell Key Drive
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Miami
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33131
City Area Code	888
Local Phone Number	798-9100
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	PIXY
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		33,661,552
Entity Central Index Key	0001675634
Amendment Flag	false
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--08-31

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Feb. 28, 2022	Aug. 31, 2021
Current assets
Cash	$ 3,349	$ 1,199
Accounts receivable	381	498
Unbilled accounts receivable	2,615	2,741
Deposit – workers’ compensation	36	155
Prepaid expenses	1,172	605
Other current assets	132	126
Current assets of discontinued operations	92	356
Total current assets	7,777	5,680
Cash and marketable securities held in Trust Account (See Notes 2 and 5)	116,732	0
Fixed assets, net	2,992	2,784
ROU operating lease	7,225
Note receivable, net	4,004	4,004
Deposits – workers’ compensation	91	386
Deposits and other assets	944	944
Deferred offering costs – SPACs (See Note 5)	0	48,261
Non-current assets of discontinued operations	232	883
Total assets	139,997	62,942
Current liabilities
Accounts payable and other accrued liabilities	9,618	6,553
Payroll related liabilities	11,173	7,876
Accrued workers’ compensation costs	597	663
Current liabilities of discontinued operations	1,291	1,516
Total current liabilities	22,679	16,608
Non-current liabilities
Operating lease liability, non-current	6,834
Accrued workers’ compensation costs	1,260	1,646
Non-current liabilities of discontinued operations	3,226	3,765
Total liabilities	33,999	22,019
Commitments and contingencies
Class A common shares subject to possible redemption 11,500,000 and no shares at $10.00 per share redemption value as of February 28, 2022 and August 31, 2021 (See Notes 2 and 5)	116,725	0
Stockholders’ equity (deficit)
Preferred stock, 50,000,000 authorized shares; $0.0001 par value	0	0
Common stock, 750,000,000 authorized shares; $0.0001 par value; 33,661,552 and 25,863,099 shares issued as of February 28, 2022 and August 31, 2021	3	3
Additional paid-in capital	146,716	142,786
Accumulated deficit	(166,940)	(149,338)
Total ShiftPixy, Inc Stockholders' deficit	(20,221)	(6,549)
Non-controlling interest in consolidated subsidiaries (See Note 5)	9,494	47,472
Total Equity (Deficit)	(10,727)	40,923
Total liabilities and equity deficit	$ 139,997	$ 62,942

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Feb. 28, 2022	Aug. 31, 2021
LIABILITIES AND EQUITY (DEFICIT)
Temporary equity, shares outstanding (in shares)	11,500,000	0
Temporary equity, redemption price per share (in dollars per share)	$ 10.00
Stockholders’ equity (deficit)
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	750,000,000	750,000,000
Common stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares issued (in shares)	33,661,552	25,863,099

XML

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
Income Statement [Abstract]
Revenues (See Note 2)	$ 10,437	$ 2,419	$ 19,378	$ 4,922
Cost of revenue	10,498	2,056	18,743	4,046
Gross profit  (loss)	(61)	363	635	876
Operating expenses:
Salaries, wages, and payroll taxes	3,653	2,592	7,543	4,785
Stock-based compensation – general and administrative	339	423	747	919
Commissions	28	49	56	87
Professional fees	1,677	1,006	3,414	1,713
Software development	1,073	786	2,234	1,663
Depreciation and amortization	130	86	253	148
General and administrative	2,014	1,380	3,946	3,139
Total operating expenses	8,915	6,322	18,193	12,454
Operating Loss	(8,976)	(5,959)	(17,558)	(11,578)
Other (expense) income:
Interest expense	(1)	(3)	(2)	(6)
Other income	13	0	16	0
Expensed SPAC offering costs	(515)	0	(515)	0
Total other expense	(503)	(3)	(501)	(6)
Loss from continuing operations	(9,479)	(5,962)	(18,059)	(11,584)
Total (loss) income from discontinued operations, net of tax	(18)	(221)	(151)	(1,535)
Net loss attributable to Shiftpixy Inc. shareholders	(9,497)	(6,183)	(18,210)	(13,119)
Deemed dividend from change in fair value from warrants modification	(7,731)	0	(7,731)	0
Net loss attributable to common shareholders	$ (17,228)	$ (6,183)	$ (25,941)	$ (13,119)
Net loss  per share, Basic and diluted
Continuing operations, basic (in dollars per share)	$ (0.55)	$ (0.18)	$ (0.77)	$ (0.36)
Continuing operations, diluted (in dollars per share)	(0.55)	(0.18)	(0.77)	(0.36)
Discontinued operations, basic (in dollars per share)	0	(0.01)	0	(0.05)
Discontinued operations, diluted (in dollars per share)	0	(0.01)	0	(0.05)
Net loss per common share, basic (in dollars per share)	(0.55)	(0.19)	(0.77)	(0.41)
Net loss per common share, diluted (in dollars per share)	$ (0.55)	$ (0.19)	$ (0.77)	$ (0.41)
Weighted average common shares outstanding, basic (in shares)	31,215,495	32,746,660	33,593,393	31,772,050
Weighted average common shares outstanding, diluted (in shares)	31,215,495	32,746,660	33,593,393	31,772,050

XML

Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Cumulative effect adjustment for ASC 842 lease accounting adoption	Private Placement	Note Warrant	Parent	Parent Cumulative effect adjustment for ASC 842 lease accounting adoption	Parent Private Placement	Parent Note Warrant	Preferred Stock Issued	Common Stock Issued	Common Stock Issued Private Placement	Common Stock Issued Note Warrant	Additional Paid-In Capital	Additional Paid-In Capital Private Placement	Additional Paid-In Capital Note Warrant	Accumulated Deficit	Accumulated Deficit Cumulative effect adjustment for ASC 842 lease accounting adoption	Noncontrolling interest
Beginning balance (in shares) at Aug. 31, 2020									0	16,902,146
Beginning balance at Aug. 31, 2020					$ (30)				$ 0	$ 2			$ 119,430			$ (119,462)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued, net of offering costs (in shares)											4,000,000
Common stock issued, net of offering costs							$ 10,701							$ 10,701
Stock-based compensation expense					863								863
Preferred stock issued for preferred option exercised (in shares)									12,500
Common stock issued on preferred stock conversion (in shares)									(12,500)	12,500
Net Loss	$ (13,119)				(13,119)											(13,119)
Ending balance (in shares) at Feb. 28, 2021									0	20,914,646
Ending balance at Feb. 28, 2021					(1,585)				$ 0	$ 2			130,994			(132,581)
Beginning balance (in shares) at Aug. 31, 2020									0	16,902,146
Beginning balance at Aug. 31, 2020					(30)				$ 0	$ 2			119,430			(119,462)
Ending balance (in shares) at Aug. 31, 2021									0	25,863,099
Ending balance at Aug. 31, 2021	$ 40,923	$ 608			(6,549)	$ 608			$ 0	$ 3			142,786			(149,338)	$ 608	$ 47,472
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2018-11
Beginning balance (in shares) at Nov. 30, 2020									0	20,902,146
Beginning balance at Nov. 30, 2020					4,156				$ 0	$ 2			130,552			(126,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense					442								442
Preferred stock issued for preferred option exercised (in shares)									12,500
Common stock issued on preferred stock conversion (in shares)									(12,500)	12,500
Net Loss	$ (6,183)				(6,183)											(6,183)
Ending balance (in shares) at Feb. 28, 2021									0	20,914,646
Ending balance at Feb. 28, 2021					(1,585)				$ 0	$ 2			130,994			(132,581)
Beginning balance (in shares) at Aug. 31, 2021									0	25,863,099
Beginning balance at Aug. 31, 2021	40,923	608			(6,549)	608			$ 0	$ 3			142,786			(149,338)	608	47,472
Ending balance (in shares) at Nov. 30, 2021									0	28,713,099
Ending balance at Nov. 30, 2021	$ 30,392	608			(17,080)	608			$ 0	$ 3			140,968			(158,051)	608	47,472
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2018-11
Beginning balance (in shares) at Aug. 31, 2021									0	25,863,099
Beginning balance at Aug. 31, 2021	$ 40,923	608			(6,549)	608			$ 0	$ 3			142,786			(149,338)	608	47,472
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued, net of offering costs (in shares)											2,850,000	4,948,453
Common stock issued, net of offering costs			$ 4,183	$ 5,409			$ 4,183	$ 5,409						$ 4,183	$ 5,409
Prefunded warrants from private placement, net of offering costs	6,861				6,861								6,861
Stock-based compensation expense	747				747								747
Excess of proceeds from the sale of private placement warrants to Sponsor	(13,270)				(13,270)								(13,270)
Withdrawal of SPAC registrations under Form S-1	(37,978)																	(37,978)
Net Loss	(18,210)				(18,210)											(18,210)
Ending balance (in shares) at Feb. 28, 2022									0	33,661,552
Ending balance at Feb. 28, 2022	(10,727)				(20,221)				$ 0	$ 3			146,716			(166,940)		9,494
Beginning balance (in shares) at Nov. 30, 2021									0	28,713,099
Beginning balance at Nov. 30, 2021	30,392	$ 608			(17,080)	$ 608			$ 0	$ 3			140,968			(158,051)	$ 608	47,472
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued, net of offering costs (in shares)												4,948,453
Common stock issued, net of offering costs				$ 5,409				$ 5,409							$ 5,409
Stock-based compensation expense	339				339								339
Withdrawal of SPAC registrations under Form S-1	(37,978)																	(37,978)
Net Loss	(9,497)				(9,497)											(9,497)
Ending balance (in shares) at Feb. 28, 2022									0	33,661,552
Ending balance at Feb. 28, 2022	$ (10,727)				$ (20,221)				$ 0	$ 3			$ 146,716			$ (166,940)		$ 9,494

XML

Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
OPERATING ACTIVITIES
Net loss	$ (18,210,000)	$ (13,119,000)
Loss from discontinued operations	(151,000)	(1,535,000)
Net loss from continuing operations	(18,059,000)	(11,584,000)
Adjustments to reconcile net loss from continuing operations to net cash used in continuing operating activities:
Depreciation and amortization	253,000	148,000
Stock-based compensation	747,000	863,000
Expensed SPAC offering costs	515,000	0
Non-cash lease expense	217,000
Changes in operating assets and liabilities:
Accounts receivable	117,000	(108,000)
Unbilled accounts receivable	126,000	261,000
Prepaid expenses and other current assets	(573,000)	(163,000)
Deposits – workers’ compensation	414,000	150,000
Deposits and other assets	0	(458,000)
Accounts payable and other accrued liabilities	3,065,000	421,000
Payroll related liabilities	3,297,000	1,243,000
Accrued workers’ compensation costs	(452,000)	(11,000)
Total Adjustments	7,726,000	2,346,000
Net cash used in continuing operating activities	(10,333,000)	(9,238,000)
Net cash used in discontinued operating activities	0	(1,192,000)
Net cash used in operating activities	(10,333,000)	(10,430,000)
INVESTING ACTIVITIES
Investment of IHC IPO proceeds into Trust Account	(116,732,000)	0
Purchase of fixed assets	(461,000)	(1,095,000)
Disposal of fixed assets	0	0
Net cash (used in) provided by investing activities	(117,193,000)	(1,095,000)
FINANCING ACTIVITIES
SPAC related offering costs paid	(3,502,000)	0
Proceeds from initial public offering of IHC	116,725,000	0
Proceeds from warrant exercises, net of offering costs	5,409,000	10,701,000
Proceeds from private placement, net of offering costs	4,183,000	0
Proceeds from private placement prefunded warrants, net of offering costs	6,861,000	0
Net cash provided by financing activities	129,676,000	10,701,000
Net increase in cash	2,150,000	(824,000)
Cash - Beginning of Period	1,199,000	4,303,000
Cash -End of Period	3,349,000	3,479,000
Supplemental Disclosure of Cash Flows Information:
Cash paid for interest	2,000	6,000
Cash paid for income taxes	0	0
Non-cash Investing and Financing Activities:
Deferred offering costs SPACs	37,978,000	0
Change in fair value due to warrants modification	13,728,000	$ 0
Operating lease assets and liabilities from ASC 842 adoption	$ 7,687,000

XML

Nature of Operations

6 Months Ended

Feb. 28, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Operations

Nature of Operations

ShiftPixy, Inc. was incorporated on June 3, 2015, in the State of Wyoming. The Company is a specialized Human Capital service provider that provides solutions for large contingent part-time workforce demands, primarily in the restaurant and hospitality service trades. The Company’s historic focus has been on the quick service restaurant industry in Southern California, but has begun to expand into other geographic areas and industries employing temporary or part-time labor sources.

The Company functions as an employment administrative services (“EAS”) provider primarily through its wholly-owned subsidiary, ReThink Human Capital Management, Inc. (“HCM”), as well as a staffing provider through another of its wholly-owned subsidiaries, ShiftPixy Staffing, Inc (“Staffing”). These subsidiaries provide a variety of services to our clients, (as a co-employer through HCM and a direct employer through Staffing), including the following: administrative services, payroll processing, human resources consulting, and workers’ compensation administration and coverage (as permitted and/or required by state law). The Company has built a human resources information systems (“HRIS”) platform to assist in customer acquisition that simplifies the onboarding of new clients into the Company’s closed proprietary operating and processing information system (the “ShiftPixy Ecosystem”). This HRIS platform is expected to facilitate additional value-added services in future reporting periods.

In January 2020, the Company sold the assets of Shift Human Capital Management Inc. (“SHCM”), a wholly-owned subsidiary of the Company, pursuant to which it assigned the majority of the Company’s billable clients at the time of the sale to a third party for cash. The continuing impact of this transaction on the Company’s financial statements is described below in Note 3, Discontinued Operations.

XML

Summary of Significant Accounting Policies

6 Months Ended

Feb. 28, 2022

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim reports of companies filing as a small reporting company. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results of operations for the three and six months ended February 28, 2022 are not necessarily indicative of the results that may be expected for the full year ending August 31, 2022.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K and 10-K/A for the fiscal year ended August 31, 2021 (“Fiscal 2021”), filed with the SEC on December 3, 2021 and February 28, 2022, respectively.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of ShiftPixy Inc, and its wholly-owned subsidiaries. The condensed consolidated financial statements also include the accounts of (a) Industrial Human Capital, Inc. ("IHC"), which is a special purpose acquisition company, or "SPAC", for which we serve as the financial sponsor (as described below), and which is deemed to be controlled by us as a result of our 15% equity ownership stake, the overlap of three of our executive officers as executive officers of IHC, and significant influence that we currently exercise over the funding and acquisition of new operations for an initial business combination ("IBC"). (See Note 2, Variable Interest Entity). All intercompany balances have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:

•Liability for legal contingencies;

•Useful lives of property and equipment;

•Deferred income taxes and related valuation allowance;

•Valuation of illiquid non-controlling interest in SPAC shares transferred;

•Valuation of long-lived assets including long term notes receivable prior to January 1, 2021; and

•Projected development of workers’ compensation claims.

Revenue and Direct Cost Recognition

For the year ended August 31, 2021 ("Fiscal 2021"), we adopted Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), using the modified retrospective approach. Under this method, the guidance is applied only to the most current period presented in the financial statements. ASU No. 2014-09 outlines a single comprehensive revenue recognition model for revenue arising from contracts with customers and superseded most of the previous revenue recognition guidance, including industry-specific guidance. Under ASU No. 2014-09, an entity recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. Our revenue recognition policies remained substantially unchanged as a result of the adoption of ASU No. 2014-09 and we did not have any significant changes in our business processes or systems.

The Company’s revenues are primarily disaggregated into fees for providing staffing solutions and EAS/HCM services. The Company enters into contracts with its clients for Staffing or EAS based on a stated rate and price in the contract. Contracts generally have a term of 12 months but are cancellable at any time by either party with 30 days’ written notice. The performance obligations in the agreements are generally combined into one performance obligation, as they are considered a series of distinct services, and are satisfied over time because the client simultaneously receives and consumes the benefits provided as the Company performs the services. Payments for the Company’s services are typically made in advance of, or at the time that the services are provided. The Company does not have significant financing components or significant payment terms for its customers and consequently has no material credit losses. The Company uses the output method based on a stated rate and price over the payroll processed to recognize revenue, as the value to the client of the goods or services transferred to date appropriately depicts our performance towards complete satisfaction of the performance obligation.

Staffing Solutions

The Company records gross billings as revenues for its staffing solutions clients. The Company is primarily responsible for fulfilling the staffing solutions services and has discretion in establishing price. The Company includes the payroll costs in revenues with a corresponding increase to cost of revenues for payroll costs associated with these services. As a result, we are the principal in this arrangement for revenue recognition purposes. For the three months ended February 28, 2021, the Company recognized no revenues that should have been evaluated under a staffing solutions model.

EAS Solutions

EAS solutions revenue is primarily derived from the Company’s gross billings, which are based on (i) the payroll cost of the Company’s worksite employees (“WSEs”) and (ii) a mark-up computed as a percentage of payroll costs for payroll taxes and workers’ compensation premiums.

Gross billings are invoiced to each EAS client concurrently with each periodic payroll of the Company’s WSEs, which coincides with the services provided and which is typically a fixed percentage of the payroll processed. Revenues, which exclude the payroll cost component of gross billings and therefore consist solely of markup, are recognized ratably over the payroll period as WSEs perform their services at the client worksite. Although the Company assumes responsibility for processing and remitting payroll and payroll related obligations, it does not assume employment-related responsibilities such as determining the amount of the payroll and related payroll obligations. As a result, the Company records revenue on a “net” basis in this arrangement for revenue recognition purposes. Revenues that have been recognized but not invoiced for EAS clients are included in unbilled accounts receivable on the Company’s consolidated balance sheets, and were $2,615,000 and $2,741,000, as of February 28, 2022 and August 31, 2021, respectively.

Consistent with the Company’s revenue recognition policy for EAS clients, direct costs do not include the payroll cost of its WSEs. The cost of revenue associated with the Company’s revenue generating activities is primarily comprised of all other

costs related to its WSEs, such as the employer portion of payroll-related taxes, employee benefit plan premiums and workers’ compensation insurance costs.

The fees collected from the worksite employers for benefits (i.e. zero-margin benefits pass-through), workers’ compensation and state unemployment taxes are presented in revenues and the associated costs of benefits, workers’ compensation and state unemployment taxes are included in operating expenses for EAS clients, as the Company does retain risk and acts as a principal with respect to this aspect of the arrangement. With respect to these fees, the Company is primarily responsible for fulfilling the service and has discretion in establishing price.

Disaggregation of Revenue

The Company’s primary revenue streams include HCM and staffing services. The Company’s disaggregated revenues for the three and six months ended February 28, 2022 and February 28, 2021 were as follows:

	For the Three Months Ended				For the Six Months Ended
Revenue (in millions):	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
HCM1	$	1.6	2.4		$	3.3	4.9
Staffing	8.8		—		16.1		—
	$	10.4	$	2.4	$	19.4	$	4.9

1 HCM revenue is presented net, $12.6 million and $25.5 million gross billings less WSE payroll costs of $11.0 million and $22.2 million for the three and six months ended February 28, 2022, respectively and $17.9 million and $37.6 million gross less WSE payroll cost of $15.5 and $32.7 million for the three and six months ended February 28, 2021, respectively.

During Fiscal 2021 the Company announced the launch of ShiftPixy Labs. We generated no revenue from this initiative during the three or six months ended February 28, 2022.

For the three and six months ended February 28, 2022 and February 28, 2021, the following geographical regions represented more than 10% of total revenues:

	For the Three Months Ended				For the Six Months Ended
Region:	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
California	53	%	67	%	54	%	68	%
Washington	13	%	10	%	13	%	10	%

Incremental Cost of Obtaining a Contract

Pursuant to the “practical expedients” provided under ASU No 2014-09, the Company expenses sales commissions when incurred because the terms of its contracts are cancellable by either party upon 30 days' notice. These costs are recorded in commissions in the Company’s Consolidated Statements of Operations.

Segment Reporting

Prior to Fiscal 2021, the Company operated as one reportable segment under ASC 280, Segment Reporting. The chief operating decision maker regularly reviews the financial information of the Company at a consolidated level in deciding how to allocate resources and in assessing performance. During Fiscal 2021, the Company entered into new business lines and geographic areas that, to date, are not material. However, with the migration to Staffing during the fiscal quarter ending May 31, 2021, the Company is beginning to manage the business on a segmented basis and therefore intends to report such information once systems and processes are updated accordingly. Reporting and monitoring activities on a segment basis will allow the chief operating decision maker to evaluate operating performance more effectively. See also Disaggregation of Revenue, above.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased as cash equivalents. The Company had no such investments as of February 28, 2022 or August 31, 2021.

Marketable Securities Held in Trust Account

At February 28, 2022, substantially all of the assets held in the Trust Account were invested in U.S. Treasury securities with maturities of 180 days or less. These funds are restricted for use and may only be used for purposes of completing an IBC or redemption of the public common shares of IHC.

Concentration of Credit Risk

The Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of February 28, 2022, there was $3,507,000 of cash on deposit in excess of the amounts insured by the FDIC.

No individual clients represented more than 10% of revenues for the three and six months ended February 28, 2022. However, four clients represented 100% of total accounts receivable as of February 28, 2022.

Fixed Assets

Fixed assets are recorded at cost, less accumulated depreciation and amortization. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When fixed assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Leasehold improvements are amortized over the shorter of the useful life or the initial lease term.

Fixed assets are recorded at cost and are depreciated over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives of property and equipment for purposes of computing depreciation are as follows:

Equipment:	5 years
Furnitures & Fixtures:	5 - 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

The amortization of these assets is included in depreciation expense on the condensed consolidated statements of operations.

Internal Use Software

Software development costs relate primarily to software coding, systems interfaces and testing of the Company’s proprietary employer information systems and are accounted for in accordance with ASC 350-40, Internal Use Software.

Internal software development costs are capitalized from the time the internal use software is considered probable of completion until the software is ready for use. Business analysis, system evaluation and software maintenance costs are expensed as incurred. The capitalized computer software development costs are reported under the section fixed assets, net in the condensed consolidated balance sheets.

The Company determined that there were no material capitalized internal software development costs for the three and six months ended February 28, 2022. All capitalized software recorded was purchased from third party vendors. Capitalized software development costs are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

The Company incurred research and development costs for the three and six months ended February 28, 2022 and February 28, 2021, of approximately $1.9 and $3.9 million and $1.4 and $2.8 million, respectively. All costs were related to internally developed or externally contracted software and related technology for the Company’s HRIS platform and related mobile application. In addition, no software costs were capitalized for the three months ended February 28, 2022 and February 28, 2021, respectively.

Lease Recognition

In February 2016, the FASB established Topic 842, Leases, by issuing ASU No. 2016-02 (“ASC 842”), which required lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The standard established a right-of-use model (“ROU”) that required a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the Condensed Statement of Operations.

The Company adopted the standard on December 1, 2021 with an effective date of September 1, 2021. A modified retrospective transition approach was required, applying the standard to all leases existing at the date of initial application. An entity could choose to use either (1) the effective date of the standard or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chose the second option, the transition requirements for existing leases also applied to leases entered into between the date of initial application and the effective date. The entity had to also recast its comparative period financial statements and provide the disclosures required by the standard for the comparative periods. The Company elected to use the effective date as its date of initial application. Consequently, financial information was not updated and the disclosures required under the standard were not provided for dates and periods prior to September 1, 2021.

The standard provided a number of optional practical expedients as part of transition accounting. The Company elected the “package of practical expedients”, which allowed the Company to avoid reassessing its prior conclusions about lease identification, lease classification and initial direct costs under the standard. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements as these were not applicable to the Company.

The standard had a material effect on the Company’s Condensed Consolidated Financial Statements. The most significant changes related to (1) the recognition of ROU assets and lease liabilities on the Condensed Consolidated Balance Sheet for its office equipment and real estate operating leases and (2) providing significant disclosures about the Company’s leasing activities.

Upon adoption, the Company recognized additional operating liabilities of approximately $7.7 million, with corresponding ROU operating lease asset, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The Company determined if an arrangement was a lease at inception. The Company used an incremental borrowing rate based on the information available at the commencement date of the lease to determine the present value of lease payments. In determining the ROU asset and lease liability at lease inception, the lease terms could include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

The standard also provided practical expedients for an entity’s ongoing accounting for leases. The Company elected the short-term lease recognition exemption for office equipment leases. For those current and prospective leases that qualify as short-term, the Company will not recognize ROU assets or lease liabilities. The Company also elected the practical expedient to not separate lease and non-lease components for all of its real estate leases.

Impairment and Disposal of Long-Lived Assets

The Company periodically evaluates its long-lived assets for impairment in accordance with ASC 360-10, Property, Plant, and Equipment. ASC 360-10 requires that an impairment loss be recognized for assets to be disposed of or held-for-use when the carrying amount of an asset is deemed not to be recoverable. If events or circumstances were to indicate that any of our long-lived assets might be impaired, the Company would assess recoverability based on the estimated undiscounted future cash flows to be generated from the applicable asset. In addition, the Company may record an impairment loss to the extent that the carrying value of the asset exceeds the fair value of the asset. Fair value is generally determined using an estimate of discounted future net cash flows from operating activities or upon disposal of the asset. There were no indicators noted of impairments during the periods ended February 28, 2022 or February 28, 2021.

Workers’ Compensation

Everest Program

Until July 2018, a portion of the Company’s workers’ compensation risk was covered by a retrospective rated policy, which calculates the final policy premium based on the Company’s loss experience during the term of the policy and the stipulated formula set forth in the policy. The Company funds the policy premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. During the policy term and thereafter, periodic adjustments may involve either a return of previously paid premiums or a payment of additional premiums by the Company or a combination of both. If the Company’s losses exceed the expected losses under that policy, then the Company could receive a demand for additional premium payments. The Company is currently engaged in litigation regarding such a demand for additional premium payments, which we believe to be without merit, as discussed at Note 11, Contingencies, Everest Litigation, below.

Sunz Program

From July 2018 through February 28, 2021, the Company’s workers’ compensation program for its WSEs was provided primarily through an arrangement with United Wisconsin Insurance Company and administered by Sunz Insurance Solutions, LLC (“Sunz”). Under this program, the Company has financial responsibility for the first $0.5 million of claims per occurrence. The Company provides and maintains a loss fund that is earmarked to pay claims and claims related expenses. The workers’ compensation insurance carrier establishes monthly funding requirements comprised of premium costs and funds to be set aside for payment of future claims (“claim loss funds”). The level of claim loss funds is primarily based upon anticipated WSE payroll levels and expected workers’ compensation loss rates, as determined by the insurance carrier. Monies funded into the program for incurred claims expected to be paid within one year are recorded as Deposit - workers’ compensation, a short-term asset, while the remainder of claim funds are included in Deposit- workers’ compensation, a long-term asset in its consolidated balance sheets. The Company is currently engaged in litigation regarding demands by Sunz for additional claims loss funds, which we believe to be without merit, as discussed at Note 11, Contingencies, Sunz Litigation, below.

Current Program

Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program. Under this program, the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria.

Under the Everest and Sunz programs, the Company utilized a third party to estimate its loss development rate, which was based primarily upon the nature of WSEs’ job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates.

As of February 28, 2022 and August 31, 2021, the Company had $0.04 million and $0.2 million, in Deposit – workers’ compensation classified as a short-term asset and $0.1 million and $0.4 million, classified as a long-term asset, respectively.

The Company’s estimate of incurred claim costs expected to be paid within one year is included in short-term liabilities, while its estimate of incurred claim costs expected to be paid beyond one year is included in long-term liabilities on its consolidated balance sheets. As of February 28, 2022 and August 31, 2021, the Company had short term accrued workers’ compensation costs of $0.6 million and $0.7 million, and long term accrued workers’ compensation costs of $1.3 million and $1.6 million, respectively.

The Company retained workers’ compensation asset reserves and workers’ compensation related liabilities for former WSEs of clients transferred to Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure Employer Services, Inc. (“Vensure”), in connection with the Vensure Asset Sale described in Note 3, Discontinued Operations, below. As of February 28, 2022, the retained workers’ compensation assets and liabilities are presented as a discontinued operation net asset or liability. As of February 28, 2022, the Company had $0.1 million in short term assets and $1.3 million of short term liabilities, and had $0.2 million of long term assets and $3.2 million of long term liabilities.

Because the Company bears the financial responsibility for claims up to the level noted above, such claims, which are the primary component of its workers’ compensation costs, are recorded in the period incurred. Workers’ compensation insurance

includes ongoing health care and indemnity coverage whereby claims are paid over numerous years following the date of injury. Accordingly, the accrual of related incurred costs in each reporting period includes estimates, which take into account the ongoing development of claims and therefore requires a significant level of judgment. In estimating ultimate loss rates, the Company utilizes historical loss experience, exposure data, and actuarial judgment, together with a range of inputs that are primarily based upon the WSE’s job responsibilities, their location, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. For each reporting period, changes in the actuarial assumptions resulting from changes in actual claims experience and other trends are incorporated into the Company’s workers’ compensation claims cost estimates. The estimated incurred claims are based upon: (i) the level of claims processed during each quarter; (ii) estimated completion rates based upon recent claim development patterns under the plan; and (iii) the number of participants in the plan.

The Company has had very limited and immaterial COVID-19 related claims between March 2020 through the date of this Quarterly Report, although there is a possibility of additional workers’ compensation claims being made by furloughed WSEs as a result of the employment downturn caused by the pandemic. On May 4, 2020, the State of California indicated that workers who become ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. There is a possibility that additional workers’ compensation claims could be made by employees required to work by their employers during the COVID-19 pandemic, which could have a material impact on our workers’ compensation liability estimates. While the Company has not seen significant additional expenses as a result of any such potential claims to date, which would include claims for reporting periods after February 28, 2022, we continue to monitor closely all workers’ compensation claims made as the COVID-19 pandemic continues.

Fair Value of Financial Instruments

ASC 820, Fair Value Measurement, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practical to estimate fair value. ASC 820 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. At February 28, 2022 and August 31, 2021, the carrying value of certain financial instruments (cash, accounts receivable and payable) approximated fair value due to the short-term nature of the instruments. Notes Receivable is valued at estimated fair value as described below.

The Company measures fair value under a framework that utilizes a hierarchy prioritizing the inputs to relevant valuation techniques. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used in measuring fair value are:

•Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

•Level 2: Inputs to the valuation methodology include:

◦Quoted prices for similar assets or liabilities in active markets;

◦Quoted prices for identical or similar assets or liabilities in inactive markets;

◦Inputs other than quoted prices that are observable for the asset or liability;

◦Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

◦If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

•Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

Funds held in trust represent U.S. treasury bills that were purchased with funds raised through the initial public offering of IHC. The funds raised from SPACs are held in trust accounts that are restricted for use and may only be used for purposes of completing an IBC or redemption of the public shares of common stock of the SPACs as set forth in their respective trust agreements. The funds held in trust are included within Level 1 of the fair value hierarchy and included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheets.

The Company did not have other Level 1 or Level 2 assets or liabilities at February 28, 2022 or August 31, 2021. We recorded the fair value of the SPAC founder shares that the Company transferred to the underwriters using non-recurring Level 3 assumptions, including quoted asset prices for SPAC shares and warrants and estimates of the likelihood of the IPOs and IBCs of our sponsored SPACs being consummated. See also Note 5, Deferred Offering Costs – SPACS, below.

The valuation of the Note Receivable from the Vensure Asset Sale (as defined below), is a Level 3 fair value measurement as of August 31, 2020 and through December 31, 2020 (end of the earn-out period as defined under the terms of the Note Receivable).

The Note Receivable, as described in Note 3, Discontinued Operations, below, was estimated using a discounted cash flow technique based on expected contingent payments identified in the Vensure Asset Sale contract and with significant inputs that are not observable in the market and thus represents a Level 3 fair value measurement as defined in ASC 820. The Company valued the Note Receivable on the January 1, 2020 transaction date using a 10% discount rate, and on August 31, 2020 and through December 31, 2020 using a 15% discount rate, which contemplates the risk and probability assessments of the expected future cash flows. The significant inputs in the Level 3 measurement not supported by market activity include the probability assessments of expected future cash flows related to the Vensure Asset Sale, appropriately discounted considering the

uncertainties associated with the obligation, and as calculated in accordance with the terms of the Vensure Asset Sale agreement. For our fiscal year ended August 31, 2020 ("Fiscal 2020"), the expected cash payments from the Note Receivable were based on estimated gross wages billed for the clients transferred to Vensure pursuant to the Vensure Asset Sale as of the measurement date.

The Company used the following assumptions to value the Note Receivable as of August 31, 2020:

•Discount rate of 15%

•Actual monthly wages billed to the extent available to the Company

For interim reporting periods after December 31, 2020, including as of February 28, 2022 and August 31, 2021, the Company valued the Note Receivable as discussed in Note 3, Discontinued Operations, below.

The development and determination of the unobservable inputs for Level 3 fair value measurements and the fair value calculations are the responsibility of the Company’s chief financial officer and are approved by the chief executive officer. There were no transfers out of Level 3 for the three or six months ended February 28, 2022.

Advertising Costs

The Company expenses all advertising as incurred. The Company incurred advertising costs totaling $435,000 and $897,000 for the three and six months ended February 28, 2022 and $719,000 and $921,000 for the three and six months ended February 28, 2021, respectively.

Income Taxes

The Company accounts for income taxes pursuant to ASC 740, Income Taxes. Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority.

Earnings (Loss) Per Share

The Company utilizes ASC 260, Earnings per Share. Basic Net Income (Net Loss) per common share is computed by dividing Net Income (Net Loss) attributable to common shareholders by the weighted-average number of shares of common stock outstanding during the reporting period. Common stock outstanding for purposes of Net Income (Net Loss) per share calculations include unexercised Preferred Options and unexercised prefunded warrants, as described in Note 7, Stockholders' Equity, below. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the

denominator is increased to include additional common stock equivalents available upon exercise of stock options and warrants using the treasury stock method. Dilutive common stock equivalents include the dilutive effect of in-the-money stock equivalents, which are calculated based on the average share price for each period using the treasury stock method, excluding any common stock equivalents if their effect would be anti-dilutive. In periods in which a net loss has been incurred, all potentially dilutive common stock shares are considered anti-dilutive and thus are excluded from the calculation. Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

	For the Three Months Ended		For the Six Months Ended
	February 28, 2022	February 28, 2021	February 28, 2022	February 28, 2021
Options (See Note 8)	1,769,497	1,822,173	1,769,497	1,822,173
Warrants (See Note 7)	27,113,736	4,396,209	22,440,225	4,396,209
Total potentially dilutive shares	28,883,233	6,218,382	28,883,233	6,218,382

For the table above, “Options” represent all options granted under the Company’s 2017 Stock Option/Stock Issuance Plan (the "Plan"), as described in Note 8, Stock Based Compensation, below.

Stock-Based Compensation

At February 28, 2022, the Company had one stock-based compensation plan under which the Company may issue awards, as described in Note 8, Stock Based Compensation, below. The Company accounts for the Plan under the recognition and measurement principles of ASC 718, Compensation- Stock Compensation, which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the condensed consolidated statements of operations at their fair values.

The grant date fair value is determined using the Black-Scholes-Merton (“Black-Scholes”) pricing model. For all employee stock options, the Company recognizes expense on an accelerated basis over the employee’s requisite service period (generally the vesting period of the equity grant).

The Company’s option pricing model requires the input of highly subjective assumptions, including the expected stock price volatility and expected term. The expected volatility is based on the historical volatility of the Company’s common stock since our initial public offering. Any changes in these highly subjective assumptions significantly impact stock-based compensation expense.

The Company elects to account for forfeitures as they occur. As such, compensation cost previously recognized for an unvested award that is forfeited because of the failure to satisfy a service condition is revised in the period of forfeiture.

The methods and assumptions used in the determination of the fair value of stock-based awards are consistent with those described in the Company's Annual Report on Form 10-K and 10-K/A for Fiscal 2021, filed with the SEC on December 3, 2021 and on February 28, 2022, respectively, which includes a detailed description of the Company's stock-based compensation awards, including information related to vesting terms, service and performance conditions, payout percentages, and process for estimating the fair value of stock options granted.

Recent Accounting Standards

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This standard requires an impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces multiple existing impairment models in current U.S. GAAP, which generally requires a loss to be incurred before it is recognized. The new standard applies to trade receivables arising from revenue transactions such as contract assets and accounts receivable. Under ASC 606, revenue is recognized when, among other criteria, it is probable that an entity will collect the consideration it is entitled to when goods or services are transferred to a customer. When trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. This guidance is effective for smaller reporting companies for annual periods beginning after December 15, 2022, including the interim periods in the year. Early adoption is permitted. The Company will adopt the guidance when it becomes effective.

On December 31, 2019, the FASB issued ASC 2019-12 “Income Taxes: Simplifying the Accounting for Income Taxes” (“Topic 740”). The amendments in this update simplify the accounting for income taxes by removing certain exceptions. For public business entities, the amendments in this update are effective for fiscal years, and interim periods

within those fiscal years, beginning after December 15, 2020. Early adoption of the amendments is permitted, including adoption in any interim period for (1) public business entities for periods for which financial statements have not yet been issued and (2) all other entities for periods for which financial statements have not yet been made available for issuance. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The Company will adopt the guidance when it becomes effective.

Variable Interest Entity

The Company is involved in the formation of various entities considered to be Variable Interest Entities (“VIEs”). The Company evaluates the consolidation of these entities as required pursuant to ASC Topic 810 relating to the consolidation of VIEs. These VIEs are primarily formed to sponsor the related SPACs.

The Company’s determination of whether it is the primary beneficiary of VIE is based in part on an assessment of whether or not the Company and its related parties are exposed to the majority of the risks and rewards of the entity. Typically, the Company is entitled to substantially all or portion of the economics of these VIEs. The Company is the primary beneficiary of the VIE entities.

During the six months ended February 28, 2022, our sponsored SPAC, IHC, completed its IPO, selling 11,500,000 units (the "IHC Units") pursuant to a registration statement and prospectus, as described below. The IPO closed on October 22, 2021, raising gross proceeds of $115 million. These proceeds were deposited in a trust account established for the benefit of the IHC public shareholders and, along with an additional $1.675 million deposited in trust by the Company reserved for interest payments for future possible redemptions by IHC stockholders, are included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheet at February 28, 2022. These proceeds are invested only in U.S. treasury securities in accordance with the governing documents of IHC.

Each IHC Unit had an offering price of $10.00 and consisted of one share of IHC common stock and one redeemable warrant. Each warrant entitles the holder thereof to purchase one share of IHC common stock at a price of $11.50 per share. The IHC public stockholders have a right to redeem all or a portion of their shares of IHC common stock upon the completion of its IBC, subject to certain limitations. Under the terms of the registration statement and prospectus, IHC is required to consummate its IBC within 12 months of the completion of the IPO. If IHC is unable to meet this deadline, and no extension is granted, then IHC will redeem 100% of the public shares of common stock outstanding for cash, subject to applicable law and certain conditions.

In connection with the IPO, we purchased, through investments, 4,639,102 private placement warrants ("Placement Warrants") at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102, and we currently own 2,110,000 Founder Shares of IHC common stock, representing approximately 15% of the issued and outstanding common stock of IHC. Before the closing of the IPO, the Sponsor transferred 15,000 Founder Shares to IHC's independent directors, reducing its shareholdings from 2,125,000 to 2,110,000. Each Placement Warrant is identical to the warrants sold in the IPO, except as described in the IPO registration statement and prospectus. Following the completion of the IHC IPO, we determined that IHC is a Variable Interest Entity ("VIE") in which we have a variable interest because IHC does not have enough equity at risk to finance its activities without additional subordinated financial support. We have also determined that IHC's public stockholders do not have substantive rights, and their equity interest constitutes temporary equity, outside of permanent equity, in accordance with ASC 480-10-S99-3A. As such, we have concluded that we are currently the primary beneficiary of IHC as a VIE, as we have the right to receive benefits or the obligation to absorb losses of the entity, as well as the power to direct a majority of the activities that significantly impact IHC's economic performance. Since we are the primary beneficiary, IHC is consolidated into our condensed consolidated financial statements.

Shares Subject to Possible Redemption

The Company accounts for its common stock holdings in its sponsored SPACs, (which are consolidated in our condensed consolidated financial statements), that are subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of common stock are classified as shareholders’ equity. Each sponsored SPAC's shares of common stock feature certain

redemption rights that are considered to be outside of the SPAC's control and subject to occurrence of uncertain future events. Accordingly, as of February 28, 2022, shares of common stock subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.

The Company recognizes changes in redemption value of these shares immediately as they occur and adjusts the carrying value of redeemable shares of common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of the redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. As of February 28, 2022, the carrying amount of the sponsored SPAC shares of IHC common stock subject to redemption was recorded at their redemption value of $116.7 million. The remeasurement of the redemption value of the redeemable shares of common stock is recorded in equity. The remeasurement in equity comprised of offering cost incurred in connection with the sale of public shares of the SPACs was $13 million, consisting of approximately $9.5 million of offering costs related to the Founder Shares transferred to the SPACs’ underwriter representative as described in Note 5, Deferred Offering Costs, and $3.5 million in other offering costs related to the IPO paid at closing in cash.

XML

Discontinued Operations

6 Months Ended

Feb. 28, 2022

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Discontinued Operations

On January 3, 2020, the Company executed an asset purchase agreement assigning client contracts comprising approximately 88% of its quarterly revenue through the date of the transaction, including 100% of its existing professional employer organization (“PEO”) business effective as of December 31, 2019, and transferring $1.5 million of working capital assets, including cash balances and certain operating assets associated with the assigned client contracts included in the agreement, to a wholly owned subsidiary of Vensure (the “Vensure Asset Sale”). Gross proceeds from the Vensure Asset Sale were $19.2 million, of which $9.7 million was received at closing and $9.5 million was scheduled to be paid out in equal monthly payments over the four years following the closing of the transaction (the “Note Receivable”), subject to adjustments for working capital and customer retention, (as measured by a gross wage guarantee included in the governing agreement), over the twelve month period following the Vensure Asset Sale.

For Fiscal 2020, the Company estimated the value of the Note Receivable at fair value as discussed in Note 2, Summary of Significant Accounting Policies, above. For the three months ended February 28, 2022, the Company recorded the Note Receivable based on our estimate of expected collections which, in turn, was based on additional information obtained through discussions with Vensure and evaluation of our records. On March 12, 2021, the Company received correspondence from Vensure proposing approximately $10.7 million of working capital adjustments under the terms of the Vensure Asset Sale agreement which, if accepted, would have had the impact of eliminating any sums owed to the Company under the Note Receivable. As indicated in the reconciliation table below, the Company has recorded $2.6 million of working capital adjustments, subject to final review and acceptance, and has provided for an additional reserve of $2.9 million for potential claims. By letter dated April 6, 2021, the Company disputed Vensure’s proposed adjustments.The disputes between the Company and Vensure regarding working capital adjustments under the Vensure Asset Sale agreement are currently the subject of litigation pending in the Delaware Chancery Court, as discussed at Note 11, Contingencies, Vensure Litigation, below.

The following is a reconciliation of the gross proceeds to the net proceeds from the Vensure Asset Sale as presented in the balance sheet for the period ended February 28, 2022.

Gross proceeds	$	19,166,000
Cash received at closing – asset sale	(9,500,000)
Cash received at closing – working capital	(166,000)
Gross note receivable	$	9,500,000
Less:  Transaction reconciliation – estimated working capital adjustments	(2,604,000)
Adjusted Note Receivable	6,896,000
Reserve for estimated potential claims	(2,892,000)
Long-term note receivable, estimated net realizable value	$	4,004,000

The entire Note Receivable is recorded as a long term note receivable as of February 28, 2022. Any adjustments to the Note Receivable are applied against payments in the order they are due to be paid.

The Vensure Asset Sale generated a gain of $15.6 million for Fiscal 2020. The Company expected a minimal tax impact from the Vensure Asset Sale as it utilized its net operating losses accumulated since inception to offset the gain resulting from discontinued operations tax provision with a corresponding offset to the valuation allowance.

The Vensure Asset Sale met the criteria of discontinued operations set forth in ASC 205 and as such the Company has reclassified its discontinued operations for all periods presented and has excluded the results of its discontinued operations from continuing operations for all periods presented.

The terms of the Vensure Asset Sale call for adjustments to the Note Receivable either for: (i) working capital adjustments or (ii) in the event that the gross wages of the business transferred is less than the required amount.

(i) Working capital adjustments: Through February 28, 2022, the Company has identified $2.6 million of likely working capital adjustments, including $88,000 related to lower net assets transferred at closing, and $2.5 million of cash remitted to the Company’s bank accounts, net of cash remitted to Vensure’s bank accounts. Under the terms of the Vensure Asset Sale, a reconciliation of the working capital was to have been completed by April 15, 2020. Due to operational difficulties and quarantined staff caused by the outbreak of COVID-19, Vensure requested a postponement of the working capital reconciliation that was due in Fiscal 2020. Although Vensure provided the Company with its working capital reconciliation on March 12, 2021, it failed to provide adequate documentation to support its calculations. Accordingly, the working capital adjustment recorded as of February 28, 2022, represents the Company’s estimate of the reconciliation adjustment by using Vensure’s claims and the limited supporting information Vensure provided as a starting point, and then making adjustments for amounts in dispute based upon our internal records and best estimates. There is no assurance that the working capital change identified as of February 28, 2022 represents the final working capital adjustment.

(ii) Gross billings adjustment: Under the terms of the Vensure Asset Sale, the proceeds of the transaction are reduced if the actual gross wages of customers transferred for Calendar 2020 are less than 90% of those customers’ Calendar 2019 gross wages. The Company has prepared an estimate of the Calendar 2020 gross wages based on a combination of factors including reports of actual transferred client billings in early Calendar 2020, actual gross wages of continuing customers of the Company, publicly available unemployment reports for the Southern California markets and the relevant COVID-19 impacts on employment levels, and other information. Based on the information available, the Company estimated that it would receive additional consideration below the required threshold and reduced the contingent consideration by $1.4 million. Vensure has not identified any such adjustments to date. Based on the information available, the Company reclassified the previously recorded gross wages claim to a general potential claims reserve during Fiscal 2021. No additional adjustment was made during the three months ended February 28, 2022.

The carrying amounts of the classes of assets and liabilities from the Vensure Asset Sale included in discontinued operations are as follows:

	February 28, 2022		August 31, 2021
Cash	$	—	$	—
Accounts receivable and unbilled account receivable	—		—
Prepaid expenses and other current assets	—		—
Deposits – workers’ compensation	92,000		356,000
Total current assets	92,000		356,000
Fixed assets, net	—		—
Deposits – workers’ compensation	232,000		883,000
Total assets	$	324,000	$	1,239,000
Accounts payable and other current liabilities	$	—	$	—
Payroll related liabilities	—		—
Accrued workers’ compensation cost	—		1,516,000
Total current liabilities	—		1,516,000
Accrued workers’ compensation cost	—		3,765,000
Total liabilities	—		5,281,000
Net liability	$	324,000	$	(4,042,000)

Reported results for the discontinued operations by period were as follows:

	For the Three Months Ended				For the Six Months Ended
	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
Revenues	$	—	$	—	$	—	$	—
Cost of revenue	18,000		221,000		151,000		1,535,000
Gross profit	(18,000)		(221,000)		(151,000)		(1,535,000)
Operating expenses:
Salaries, wages and payroll taxes	—		—		—		—
Commissions	—		—		—		—
Total operating expenses	—		—		—		—
(Loss) income from discontinued operations	$	(18,000)	$	(221,000)	$	(151,000)	$	(1,535,000)

XML

Special Purpose Acquisition Company ("SPAC") Sponsorship

6 Months Ended

Feb. 28, 2022

Investments in and Advances to Affiliates [Abstract]

Special Purpose Acquisition Company ("SPAC") Sponsorship

Special Purpose Acquisition Company ("SPAC") Sponsorship

On April 29, 2021, we announced our sponsorship, through our wholly-owned subsidiary, ShiftPixy Investments, Inc. ("Investments"), of four SPACs.

Each SPAC was seeking to raise approximately $150 million in capital investment, through an IPO, to acquire companies in the healthcare and technology segments of the staffing industry, as well as one or more insurance entities, while IHC has completed its IPO and is seeking to acquire companies in the light industrial segment of the staffing industry, as described below. We anticipated that, through our wholly-owned subsidiary, we would own approximately 15% of the issued and outstanding stock in each entity upon their IPOs being consummated, and that each would operate as a separately managed, publicly traded entity following the completion of their respective IBCs. We also anticipated entering into service agreements with each of the staffing entities that would allow them to participate in our HRIS platform. We also expected to facilitate the procurement of workers’ compensation, personal liability, and other similar insurance products for these staffing entities through our anticipated relationship with the insurance SPAC after it completed its IBC. For the three and six month periods ended

February 28, 2022, the sponsorship operations for all of these entities, with the exception of IHC, are consolidated in the accompanying financial statements as they were being conducted under a wholly-owned subsidiary. The operations of IHC have been consolidated in the accompanying financial statements for the reasons set forth above.

The registration statement and prospectus covering the IPO of IHC was declared effective by the SEC on October 19, 2021, and IHC Units, consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the New York Stock Exchange (“NYSE”) on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, we purchased, through our wholly-owned subsidiary, 4,639,102 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102.

Following the closing of the IPO, the sum of $116,725,000 was placed in a trust account (the “Trust Account”), and has been invested in U.S. government securities within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the "ICA"), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the ICA, as determined by the Company, until the earlier of: (i) the completion of the IBC and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The $116,725,000 consisted of the $115,000,000 of gross proceeds from the sale of the IHC Units in the IPO and $1,725,000 funded by the Company, as the corporate parent of the Sponsor, representing guaranteed interest for future redemptions and calculated as one year's interest at 1.5%. With the completion of the IPO, the Company recorded approximately $38.0 million of deferred costs in APIC as of February 28, 2022, and $274,000 of offering costs paid on behalf of IHC. During the six months ended February 28, 2022, IHC incurred approximately $3.5 million in offering costs. No other offering costs have been incurred during the three month period ended February 28, 2022, for the other SPACs. The Trust Account generated interest income for the six month period ended February 28, 2022 of approximately $7,000.

On March 18, 2022, we announced the withdrawal of the IPO registration statements related to Vital Human Capital, Inc. ("Vital"), TechStackery, Inc. ("TechStackery"), and Firemark Global Capital, Inc. ("Firemark"), in order to focus on the growth and expansion of our Company and to completing IHC's IBC.

XML

Deferred Offering Costs - SPACs

6 Months Ended

Feb. 28, 2022

Noncontrolling Interest [Abstract]

Deferred Offering Costs - SPACs

Deferred Offering Costs - SPACs

During Fiscal 2021, the Company incurred professional fees related to the filing of registration statements for the IPOs of four SPACs. The Company also transferred certain Founder Shares of those SPACs to a third party which created a non-controlling interest in those entities. These Founder Shares of common stock were transferred to the SPACs’ underwriter representative (the “Representative”) at below fair market value, resulting in compensation and therefore deferred offering costs for the SPACs, and the creation of a minority interest. The non-controlling interest is recorded as a minority interest on the Balance Sheet and the Statement of Equity.

As of August 31, 2021, Deferred offering costs - SPACs totaled $48,261,000, consisting of $789,000 of legal and accounting fees related to the SPACs’ IPOs and $47,472,000 related to the non-controlling interest in consolidated subsidiaries.

The non-controlling interest – deferred offering costs represents the estimated value of the portion of our Founder Shares in each of the following SPACs that we received as a result of our sponsorship, and which we transferred to the Representative on April 22, 2021, at a price below the fair market value of the shares, as follows: (i) 2,000,000 shares of IHC common stock; (ii) 2,000,000 shares of TechStackery common stock; (iii) 2,000,000 shares of Vital common stock; and (iv) 4,000,000 shares of Firemark common stock. We estimate the total value of the 10,000,000 shares transferred, which represents deferred compensation to the Representative, to be $47,472,000, or $4.7472 per share. We arrived at this valuation by reference to similar SPAC IPO transactions, as set forth below:

1.Consistent with most SPAC IPOs, the market price of units (consisting of some combination of common stock and warrants) sold to the public in a SPAC IPO is $10 per unit.

2.We have valued the warrant portion of each Unit at $0.75. Deducting this value from the Unit yields a value of $9.25 per share of common stock at the time of the IPO, which we have applied to the value of each of the Founder Shares that we issued to the Representative.

3.We have applied a further discount of 48.8%, which is a blended discount designed to reflect the following contingencies and uncertainties: (a) 20% probability that the SPAC IPOs are never consummated; (b) 20% probability that none of our sponsored SPACs successfully complete their IBC; and (c) 21% additional discounts to account for future sponsor and Representative concessions, as well as the possibility of decrease in the value of the common stock of each SPAC.

One of the Company's sponsored SPACs, IHC, completed its IPO on October 22, 2021, resulting in the recognition of approximately $13 million of offering costs, including $9.8 million that had been deferred as of August 31, 2021. No offering costs were incurred for TechStackery, Vital, or Firemark during the quarter ended February 28, 2022.As discussed in Note 4, Special Purpose Acquisition Company ("SPAC") Sponsorship , and Note 12, Subsequent Events, the Company has announced its withdrawal of registration statements on Form S-1 previously filed with the SEC relating to three of its Sponsored SPACs — Vital, TechStackery, and Firemark -- to devote its resources to completing IHC's IBC. The abandonment of these SPAC IPOs, resulted in our recognition of approximately $38.5 million of deferred offering costs against $38 million in non-controlling interest and $0.5 million in the other expenses in our Condensed Consolidated Statement of Operations.

XML

Going Concern

6 Months Ended

Feb. 28, 2022

Risks and Uncertainties [Abstract]

Going Concern

Going Concern

The accompanying financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. As of February 28, 2022, the Company had cash of $3.3 million and a working capital deficit of $14.9 million. During this same period, the Company used approximately $10.33 million of cash from its continuing operations and incurred recurring losses, resulting in an accumulated deficit of $166.9 million as of February 28, 2022.

Historically, our principal source of financing has come through the sale of our common stock and issuance of convertible notes. In May 2020, we successfully completed an underwritten public offering, raising a total of $12 million ($10.3 million net of costs), and closed an additional $1.35 million ($1.24 million net of costs) between June 1, 2020 and July 7, 2020 pursuant to the underwriter’s over-allotment. In October 2020, we closed an additional $12 million equity offering ($10.7 million net of costs). In May 2021, we raised approximately $12 million ($11.1 million net of costs) in connection with the sale of common stock and warrants. More recently, in September 2021, we raised approximately $12 million ($11.1 million net of costs) in connection with the sale of common stock and warrants, and in January 2022, we entered into a warrant exercise agreement that raised approximately $5.9 million ($5.4 million net of costs).

The recurring losses, negative working capital and cash used in the Company’s operations are indicators of substantial doubt as to the Company’s ability to continue as going concern for at least one year from issuance of these financial statements. Our plans and expectations for the next twelve months include raising additional capital to help fund expansion of our operations, including the continued development and support of our information technology (“IT”) and HRIS platform, as well as our activities in connection with our sponsorship of IHC described above. We expect to continue to invest in our HRIS platform, ShiftPixy Labs, our sponsorship of IHC and other growth initiatives, all of which have required and will continue to require significant cash expenditures.

The Company believes that IHC has the potential to generate additional payroll billings revenue during the fiscal year ending August 31, 2022 ("Fiscal 2022"), provided that IHC successfully completes its IBC and the Company is able to enter into one or more client services agreements with IHC on favorable terms.

The Company also expects its ShiftPixy Labs growth initiative to generate cash flow once launched, by functioning as an incubator of food service and restaurant concepts through collaboration and partnerships with local innovative chefs. If successful, the Company believes that this initiative will produce sound businesses that provide recurring revenue through direct sales, as well as through utilization of the ShiftPixy Ecosystem, HRIS platform, and other human capital services that the Company provides. To the extent that this business model is successful and can be replicated in other locations, the Company believes that it has the potential to contribute significant revenue to ShiftPixy in the future. The Company may also take equity stakes in various branded restaurants that it develops and operates with its partners through ShiftPixy Labs. Such ownership interests will be held to the extent that it is consistent with the Company’s continued existence as an operating company, and to the extent that the Company believes such ownership interests have the potential to create significant value for its shareholders.

The Company expects to engage in additional sales of its securities during Fiscal 2022, either through registered public offerings or private placements, the proceeds of which the Company intends to use to fund its operations and growth initiatives.

The Company’s management believes that its current cash position, (including the proceeds of the January 2022 warrant exercise described above), along with its anticipated revenue growth and proceeds from future sales of its securities, when combined with prudent expense management, will be sufficient to alleviate substantial doubt about its ability to continue as a going concern and to fund its operations for at least one year from the date these financials are available (especially when considering the absence of any funded debt outstanding on its balance sheet). If these sources do not provide the capital necessary to fund the Company’s operations during the next twelve months, it may need to curtail certain aspects of its operations or expansion activities, consider the sale of additional assets, or consider other means of financing. The Company

can give no assurance that it will be successful in implementing its business plan and obtaining financing on advantageous terms, or that any such additional financing will be available. These consolidated financial statements do not include any adjustments for this uncertainty.

XML

Stockholders' Equity

6 Months Ended

Feb. 28, 2022

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

Preferred Stock

Preferred Stock

As previously disclosed, in September 2016, the founding shareholders of the Company were granted options to acquire preferred stock of the Company (the “Preferred Options”). The number of Preferred Options granted was based upon the number of shares held at the time of the grant. These Preferred Options are nontransferable and forfeited upon the sale of the related founding shares of common stock held by the option holder. Upon the occurrence of certain specified events, such founding shareholders can exercise each Preferred Option to purchase one share of preferred stock of the Company at an exercise price of $0.0001 per share. The preferred stock underlying the Preferred Options does not include any rights to dividends or preference upon liquidation of the Company and is convertible into shares of the Company’s common stock on a one-for-one basis. Upon consummation of the Vensure Asset Sale in January 2020, a total of 24,634,560 Preferred Options became exercisable and exchangeable into an equal number of shares of our common stock.

On June 4, 2020, Scott W. Absher, the Company’s Chief Executive Officer, exercised 12,500,000 Preferred Options to purchase 12,500,000 shares of our preferred stock for an aggregate purchase price of $1,250. Immediately following the exercise of the Preferred Options described above, Mr. Absher elected to convert the 12,500,000 shares of preferred stock into 12,500,000 shares of common stock, which are subject to a 24-month lock-up period during which such shares may not be traded. Between July 20, 2020 and November 30, 2020, an additional 294,490 Preferred Options were exercised and converted into 294,490 shares of common stock, which were subject to a six-month lock up period at the time they were issued, during which such shares could not be traded on the open market. As of February 28, 2022, the restrictions on all of these shares have been lifted, rendering them freely tradeable.

On October 22, 2021, the Company’s board of directors canceled 11,790,000 of these Preferred Options previously issued to its co-founder, J. Stephen Holmes. Accordingly, these Preferred Options are no longer exercisable. A total of 37,570 Preferred Options issued pursuant to the September 2016 grant and triggered by the Vensure Asset Sale remain unexercised.

The amount of Preferred Options, and the number of shares of preferred stock issuable upon exercise of such options, is based upon the number of shares of common stock held by the option holders at the time the Preferred Options were issued in September 2016. Accordingly, in order to confirm the original intent of the granting of up to 25,000,000 Preferred Options to Mr. Absher, it has always been the Company’s intent to adopt a second grant of an additional 12,500,000 Preferred Options to Mr. Absher, whereby each option permits the holder to acquire one share of the Company’s preferred stock for $0.0001 per share. On August 13, 2021, consistent with this intent, the Company granted 12,500,000 Preferred Options to Mr. Absher to purchase shares of Preferred Stock, par value $0.0001 per share, for consideration of $0.0001 per share. Each Preferred Option is exercisable for a period of twenty-four months upon (i) the acquisition of a Controlling Interest (as defined below) in the Company by any single shareholder or group of shareholders acting in concert, (other than Mr. Absher), or (ii) the announcement of (x) any proposed merger, consolidation, or business combination in which the Company’s Common Stock is changed or exchanged, or (y) any sale or distribution of at least 50% of the Company’s assets or earning power, other than through a reincorporation. Each share of Preferred Stock is convertible into Common Stock on a one-for-one basis. “Controlling Interest” means the ownership or control of outstanding voting shares of the Company sufficient to enable the acquiring person, directly or indirectly and individually or in concert with others, to exercise one-fifth or more of all the voting power of the Company in the election of directors or any other business matter on which shareholders have the right to vote under the Wyoming Business Corporation Act. As of February 28, 2022, no events have occurred that would trigger the exercise of the Preferred Options issued to Mr. Absher in August 2021.

Common Stock and Warrants

During the six months ended February 28, 2022, the Company closed the following transactions:

January 2022 Warrant Exercise Agreement

On May 17, 2021, we issued warrants to purchase up to an aggregate of 4,948,453 shares of our common stock, par value $0.0001 per share, with an exercise price of $2.425 (the "Existing Warrants"). The Existing Warrants were immediately exercisable and expire on June 15, 2026. On January 26, 2022, we entered into a Warrant Exercise Agreement ("the Exercise Agreement") with the holder of the Existing Warrants (the "Exercising Holder"). Pursuant to the Exercise Agreement, the

Exercise Holder and the Company agreed that, subject to any applicable beneficial ownership limitations, the Exercising Holder would cash exercise up to 4,948,453 of its Existing Warrants (the "Investor Warrants") into shares of our common stock underlying such Existing Warrants (the "Exercised Shares"). To induce the Exercising Holder to exercise the Investor Warrants, the Exercise Agreement (i) amended the Investor Warrants to reduce their exercise price per share to $1.20 and (ii) provided for the issuance of a new warrant to purchase up to an aggregate of approximately 9,896,906 shares of our common stock (the “January 2022 Common Warrant”), with such January 2022 Common Warrant being issued on the basis of two January 2022 Common Warrant shares for each share of the Existing Warrant that was exercised for cash. The January 2022 Common Warrant is exercisable commencing on July 28, 2022, terminates on July 28, 2027, and has an exercise price per share of $1.55. The Exercise Agreement generated aggregate proceeds to the Company of approximately $5.9 million, prior to the deduction of $461,000 of costs consisting of placement agent commissions and offering expenses payable by the Company. As a result of the warrant modification, which reduced the exercise price of the Existing Warrants, as well as the issuance of the January 2022 Common Warrants, the Company recorded approximately (i) $639,000 for the increased fair value of the modified warrants; and (ii) $12,590,000 as the fair value of the January 2022 Common Warrants on the date of issuance. We recorded approximately $5,477,000 as issuance costs that offset the $5.5 million of additional paid-in capital the Company received for the cash exercise of the Existing Warrants at the reduced exercise price, while the remaining $7,731,000 was recorded as a deemed dividend on the Condensed Consolidated Statements of Operations, resulting in a reduction of income available to common shareholders in our basic earnings per share calculation.

September 2021 Private Placement

In September 2021, the Company entered into a $12 million private placement transaction, inclusive of $0.9 million of placement agent fees and costs, with a large institutional investor pursuant to which the Company sold to the investor an aggregate of (i) 2,850,000 shares of Common Stock, together with warrants (the “September 2021 Common Warrants”) to purchase up to 2,850,000 shares of Common Stock, with each September 2021 Common Warrant exercisable for one share of Common Stock at a price per share of $1.595, and (ii) 4,673,511 prefunded warrants (the “September 2021 Prefunded Warrants”), together with the September 2021 Common Warrants to purchase up to 7,523,511 shares of Common Stock, with each September 2021 Prefunded Warrant exercisable for one share of Common Stock at a price per share of $0.0001. Each share of Common Stock and accompanying September 2021 Common Warrant were sold together at a combined offering price of $1.595 and each September 2021 Prefunded Warrant and accompanying September 2021 Common Warrant were sold together at a combined offering price of $1.5949.

The September 2021 Prefunded Warrants are immediately exercisable, at a nominal exercise price of $0.0001, and may be exercised at any time until all of the September 2021 Prefunded Warrants are exercised in full. The September 2021 Common Warrants have an exercise price of $1.595 per share, are immediately exercisable, and will expire five years from the date that the registration statement covering the resale of the shares underlying the September 2021 Common Warrants is declared effective (which has not yet occurred). The private placement generated gross proceeds of approximately $12.0 million, prior to deducting $0.9 million of costs consisting of placement agent commissions and offering expenses payable by the Company. In addition to the seven percent (7%) of the aggregate gross proceeds cash fee, the Company issued to the placement agent warrants to purchase 376,176 shares of our common stock issuable upon exercise of the September 2021 Prefunded Warrants sold in the offering (the “September Placement Agent Warrants”). The September Placement Agent Warrants are exercisable for a period commencing on March 3, 2022 (six months after issuance) and expire four years from the effective date (which has not yet occurred) of a registration statement for the resale of the underlying shares, and have an initial exercise price per share of $1.7545.

The following table summarizes the changes in the Company’s common stock and Prefunded  Warrants from August 31, 2021 to February 28, 2022.

	Number of shares	Weighted average remaining life (years)	Weighted average exercise price
Warrants outstanding, August 31, 2021	9,592,085	4.7	$	3.87
Issued	22,470,104	4.7	1.58
(Cancelled)	—	—	—
(Exercised)	(4,948,453)	4.3	1.2
Warrants outstanding, February 28, 2022	27,113,736	4.7	2.83
Warrants exercisable, February 28, 2022	16,840,654	4.2	$	0.95

The following table summarizes the Company’s warrants outstanding as of February 28, 2022:

	Warrants Outstanding	Weighted average Life of Outstanding Warrants in years	Exercise price
Jan 2022 Common Warrants(1)	9,896,906	5.4	$	1.55
Sep 2021 Common Warrants	7,523,511	4.5	1.60
Sep 2021 Prefunded Warrants(2)	4,673,511	4.5	N/A
Sep 2021Underwriter Warrants (3)	376,176	4.5	1.75
May 2021Underwriter Warrants	247,423	4.2	2.43
October 2020 Common Warrants	2,300,000	3.6	3.30
October 2020 Underwriter Warrants	200,000	3.6	3.30
February 2021 Common Warrants	1,277,580	3.2	5.40
February 2021 Underwriter Warrants	111,108	3.2	5.40
March 2020 Exchange Warrants	423,669	3.6	10.17
Amended March 2019 Warrants	66,288	2.0	40.00
March 2019 Services Warrants	3,366	2.0	70.00
June 2018 Warrants	6,276	1.8	40.00
June 2018 Services Warrants	5,422	1.8	99.60
2017 PIPE Warrants	2,500	0.3	276.00
	27,113,736	4.7	$	2.22

(1)The January 2022 Common Warrants are exercisable commencing on July 28, 2022 and terminate on July 28, 2027..

(2)The September 2021 Prefunded Warrants were sold as part of a Prefunded Warrant Unit as described above at a nominal price of $0.0001 per share.

(3)The September 2021 Placement Agent Warrants become exercisable six months from issuance and expire four years from the effective date (which has not yet occurred) of the registration statement covering the resale of the underlying shares.

XML

Stock Based Compensation

6 Months Ended

Feb. 28, 2022

Share-based Payment Arrangement [Abstract]

Stock Based Compensation

Stock Based Compensation

Employee Stock Option Plan Increase

In March 2017, the Company adopted its 2017 Stock Option/Stock Issuance Plan (the “Plan”). The Plan provides incentives to eligible employees, officers, directors and consultants in the form of incentive stock options (“ISOs”), non-qualified stock options (“NQs”), (each of which is exercisable into shares of common stock), (collectively, “Options”) or shares of common stock (“Share Grants”).

On July 1, 2020, the Company's board of directors unanimously approved an increase in the number of shares of common stock issuable under the Plan from 250,000 to 3,000,000. On March 31, 2021, the Company’s shareholders approved the increase in the number of shares of common stock issuable under the Plan as well as any contingent grant awards under the Plan on or subsequent to July 1, 2020. On June 4, 2021, the Company registered an aggregate of 3,000,000 shares, par value $0.0001 per share, reserved for issuance under the Plan.

For all options granted prior to July 1, 2020, each option has a term of service vesting provision over a period of time as follows: 25% vest after a 12-month service period following the award, with the balance vesting in equal monthly installments over the succeeding 36 months. Options granted on or after July 1, 2020 typically vest over four years, with 25% of the grant vesting one year from the grant date, and the remainder in equal quarterly installments over the succeeding 12 quarters. All options granted to date have a stated ten-year term and, as of February 28, 2022, all options granted to date are exercisable.

Stock grants are issued at fair value, considered to be the market price on the grant date. The fair value of option awards is estimated on the grant date using the Black-Scholes stock option pricing model.

Following its adoption of ASU 2016-9, the Company elected to account for forfeitures under the Plan as they occur. Any compensation cost previously recognized for an unvested award that is forfeited because of a failure to satisfy a service condition is reversed in the period of the forfeiture.

The Company recognized approximately $339,000 and $747,000 of compensation expense for the three and six months ended February 28, 2022, respectively.

The Company compensates its board members through grants of common stock for services performed. These services have been accrued within the accounts payable and other accrued liabilities on the condensed consolidated balance sheet. The Company has incurred $81,000 and $205,000 for the three and six months ended February 28, 2022, respectively.

The following table summarizes option activity during the six months ended February 28, 2022:

	Options Outstanding and Exercisable
	Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance Outstanding, August 31, 2021	1,776,115	8.90	$	6.80
Granted	120,000	9.76	0.76
Exercised	—	—	—
Forfeited	(126,618)	8.66	(3.70)
Balance Outstanding at February 28, 2022	1,769,497	8.61	$	6.98
Balance Exercisable at February 28, 2022	1,769,497

 

Options outstanding as of February 28, 2022 had aggregate intrinsic value of $1,415. 

At February 28, 2022, the total unrecognized deferred share-based compensation expected to be recognized over the remaining weighted average vesting periods of 2.77 years for outstanding grants was $3,002,000. Option vesting activity from August 31, 2021, through February 28, 2022 was as follows:

Options Vested	Number of Options	Weighted Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance, August 31, 2021	309,257	8.63	$	16.92
Vested	218,077	8.57	4.88
Exercised	—	—	—
Forfeited	(8,011)	7.87	7.97
Balance, February 28, 2022	519,323	8.28	$	12.14

The following table summarizes information about stock options outstanding and vested at February 28, 2022: 

	Options Outstanding				Options Vested
Exercise Prices	Number of Options Exercisable	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In Years)				(In Years)
$0.75 - 10.00	1,730,808	8.6	$	4.27	483,756	8.4	$	4.93
$10.01 - $40.00	2,000	7.3	18.95		1,453	7.3	19.01
$40.01 - $80.00	13,100	7.1	51.21		11,066	7.1	51.21
$80.01 - $120.00	10,271	6.2	102.91		9,862	6.2	102.93
$120.01 - $160.00	12,193	5.5	155.36		12,060	5.5	155.39
$160.01 - $391.60	1,125	5.4	391.60		1,125	5.4	391.60
	1,769,497	8.6	$	6.64	519,322	8.3	$	12.14

XML

Related Parties

6 Months Ended

Feb. 28, 2022

Related Party Transactions [Abstract]

Related Parties

Related Parties

Director Compensation

On February 10, 2020, Amanda Murphy was appointed to our Board. Ms. Murphy was our Director of Operations at the time of her appointment. Ms. Murphy received approximately $240,000 in Fiscal 2021 and on October 22, 2021, our Board approved the promotion of Ms. Murphy to the position of Chief Operating Officer, as well as an increase in her annual salary to $500,000, all of which were effective January 1, 2022. As of February 28, 2022, Ms. Murphy has deferred payment of her salary increase. Nevertheless, Ms. Murphy's base pay increase is recorded in accrued liabilities on the condensed balance sheets.

During Fiscal 2021, in connection with her relocation to Miami, Florida as part of the relocation of our principal executive offices, Ms. Murphy received a one-time incentive payment of approximately $80,000 in addition to reimbursement of her expenses associated with her relocation.

Scott W. Absher, our CEO and Chair of our Board, received compensation in the form of salary of approximately $750,000 for Fiscal 2021. On October 22, 2021, our Board approved raising Mr. Absher’s annual salary to $1,000,000, effective January 1, 2022, and also approved the payment of a $500,000 bonus to Mr. Absher, 50% of which was payable upon Board approval, and the remainder of which was payable on January 1, 2022. As of February 28, 2022, Mr. Absher had not received any bonus payments and has deferred payment of his salary increase and bonus. Nevertheless, the bonuses and the incremental base salary for Mr. Absher's base pay increase are recorded in accrued liabilities in the condensed consolidated balance sheets. Further, the Company paid Mr. Absher 50% of his bonus, or $250,000, in March 2022.

In addition, Mr. Absher received the following additional payments during Fiscal 2021: (i) a one-time incentive payment of approximately $170,000 in connection with his relocation to Miami, Florida as part of the relocation of our principal executive offices, in addition to reimbursement of his expenses associated with his relocation; and (ii) a one-time bonus payment in the amount of $240,000 in recognition of his efforts on behalf of the Company.

J. Stephen Holmes

J. Stephen Holmes formerly served as a non-employee sales manager advisor to and was a significant shareholder of the Company. The Company incurred $750,000 in professional fees for services provided by Mr. Holmes during each of Fiscal 2021. For the six months ended February 28, 2022, Mr. Holmes was compensated $120,000 for his services.

On or about October 22, 2021, we severed all ties with Mr. Holmes, effective immediately, and cancelled Preferred Options that had previously been issued to him but had not been exercised. As a result of these actions, the Company no longer has any financial obligation to Mr. Holmes, and believes that he is no longer a significant shareholder of the Company. See Note 7, Stockholders Equity.

Related Persons to Scott Absher

Mark Absher, the brother of Scott Absher, was previously employed as our Registered In-House Counsel, Director and Secretary. Mr. Absher resigned from his positions with the Company on February 6, 2019 and received compensation of $276,951 in Fiscal 2019. On November 18, 2021, Mr. Absher rejoined the Company as Deputy General Counsel – Special Projects, for an annual salary of $240,000 for Fiscal 2022. Based on his re-hire date, Mr. Absher did not receive any compensation from the Company in Fiscal 2021 or Fiscal 2020.

David May, a member of our business development team, is the son-in-law of Scott Absher. Mr. May received compensation of approximately $125,000 in Fiscal 2021. In addition, in connection with his relocation to Miami, Florida, as part of the relocation of our principal executive offices, Mr. May received a one-time incentive payment of approximately $103,000 during Fiscal 2021, in addition to reimbursement for expenses associated with his relocation.

Jason Absher, a member of our business development team, is the nephew of Scott Absher and the son of Mark Absher. Mr. Absher was hired on February 22, 2021 at an annual salary of $75,000, which was subsequently raised to $120,000, effective August 1, 2021.

Phil Eastvold, the Executive Producer of ShiftPixy Labs, is the son-in-law of Scott Absher. Mr. Eastvold was hired on September 1, 2020. Mr. Eastvold received compensation for Fiscal 2021 of approximately $200,000. In addition, in connection with his relocation to Miami, Florida as part of the relocation of our principal executive offices, Mr. Eastvold received a one-time incentive payment of approximately $111,000 during Fiscal 2021, in addition to reimbursement for expenses associated with his relocation.

Connie Absher, (the spouse of Scott Absher), Elizabeth Eastvold, (the daughter of Scott Absher and spouse of Mr. Eastvold), and Hannah Absher, (the daughter of Scott Absher), are also employed by the Company. These individuals, as a group, received aggregate compensation of $183,000 in Fiscal 2021. In addition, in connection with her relocation to Miami, Florida as part of the relocation of our principal executive offices, Hannah Absher received a one-time incentive payment of approximately $18,000 during Fiscal 2021, in addition to reimbursement for expenses associated with her relocation. Connie Absher and Elizabeth Eastvold did not receive any such relocation bonus.

XML

Commitments

6 Months Ended

Feb. 28, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments

Commitments

Operating Leases & License Agreements

Effective April 15, 2016, the Company entered into a non-cancelable five-year operating lease for its Irvine facility. On July 25, 2017, the Company entered into a non-cancelable operating lease for expansion space at its Irvine offices with a termination date that coincides with the termination date of the prior lease and extended the terms of the original lease until 2022. The leases for certain facilities contain escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $35,000.

Effective August 13, 2020, the Company entered into a non-cancelable seven-year lease for 13,246 square feet of office space located in Miami, Florida to house its principal executive offices commencing October 2020, and continuing through September 2027. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $57,000.

Effective October 1, 2020, the Company entered into a non-cancelable 64-month lease for 23,500 square feet of primarily industrial space located in Miami, Florida, to house ghost kitchens, production facilities, and certain marketing and technical functions, including those associated with ShiftPixy Labs. The lease contains escalation clauses relating to increases in real property taxes as well as certain maintenance costs. Monthly rent expense under this lease is approximately $34,000.

Effective June 7, 2021, the Company entered into a non-cancelable sublease agreement with Verifone, Inc. to sublease premises consisting of approximately 8,000 square feet of office space located in Miami, Florida, that the Company anticipates using for its sales and operations workforce. The lease has a term of three years expiring on May 31, 2024. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the sublease. Monthly rent expense under this lease is approximately $26,000.

Effective June 21, 2021, the Company entered into a non-cancelable 77-month lease, with an anticipated possession date of March 1, 2022, for premises consisting of approximately 13,418 square feet of office space located in Sunrise, Florida, that the Company anticipates using primarily to house its operations personnel and other elements of its workforce. The base rent is paid monthly and escalates annually pursuant to a schedule set forth in the lease. Monthly rent expense under this lease is approximately $27,000.

The components of lease expense is as follows:

	Three Months ended February 28, 2022		Six Months ended on February 28, 2022
Operating Lease Cost	$	334,251	$	788,203

Future minimum lease and licensing payments under non-cancelable operating leases at February 28, 2022, are as follows:

	Minimum lease commitments
2022	$	731,000
2023	1,739,000
2024	1,737,000
2025	1,532,000
2026	1,275,000
Thereafter	1,515,000
Total minimum payments	$	8,529,000
Less: present value discount	1,164,000
Lease Liability	$	7,365,000
Weighted-average remaining lease term - operating leases (months)	54
Weighted-average discount rate	5.54		%

The Company has a finance lease for a copier located in our Irvine office totaling $33,030 with a monthly minimum lease payment of $756, which began on April 1, 2020 and continues through March 2, 2025. The principal balance of the finance lease was $23,391 and $26,260 as of February 28, 2022 and August 31, 2021, respectively, and is included within our accounts payable and other accrued liabilities in our Condensed Consolidated Balance Sheets.

Non-contributory 401(k) Plan

The Company has a non-contributory 401(k) Plan (the “401(k) Plan”). The 401(k) Plan covers all non-union employees who are at least 21 years of age and have completed 3 months of service. There were no employer contributions to the 401(k) Plan for the three or six months ended February 28, 2022 and February 28, 2021.

Special Purpose Acquisition Company Sponsorship

On April 29, 2021, the Company announced its sponsorship, through a wholly-owned subsidiary, of four SPAC IPOs. The Company purchased founder shares in each SPAC (the "Founder Shares"), through its wholly-owned subsidiary, for an aggregate purchase price of $25,000 per SPAC. The number of Founder Shares issued was determined based on the expectation that such Founder Shares would represent 15% of the outstanding shares of each SPAC after its IPO (excluding the private placement warrants described below and their underlying securities).

The registration statement and prospectus covering the IPO of one of these SPACs, IHC, was declared effective by the SEC on October 19, 2021, and IHC units (the “IHC Units”), consisting of one share of common stock and an accompanying warrant to purchase one share of IHC common stock, began trading on the NYSE on October 20, 2021. The IHC IPO closed on October 22, 2021, raising gross proceeds for IHC of $115 million. In connection with the IHC IPO, the Company purchased, through its wholly-owned subsidiary, 4,639,102 placement warrants at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102. Each private placement warrant is exercisable to purchase one whole share of common stock in IHC at $11.50 per share. The private placement warrants will be worthless to the extent that IHC does not complete an initial business combination.

The investment amounts set forth above do not include loans that the Company may extend to each SPAC in an amount not to exceed $500,000 individually (or $2 million in the aggregate), in its role as sponsor. As of February 28, 2022, the Company had advanced, through its wholly owned subsidiary, an aggregate of approximately $820,000 to the SPACs for payment of various expenses in connection with the SPAC IPOs, principally consisting of SEC registration, legal and auditing fees.

The Company previously disclosed that it anticipates that each of the SPACs will repay these advanced expenses from the proceeds of their respective SPAC IPOs. On March 18, 2022, however, we announced the withdrawal of registration statements on Form S-1 previously filed with the SEC relating to the following three SPACs for which we had served as Sponsor through our wholly-owned subsidiary: Firemark, TechStackery and Vital. Accordingly, the Company does not anticipate receiving repayment of any advanced expenses on behalf of these three SPACs, which total $625,000 as of February 28, 2022. During the six month period ended February 28, 2022, the Company received approximately $183,000 from IHC, as repayment of advances provided by the sponsor.

XML

Contingencies

6 Months Ended

Feb. 28, 2022

Commitments and Contingencies Disclosure [Abstract]

Contingencies

Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will be resolved only when one or more future events occur or fail to occur. The Company’s management, in consultation with its legal counsel as appropriate, assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

During the ordinary course of business, the Company is subject to various claims and litigation. Management believes that after consulting legal counsel the outcome of such claims or litigation will not have a material adverse effect on the Company’s financial position, results of operations or cash flow.

Kadima Litigation

The Company is in a dispute with its former software developer, Kadima Ventures (“Kadima”), over incomplete but paid for software development work. In May 2016, the Company entered into a contract with Kadima for the development and deployment of user features that were proposed by Kadima for an original build cost of $2.2 million to complete. This proposal was later revised upward to approximately $7.2 million to add certain features to the original proposal. As of February 28, 2022, the Company has paid approximately $11 million to Kadima, but has never been provided access to the majority of the promised software. Kadima has refused to continue development work, denied access to developed software, and refused to surrender to the Company any software that it has developed unless the Company pays an additional $12.0 million above the $11.0 million already paid. In April 2019, Kadima filed a complaint against the Company in the Superior Court of the State of Arizona, Maricopa County, alleging claims for breach of contract, promissory estoppel and unjust enrichment, and seeking damages in excess of $11.0 million. The Company vigorously disputes and denies each of Kadima’s claims, including that it owes any sums to Kadima, and further believes that it is entitled, at a minimum, to a refund of a substantial portion of the sums that it has already paid, along with the release of the software modules currently being withheld. In June 2020, the Company engaged in a mediation with Kadima in an attempt to resolve the matter, which was unsuccessful. On July 14, 2020 the Company filed an answer to Kadima’s complaint, which denied Kadima’s claims and asserted counter-claims for breach of contract and fraud. Discovery is complete, and the Court has set a trial date of September 12, 2022.

Splond Litigation

On April 8, 2019, claimant, Corey Splond, filed a class action lawsuit, on behalf of himself and other similarly situated individuals in the Eighth Judicial District Court for the State of Nevada, Clark County, naming the Company and its client as defendants, and alleging violations of certain wage and hour laws. This lawsuit is in the initial stages, and the Company denies any liability. Even if the plaintiff ultimately prevails, the potential damages recoverable will depend substantially upon whether the Court determines in the future that this lawsuit may appropriately be maintained as a class action. Further, in the event that the Court ultimately enters a judgment in favor of plaintiff, the Company believes that it would be contractually entitled to be indemnified by its client against at least a portion of any damage award.

Radaro Litigation

On July 9, 2020, the Company was served with a complaint filed by one of its former software vendors, Radaro Inc., in the United States District Court for the Central District of California, alleging damages arising from claims sounding in breach of contract and fraud. By Order filed October 21, 2020, the Court dismissed plaintiff’s claims for fraud and for punitive damages, with leave to replead. The Company denies plaintiff’s claims and is defending the lawsuit vigorously. Discovery is underway, and the Court has set a trial date of September 6, 2022.

Everest Litigation

On December 18, 2020, the Company was served with a Complaint filed in the United States District Court for the Central District of California by its former workers’ compensation insurance carrier, Everest National Insurance Company. The Complaint asserts claims for breach of contract, alleging that the Company owes certain premium payments to plaintiff under a retrospective rated policy, and seeks damages of approximately $600,000. On February 5, 2021, the Company filed an Answer to Plaintiff’s Complaint denying its claims for relief, and also filed a cross-claim against the third party claims administrator, Gallagher Bassett Services, Inc., for claims sounding in breach of contract and negligence based upon its administration of claims arising under the policy. By order dated April 7, 2021, the Court dismissed the Company’s complaint against Gallagher Bassett without prejudice to re-filing in another forum. On May 17, 2021, the Company refiled its complaint against Gallagher Basset in the Circuit Court of Cook County, Illinois, and the Court substantially denied Gallagher Basset's motion to dismiss the complaint by order dated January 31, 2022. Discovery is underway in both cases, and the California Court has set a trial date in the Everest case of February 7, 2023, while no trial date has been set in the Illinois case.

Sunz Litigation

On March 19, 2021, the Company was served with a Complaint filed in the Circuit Court for the 11th Judicial Circuit, Manatee County, Florida, by its former workers’ compensation insurance carrier, Sunz Insurance Solutions, LLC. The Complaint asserts claims for breach of contract, alleging that the Company owes payments for loss reserve funds totaling approximately $10 million. The Company denies plaintiff’s allegations and is defending the lawsuit vigorously. On May 12, 2021, the Company filed a motion to dismiss the complaint, and Sunz filed an amended complaint in response. Discovery is proceeding in the matter and no trial date has been set.

Vensure Litigation

On September 7, 2021, Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure, filed a complaint against the Company in the Court of Chancery of the State of Delaware asserting claims arising from the Asset Purchase Agreement (the “APA”) governing the Vensure Asset Sale described above. The APA provided for Vensure to purchase, through its wholly-owned subsidiary, certain of the Company’s assets for total consideration of $19 million in cash, with $9.5 million to be paid at closing, and the remainder to be paid in 48 equal monthly installments (the “Installment Sum”). The Installment Sum was subject to certain adjustments to account for various post-closing payments made by the parties, and the APA provided for the following procedure to determine the final amount of the Installment Sum: (i) Within 90 days of the effective date, Vensure was required to provide the Company with a “Proposed Closing Statement”, which must detail any adjustments; (ii) Within 30 days of its receipt of Vensure’s Proposed Closing Statement, the Company had the right to challenge any of the proposed adjustments contained therein; and (iii) If the Company disputed Vensure’s Proposed Closing Statement, a 30-day period ensued for the parties to attempt to resolve the dispute, with the Company entitled to examine “such Books and Records of [Vensure] as relate to the specific items of dispute . . .”

Vensure resisted the Company’s repeated efforts to obtain the Proposed Closing Statement for over one year after the closing of the transaction. Finally, on March 12, 2021, under threat of legal action by the Company, Vensure provided its Proposed Closing Statement, in which it contended for the first time that it owes nothing to the Company, and that the Company actually owes Vensure the sum of $1,519,991. By letter dated April 6, 2021, the Company provided Vensure with its objections to the Proposed Closing Statement, which included Vensure’s gross overstatement of payments it purportedly made on the Company’s behalf, as well as its bad faith actions in obstructing the Company’s efforts to make these payments.

From April 2021 through August 2021, Vensure and the Company engaged in the “30-day negotiation period” referred to above, which was extended multiple times at Vensure’s request to provide Vensure an opportunity to provide evidence supporting its assertions. Over the course of these negotiations, Vensure withdrew its claim for approximately $1.5 million from the Company, and acknowledged that Vensure owed ShiftPixy some portion of the Installment Fund. Nevertheless, in early September 2021, without warning and contrary to the dispute resolution provisions of the APA, Vensure filed suit against the Company in Delaware Chancery Court for breach of contract and declaratory judgment, seeking unspecified damages. The Company vigorously disputes and denies each of Vensure’s claims. Accordingly, on November 4, 2021, the Company filed its Answer and Counterclaim to Vensure’s Complaint, in which it not only denied Vensure’s claims, but also asserted counterclaims for breach of contract and tortious interference with contract. The counterclaim seeks damages from Vensure totaling approximately $9.5 million – the full amount due under the APA - plus an award of attorneys’ fees and expenses. Discovery is expected to commence shortly.

XML

Subsequent Events

6 Months Ended

Feb. 28, 2022

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Management has evaluated events that have occurred subsequent to the date of these consolidated financial statements and has determined that, other than those listed below, no such reportable subsequent events exist through the date the financial statements were issued in accordance with FASB ASC Topic 855, "Subsequent Events."

Withdrawal of Certain SPAC Sponsorships

On March 18, 2022, the Company announced the withdrawal of registration statements on Form S-1 previously filed with the SEC relating to three SPACs for which its wholly owned subsidiary, ShiftPixy Investments, Inc., had previously been identified as the Sponsor: Vital, TechStackery, and Firemark. We noted in a press release accompanying this announcement that we had decided to devote our resources to assisting our other sponsored SPAC, IHC, which previously consummated its IPO, to completing its IBC as quickly as possible.

Nasdaq Listing Notification

On April 4, 2022, we received a letter from the staff of the Listing Qualifications Department (the "Staff") of Nasdaq notifying us that for the previous 30 consecutive business days, the bid price for our common stock had closed below the minimum $1.00 per share requirement for continued listing under Nasdaq's Listing Rule 5550(a)(2) (the "Minimum Bid Requirement"). This notification has no immediate effect on the listing or trading of our common stock on Nasdaq. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), if during the 180 calendar days following the notification, or prior to October 3, 2022, the closing bid price of our common stock is at or above $1.00 per share for a minimum of ten consecutive business days, the Staff will provide us with written confirmation of compliance. If we do not achieve the Minimum Bid Price Requirement by October 3, 2022, we may be eligible for an additional 180 calendar days compliance period if we meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for Nasdaq, with the exception of the Minimum Bid Price Requirement, and we provide written notice of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. However, if it appears to the Staff that we will not be able to cure the deficiency, or if we are otherwise not eligible, then the Staff would notify us that our securities would be subject to delisting. In the event of such notification, we may appeal the Staff's determination to delist our securities, but the Staff may refuse to grant our request for continued listing.

XML

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Feb. 28, 2022

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) applicable to interim reports of companies filing as a small reporting company. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results of operations for the three and six months ended February 28, 2022 are not necessarily indicative of the results that may be expected for the full year ending August 31, 2022.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K and 10-K/A for the fiscal year ended August 31, 2021 (“Fiscal 2021”), filed with the SEC on December 3, 2021 and February 28, 2022, respectively.

Principles of Consolidation

Principles of Consolidation

The condensed consolidated financial statements include the accounts of ShiftPixy Inc, and its wholly-owned subsidiaries. The condensed consolidated financial statements also include the accounts of (a) Industrial Human Capital, Inc. ("IHC"), which is a special purpose acquisition company, or "SPAC", for which we serve as the financial sponsor (as described below), and which is deemed to be controlled by us as a result of our 15% equity ownership stake, the overlap of three of our executive officers as executive officers of IHC, and significant influence that we currently exercise over the funding and acquisition of new operations for an initial business combination ("IBC"). (See Note 2, Variable Interest Entity). All intercompany balances have been eliminated in consolidation.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:

•Liability for legal contingencies;

•Useful lives of property and equipment;

•Deferred income taxes and related valuation allowance;

•Valuation of illiquid non-controlling interest in SPAC shares transferred;

•Valuation of long-lived assets including long term notes receivable prior to January 1, 2021; and

•Projected development of workers’ compensation claims.

Revenue and Direct Cost Recognition

Revenue and Direct Cost Recognition

For the year ended August 31, 2021 ("Fiscal 2021"), we adopted Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), using the modified retrospective approach. Under this method, the guidance is applied only to the most current period presented in the financial statements. ASU No. 2014-09 outlines a single comprehensive revenue recognition model for revenue arising from contracts with customers and superseded most of the previous revenue recognition guidance, including industry-specific guidance. Under ASU No. 2014-09, an entity recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. Our revenue recognition policies remained substantially unchanged as a result of the adoption of ASU No. 2014-09 and we did not have any significant changes in our business processes or systems.

The Company’s revenues are primarily disaggregated into fees for providing staffing solutions and EAS/HCM services. The Company enters into contracts with its clients for Staffing or EAS based on a stated rate and price in the contract. Contracts generally have a term of 12 months but are cancellable at any time by either party with 30 days’ written notice. The performance obligations in the agreements are generally combined into one performance obligation, as they are considered a series of distinct services, and are satisfied over time because the client simultaneously receives and consumes the benefits provided as the Company performs the services. Payments for the Company’s services are typically made in advance of, or at the time that the services are provided. The Company does not have significant financing components or significant payment terms for its customers and consequently has no material credit losses. The Company uses the output method based on a stated rate and price over the payroll processed to recognize revenue, as the value to the client of the goods or services transferred to date appropriately depicts our performance towards complete satisfaction of the performance obligation.

Staffing Solutions

The Company records gross billings as revenues for its staffing solutions clients. The Company is primarily responsible for fulfilling the staffing solutions services and has discretion in establishing price. The Company includes the payroll costs in revenues with a corresponding increase to cost of revenues for payroll costs associated with these services. As a result, we are the principal in this arrangement for revenue recognition purposes. For the three months ended February 28, 2021, the Company recognized no revenues that should have been evaluated under a staffing solutions model.

EAS Solutions

EAS solutions revenue is primarily derived from the Company’s gross billings, which are based on (i) the payroll cost of the Company’s worksite employees (“WSEs”) and (ii) a mark-up computed as a percentage of payroll costs for payroll taxes and workers’ compensation premiums.

Gross billings are invoiced to each EAS client concurrently with each periodic payroll of the Company’s WSEs, which coincides with the services provided and which is typically a fixed percentage of the payroll processed. Revenues, which exclude the payroll cost component of gross billings and therefore consist solely of markup, are recognized ratably over the payroll period as WSEs perform their services at the client worksite. Although the Company assumes responsibility for processing and remitting payroll and payroll related obligations, it does not assume employment-related responsibilities such as determining the amount of the payroll and related payroll obligations. As a result, the Company records revenue on a “net” basis in this arrangement for revenue recognition purposes. Revenues that have been recognized but not invoiced for EAS clients are included in unbilled accounts receivable on the Company’s consolidated balance sheets, and were $2,615,000 and $2,741,000, as of February 28, 2022 and August 31, 2021, respectively.

Consistent with the Company’s revenue recognition policy for EAS clients, direct costs do not include the payroll cost of its WSEs. The cost of revenue associated with the Company’s revenue generating activities is primarily comprised of all other

costs related to its WSEs, such as the employer portion of payroll-related taxes, employee benefit plan premiums and workers’ compensation insurance costs.

The fees collected from the worksite employers for benefits (i.e. zero-margin benefits pass-through), workers’ compensation and state unemployment taxes are presented in revenues and the associated costs of benefits, workers’ compensation and state unemployment taxes are included in operating expenses for EAS clients, as the Company does retain risk and acts as a principal with respect to this aspect of the arrangement. With respect to these fees, the Company is primarily responsible for fulfilling the service and has discretion in establishing price.

Disaggregation of Revenue

The Company’s primary revenue streams include HCM and staffing services. The Company’s disaggregated revenues for the three and six months ended February 28, 2022 and February 28, 2021 were as follows:

	For the Three Months Ended				For the Six Months Ended
Revenue (in millions):	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
HCM1	$	1.6	2.4		$	3.3	4.9
Staffing	8.8		—		16.1		—
	$	10.4	$	2.4	$	19.4	$	4.9

1 HCM revenue is presented net, $12.6 million and $25.5 million gross billings less WSE payroll costs of $11.0 million and $22.2 million for the three and six months ended February 28, 2022, respectively and $17.9 million and $37.6 million gross less WSE payroll cost of $15.5 and $32.7 million for the three and six months ended February 28, 2021, respectively.

During Fiscal 2021 the Company announced the launch of ShiftPixy Labs. We generated no revenue from this initiative during the three or six months ended February 28, 2022.

For the three and six months ended February 28, 2022 and February 28, 2021, the following geographical regions represented more than 10% of total revenues:

	For the Three Months Ended				For the Six Months Ended
Region:	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
California	53	%	67	%	54	%	68	%
Washington	13	%	10	%	13	%	10	%

Incremental Cost of Obtaining a Contract

Pursuant to the “practical expedients” provided under ASU No 2014-09, the Company expenses sales commissions when incurred because the terms of its contracts are cancellable by either party upon 30 days' notice. These costs are recorded in commissions in the Company’s Consolidated Statements of Operations.

Segment Reporting

Segment Reporting

Prior to Fiscal 2021, the Company operated as one reportable segment under ASC 280, Segment Reporting. The chief operating decision maker regularly reviews the financial information of the Company at a consolidated level in deciding how to allocate resources and in assessing performance. During Fiscal 2021, the Company entered into new business lines and geographic areas that, to date, are not material. However, with the migration to Staffing during the fiscal quarter ending May 31, 2021, the Company is beginning to manage the business on a segmented basis and therefore intends to report such information once systems and processes are updated accordingly. Reporting and monitoring activities on a segment basis will allow the chief operating decision maker to evaluate operating performance more effectively. See also Disaggregation of Revenue, above.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased as cash equivalents. The Company had no such investments as of February 28, 2022 or August 31, 2021.

Marketable Securities Held in Trust Account

At February 28, 2022, substantially all of the assets held in the Trust Account were invested in U.S. Treasury securities with maturities of 180 days or less. These funds are restricted for use and may only be used for purposes of completing an IBC or redemption of the public common shares of IHC.

Concentration of Credit Risk

Concentration of Credit RiskThe Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal.

Fixed Assets

Fixed Assets

Fixed assets are recorded at cost, less accumulated depreciation and amortization. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When fixed assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Leasehold improvements are amortized over the shorter of the useful life or the initial lease term.

Fixed assets are recorded at cost and are depreciated over the estimated useful lives of the related assets using the straight-line method. The estimated useful lives of property and equipment for purposes of computing depreciation are as follows:

Equipment:	5 years
Furnitures & Fixtures:	5 - 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

The amortization of these assets is included in depreciation expense on the condensed consolidated statements of operations.

Internal Use Software

Internal Use Software

Software development costs relate primarily to software coding, systems interfaces and testing of the Company’s proprietary employer information systems and are accounted for in accordance with ASC 350-40, Internal Use Software.

Internal software development costs are capitalized from the time the internal use software is considered probable of completion until the software is ready for use. Business analysis, system evaluation and software maintenance costs are expensed as incurred. The capitalized computer software development costs are reported under the section fixed assets, net in the condensed consolidated balance sheets.

The Company determined that there were no material capitalized internal software development costs for the three and six months ended February 28, 2022. All capitalized software recorded was purchased from third party vendors. Capitalized software development costs are amortized using the straight-line method over the estimated useful life of the software, generally three to five years from when the asset is placed in service.

Lease Recognition

Lease Recognition

In February 2016, the FASB established Topic 842, Leases, by issuing ASU No. 2016-02 (“ASC 842”), which required lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The standard established a right-of-use model (“ROU”) that required a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the Condensed Statement of Operations.

The Company adopted the standard on December 1, 2021 with an effective date of September 1, 2021. A modified retrospective transition approach was required, applying the standard to all leases existing at the date of initial application. An entity could choose to use either (1) the effective date of the standard or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chose the second option, the transition requirements for existing leases also applied to leases entered into between the date of initial application and the effective date. The entity had to also recast its comparative period financial statements and provide the disclosures required by the standard for the comparative periods. The Company elected to use the effective date as its date of initial application. Consequently, financial information was not updated and the disclosures required under the standard were not provided for dates and periods prior to September 1, 2021.

The standard provided a number of optional practical expedients as part of transition accounting. The Company elected the “package of practical expedients”, which allowed the Company to avoid reassessing its prior conclusions about lease identification, lease classification and initial direct costs under the standard. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements as these were not applicable to the Company.

The standard had a material effect on the Company’s Condensed Consolidated Financial Statements. The most significant changes related to (1) the recognition of ROU assets and lease liabilities on the Condensed Consolidated Balance Sheet for its office equipment and real estate operating leases and (2) providing significant disclosures about the Company’s leasing activities.

Upon adoption, the Company recognized additional operating liabilities of approximately $7.7 million, with corresponding ROU operating lease asset, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The Company determined if an arrangement was a lease at inception. The Company used an incremental borrowing rate based on the information available at the commencement date of the lease to determine the present value of lease payments. In determining the ROU asset and lease liability at lease inception, the lease terms could include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

The standard also provided practical expedients for an entity’s ongoing accounting for leases. The Company elected the short-term lease recognition exemption for office equipment leases. For those current and prospective leases that qualify as short-term, the Company will not recognize ROU assets or lease liabilities. The Company also elected the practical expedient to not separate lease and non-lease components for all of its real estate leases.

Impairment and Disposal of Long-Lived Assets

Impairment and Disposal of Long-Lived AssetsThe Company periodically evaluates its long-lived assets for impairment in accordance with ASC 360-10, Property, Plant, and Equipment. ASC 360-10 requires that an impairment loss be recognized for assets to be disposed of or held-for-use when the carrying amount of an asset is deemed not to be recoverable. If events or circumstances were to indicate that any of our long-lived assets might be impaired, the Company would assess recoverability based on the estimated undiscounted future cash flows to be generated from the applicable asset. In addition, the Company may record an impairment loss to the extent that the carrying value of the asset exceeds the fair value of the asset. Fair value is generally determined using an estimate of discounted future net cash flows from operating activities or upon disposal of the asset.

Workers' Compensation

Workers’ Compensation

Everest Program

Until July 2018, a portion of the Company’s workers’ compensation risk was covered by a retrospective rated policy, which calculates the final policy premium based on the Company’s loss experience during the term of the policy and the stipulated formula set forth in the policy. The Company funds the policy premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. During the policy term and thereafter, periodic adjustments may involve either a return of previously paid premiums or a payment of additional premiums by the Company or a combination of both. If the Company’s losses exceed the expected losses under that policy, then the Company could receive a demand for additional premium payments. The Company is currently engaged in litigation regarding such a demand for additional premium payments, which we believe to be without merit, as discussed at Note 11, Contingencies, Everest Litigation, below.

Sunz Program

From July 2018 through February 28, 2021, the Company’s workers’ compensation program for its WSEs was provided primarily through an arrangement with United Wisconsin Insurance Company and administered by Sunz Insurance Solutions, LLC (“Sunz”). Under this program, the Company has financial responsibility for the first $0.5 million of claims per occurrence. The Company provides and maintains a loss fund that is earmarked to pay claims and claims related expenses. The workers’ compensation insurance carrier establishes monthly funding requirements comprised of premium costs and funds to be set aside for payment of future claims (“claim loss funds”). The level of claim loss funds is primarily based upon anticipated WSE payroll levels and expected workers’ compensation loss rates, as determined by the insurance carrier. Monies funded into the program for incurred claims expected to be paid within one year are recorded as Deposit - workers’ compensation, a short-term asset, while the remainder of claim funds are included in Deposit- workers’ compensation, a long-term asset in its consolidated balance sheets. The Company is currently engaged in litigation regarding demands by Sunz for additional claims loss funds, which we believe to be without merit, as discussed at Note 11, Contingencies, Sunz Litigation, below.

Current Program

Effective March 1, 2021, the Company migrated its clients to a guaranteed cost program. Under this program, the Company’s financial responsibility is limited to the cost of the workers’ compensation premium. The Company funds the workers’ compensation premium based on standard premium rates on a monthly basis and based on the gross payroll applicable to workers covered by the policy. Any final adjustments to the premiums are based on the final audited exposure multiplied by the applicable rates, classifications, experience modifications and any other associated rating criteria.

Under the Everest and Sunz programs, the Company utilized a third party to estimate its loss development rate, which was based primarily upon the nature of WSEs’ job responsibilities, the location of WSEs, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. Each reporting period, changes in the assumptions resulting from changes in actual claims experience and other trends are incorporated into its workers’ compensation claims cost estimates.

As of February 28, 2022 and August 31, 2021, the Company had $0.04 million and $0.2 million, in Deposit – workers’ compensation classified as a short-term asset and $0.1 million and $0.4 million, classified as a long-term asset, respectively.

The Company’s estimate of incurred claim costs expected to be paid within one year is included in short-term liabilities, while its estimate of incurred claim costs expected to be paid beyond one year is included in long-term liabilities on its consolidated balance sheets. As of February 28, 2022 and August 31, 2021, the Company had short term accrued workers’ compensation costs of $0.6 million and $0.7 million, and long term accrued workers’ compensation costs of $1.3 million and $1.6 million, respectively.

The Company retained workers’ compensation asset reserves and workers’ compensation related liabilities for former WSEs of clients transferred to Shiftable HR Acquisition, LLC, a wholly-owned subsidiary of Vensure Employer Services, Inc. (“Vensure”), in connection with the Vensure Asset Sale described in Note 3, Discontinued Operations, below. As of February 28, 2022, the retained workers’ compensation assets and liabilities are presented as a discontinued operation net asset or liability. As of February 28, 2022, the Company had $0.1 million in short term assets and $1.3 million of short term liabilities, and had $0.2 million of long term assets and $3.2 million of long term liabilities.

Because the Company bears the financial responsibility for claims up to the level noted above, such claims, which are the primary component of its workers’ compensation costs, are recorded in the period incurred. Workers’ compensation insurance

includes ongoing health care and indemnity coverage whereby claims are paid over numerous years following the date of injury. Accordingly, the accrual of related incurred costs in each reporting period includes estimates, which take into account the ongoing development of claims and therefore requires a significant level of judgment. In estimating ultimate loss rates, the Company utilizes historical loss experience, exposure data, and actuarial judgment, together with a range of inputs that are primarily based upon the WSE’s job responsibilities, their location, the historical frequency and severity of workers’ compensation claims, and an estimate of future cost trends. For each reporting period, changes in the actuarial assumptions resulting from changes in actual claims experience and other trends are incorporated into the Company’s workers’ compensation claims cost estimates. The estimated incurred claims are based upon: (i) the level of claims processed during each quarter; (ii) estimated completion rates based upon recent claim development patterns under the plan; and (iii) the number of participants in the plan.

The Company has had very limited and immaterial COVID-19 related claims between March 2020 through the date of this Quarterly Report, although there is a possibility of additional workers’ compensation claims being made by furloughed WSEs as a result of the employment downturn caused by the pandemic. On May 4, 2020, the State of California indicated that workers who become ill with COVID-19 would have a potential claim against workers’ compensation insurance for their illnesses. There is a possibility that additional workers’ compensation claims could be made by employees required to work by their employers during the COVID-19 pandemic, which could have a material impact on our workers’ compensation liability estimates. While the Company has not seen significant additional expenses as a result of any such potential claims to date, which would include claims for reporting periods after February 28, 2022, we continue to monitor closely all workers’ compensation claims made as the COVID-19 pandemic continues.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

ASC 820, Fair Value Measurement, requires entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practical to estimate fair value. ASC 820 defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. At February 28, 2022 and August 31, 2021, the carrying value of certain financial instruments (cash, accounts receivable and payable) approximated fair value due to the short-term nature of the instruments. Notes Receivable is valued at estimated fair value as described below.

The Company measures fair value under a framework that utilizes a hierarchy prioritizing the inputs to relevant valuation techniques. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of inputs used in measuring fair value are:

•Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

•Level 2: Inputs to the valuation methodology include:

◦Quoted prices for similar assets or liabilities in active markets;

◦Quoted prices for identical or similar assets or liabilities in inactive markets;

◦Inputs other than quoted prices that are observable for the asset or liability;

◦Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

◦If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

•Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

Funds held in trust represent U.S. treasury bills that were purchased with funds raised through the initial public offering of IHC. The funds raised from SPACs are held in trust accounts that are restricted for use and may only be used for purposes of completing an IBC or redemption of the public shares of common stock of the SPACs as set forth in their respective trust agreements. The funds held in trust are included within Level 1 of the fair value hierarchy and included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheets.

The Company did not have other Level 1 or Level 2 assets or liabilities at February 28, 2022 or August 31, 2021. We recorded the fair value of the SPAC founder shares that the Company transferred to the underwriters using non-recurring Level 3 assumptions, including quoted asset prices for SPAC shares and warrants and estimates of the likelihood of the IPOs and IBCs of our sponsored SPACs being consummated. See also Note 5, Deferred Offering Costs – SPACS, below.

The valuation of the Note Receivable from the Vensure Asset Sale (as defined below), is a Level 3 fair value measurement as of August 31, 2020 and through December 31, 2020 (end of the earn-out period as defined under the terms of the Note Receivable).

The Note Receivable, as described in Note 3, Discontinued Operations, below, was estimated using a discounted cash flow technique based on expected contingent payments identified in the Vensure Asset Sale contract and with significant inputs that are not observable in the market and thus represents a Level 3 fair value measurement as defined in ASC 820. The Company valued the Note Receivable on the January 1, 2020 transaction date using a 10% discount rate, and on August 31, 2020 and through December 31, 2020 using a 15% discount rate, which contemplates the risk and probability assessments of the expected future cash flows. The significant inputs in the Level 3 measurement not supported by market activity include the probability assessments of expected future cash flows related to the Vensure Asset Sale, appropriately discounted considering the

uncertainties associated with the obligation, and as calculated in accordance with the terms of the Vensure Asset Sale agreement. For our fiscal year ended August 31, 2020 ("Fiscal 2020"), the expected cash payments from the Note Receivable were based on estimated gross wages billed for the clients transferred to Vensure pursuant to the Vensure Asset Sale as of the measurement date.

The Company used the following assumptions to value the Note Receivable as of August 31, 2020:

•Discount rate of 15%

•Actual monthly wages billed to the extent available to the Company

For interim reporting periods after December 31, 2020, including as of February 28, 2022 and August 31, 2021, the Company valued the Note Receivable as discussed in Note 3, Discontinued Operations, below.

The development and determination of the unobservable inputs for Level 3 fair value measurements and the fair value calculations are the responsibility of the Company’s chief financial officer and are approved by the chief executive officer. There were no transfers out of Level 3 for the three or six months ended February 28, 2022.

Advertising Costs

Advertising CostsThe Company expenses all advertising as incurred.

Income Taxes

Income Taxes

The Company accounts for income taxes pursuant to ASC 740, Income Taxes. Under ASC 740, deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The provision for income taxes represents the tax expense for the period, if any, and the change during the period in deferred tax assets and liabilities. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. Under ASC 740, the impact of an uncertain tax position on the income tax return may only be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority.

Earnings (Loss) Per Share

Earnings (Loss) Per Share

The Company utilizes ASC 260, Earnings per Share. Basic Net Income (Net Loss) per common share is computed by dividing Net Income (Net Loss) attributable to common shareholders by the weighted-average number of shares of common stock outstanding during the reporting period. Common stock outstanding for purposes of Net Income (Net Loss) per share calculations include unexercised Preferred Options and unexercised prefunded warrants, as described in Note 7, Stockholders' Equity, below. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the

denominator is increased to include additional common stock equivalents available upon exercise of stock options and warrants using the treasury stock method. Dilutive common stock equivalents include the dilutive effect of in-the-money stock equivalents, which are calculated based on the average share price for each period using the treasury stock method, excluding any common stock equivalents if their effect would be anti-dilutive. In periods in which a net loss has been incurred, all potentially dilutive common stock shares are considered anti-dilutive and thus are excluded from the calculation. Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

	For the Three Months Ended		For the Six Months Ended
	February 28, 2022	February 28, 2021	February 28, 2022	February 28, 2021
Options (See Note 8)	1,769,497	1,822,173	1,769,497	1,822,173
Warrants (See Note 7)	27,113,736	4,396,209	22,440,225	4,396,209
Total potentially dilutive shares	28,883,233	6,218,382	28,883,233	6,218,382

For the table above, “Options” represent all options granted under the Company’s 2017 Stock Option/Stock Issuance Plan (the "Plan"), as described in Note 8, Stock Based Compensation, below.

Share-Based Compensation

Stock-Based Compensation

At February 28, 2022, the Company had one stock-based compensation plan under which the Company may issue awards, as described in Note 8, Stock Based Compensation, below. The Company accounts for the Plan under the recognition and measurement principles of ASC 718, Compensation- Stock Compensation, which requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the condensed consolidated statements of operations at their fair values.

The grant date fair value is determined using the Black-Scholes-Merton (“Black-Scholes”) pricing model. For all employee stock options, the Company recognizes expense on an accelerated basis over the employee’s requisite service period (generally the vesting period of the equity grant).

The Company’s option pricing model requires the input of highly subjective assumptions, including the expected stock price volatility and expected term. The expected volatility is based on the historical volatility of the Company’s common stock since our initial public offering. Any changes in these highly subjective assumptions significantly impact stock-based compensation expense.

The Company elects to account for forfeitures as they occur. As such, compensation cost previously recognized for an unvested award that is forfeited because of the failure to satisfy a service condition is revised in the period of forfeiture.

The methods and assumptions used in the determination of the fair value of stock-based awards are consistent with those described in the Company's Annual Report on Form 10-K and 10-K/A for Fiscal 2021, filed with the SEC on December 3, 2021 and on February 28, 2022, respectively, which includes a detailed description of the Company's stock-based compensation awards, including information related to vesting terms, service and performance conditions, payout percentages, and process for estimating the fair value of stock options granted.

Recent Accounting Standards

Recent Accounting Standards

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). This standard requires an impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces multiple existing impairment models in current U.S. GAAP, which generally requires a loss to be incurred before it is recognized. The new standard applies to trade receivables arising from revenue transactions such as contract assets and accounts receivable. Under ASC 606, revenue is recognized when, among other criteria, it is probable that an entity will collect the consideration it is entitled to when goods or services are transferred to a customer. When trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. This guidance is effective for smaller reporting companies for annual periods beginning after December 15, 2022, including the interim periods in the year. Early adoption is permitted. The Company will adopt the guidance when it becomes effective.

On December 31, 2019, the FASB issued ASC 2019-12 “Income Taxes: Simplifying the Accounting for Income Taxes” (“Topic 740”). The amendments in this update simplify the accounting for income taxes by removing certain exceptions. For public business entities, the amendments in this update are effective for fiscal years, and interim periods

within those fiscal years, beginning after December 15, 2020. Early adoption of the amendments is permitted, including adoption in any interim period for (1) public business entities for periods for which financial statements have not yet been issued and (2) all other entities for periods for which financial statements have not yet been made available for issuance. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The Company will adopt the guidance when it becomes effective.

Variable Interest Entity

Variable Interest Entity

The Company is involved in the formation of various entities considered to be Variable Interest Entities (“VIEs”). The Company evaluates the consolidation of these entities as required pursuant to ASC Topic 810 relating to the consolidation of VIEs. These VIEs are primarily formed to sponsor the related SPACs.

The Company’s determination of whether it is the primary beneficiary of VIE is based in part on an assessment of whether or not the Company and its related parties are exposed to the majority of the risks and rewards of the entity. Typically, the Company is entitled to substantially all or portion of the economics of these VIEs. The Company is the primary beneficiary of the VIE entities.

During the six months ended February 28, 2022, our sponsored SPAC, IHC, completed its IPO, selling 11,500,000 units (the "IHC Units") pursuant to a registration statement and prospectus, as described below. The IPO closed on October 22, 2021, raising gross proceeds of $115 million. These proceeds were deposited in a trust account established for the benefit of the IHC public shareholders and, along with an additional $1.675 million deposited in trust by the Company reserved for interest payments for future possible redemptions by IHC stockholders, are included in Cash and marketable securities held in Trust Account in the accompanying condensed consolidated balance sheet at February 28, 2022. These proceeds are invested only in U.S. treasury securities in accordance with the governing documents of IHC.

Each IHC Unit had an offering price of $10.00 and consisted of one share of IHC common stock and one redeemable warrant. Each warrant entitles the holder thereof to purchase one share of IHC common stock at a price of $11.50 per share. The IHC public stockholders have a right to redeem all or a portion of their shares of IHC common stock upon the completion of its IBC, subject to certain limitations. Under the terms of the registration statement and prospectus, IHC is required to consummate its IBC within 12 months of the completion of the IPO. If IHC is unable to meet this deadline, and no extension is granted, then IHC will redeem 100% of the public shares of common stock outstanding for cash, subject to applicable law and certain conditions.

In connection with the IPO, we purchased, through investments, 4,639,102 private placement warrants ("Placement Warrants") at a price of $1.00 per warrant, for an aggregate purchase price of $4,639,102, and we currently own 2,110,000 Founder Shares of IHC common stock, representing approximately 15% of the issued and outstanding common stock of IHC. Before the closing of the IPO, the Sponsor transferred 15,000 Founder Shares to IHC's independent directors, reducing its shareholdings from 2,125,000 to 2,110,000. Each Placement Warrant is identical to the warrants sold in the IPO, except as described in the IPO registration statement and prospectus. Following the completion of the IHC IPO, we determined that IHC is a Variable Interest Entity ("VIE") in which we have a variable interest because IHC does not have enough equity at risk to finance its activities without additional subordinated financial support. We have also determined that IHC's public stockholders do not have substantive rights, and their equity interest constitutes temporary equity, outside of permanent equity, in accordance with ASC 480-10-S99-3A. As such, we have concluded that we are currently the primary beneficiary of IHC as a VIE, as we have the right to receive benefits or the obligation to absorb losses of the entity, as well as the power to direct a majority of the activities that significantly impact IHC's economic performance. Since we are the primary beneficiary, IHC is consolidated into our condensed consolidated financial statements.

Shares Subject to Possible Redemption

Shares Subject to Possible Redemption

The Company accounts for its common stock holdings in its sponsored SPACs, (which are consolidated in our condensed consolidated financial statements), that are subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of common stock are classified as shareholders’ equity. Each sponsored SPAC's shares of common stock feature certain

redemption rights that are considered to be outside of the SPAC's control and subject to occurrence of uncertain future events. Accordingly, as of February 28, 2022, shares of common stock subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.The Company recognizes changes in redemption value of these shares immediately as they occur and adjusts the carrying value of redeemable shares of common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of the redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.

XML

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Feb. 28, 2022

Accounting Policies [Abstract]

Disaggregation of Revenue

The Company’s disaggregated revenues for the three and six months ended February 28, 2022 and February 28, 2021 were as follows:

	For the Three Months Ended				For the Six Months Ended
Revenue (in millions):	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
HCM1	$	1.6	2.4		$	3.3	4.9
Staffing	8.8		—		16.1		—
	$	10.4	$	2.4	$	19.4	$	4.9

1 HCM revenue is presented net, $12.6 million and $25.5 million gross billings less WSE payroll costs of $11.0 million and $22.2 million for the three and six months ended February 28, 2022, respectively and $17.9 million and $37.6 million gross less WSE payroll cost of $15.5 and $32.7 million for the three and six months ended February 28, 2021, respectively.

Revenue from External Customers by Geographic Areas

For the three and six months ended February 28, 2022 and February 28, 2021, the following geographical regions represented more than 10% of total revenues:

	For the Three Months Ended				For the Six Months Ended
Region:	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
California	53	%	67	%	54	%	68	%
Washington	13	%	10	%	13	%	10	%

Schedule of Estimated Useful Lives of Property and Equipment

The estimated useful lives of property and equipment for purposes of computing depreciation are as follows:

Equipment:	5 years
Furnitures & Fixtures:	5 - 7 years
Leasehold improvements	Shorter of useful life or the remaining lease term, typically 5 years

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Securities that are excluded from the calculation of weighted average dilutive common stock, because their inclusion would have been antidilutive, are:

	For the Three Months Ended		For the Six Months Ended
	February 28, 2022	February 28, 2021	February 28, 2022	February 28, 2021
Options (See Note 8)	1,769,497	1,822,173	1,769,497	1,822,173
Warrants (See Note 7)	27,113,736	4,396,209	22,440,225	4,396,209
Total potentially dilutive shares	28,883,233	6,218,382	28,883,233	6,218,382

XML

Discontinued Operations (Tables)

6 Months Ended

Feb. 28, 2022

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups Including Discontinued Operations, Reconciliation of Gross Proceeds to Net Proceeds as Presented in Cash Flow Statement

The following is a reconciliation of the gross proceeds to the net proceeds from the Vensure Asset Sale as presented in the balance sheet for the period ended February 28, 2022.

Gross proceeds	$	19,166,000
Cash received at closing – asset sale	(9,500,000)
Cash received at closing – working capital	(166,000)
Gross note receivable	$	9,500,000
Less:  Transaction reconciliation – estimated working capital adjustments	(2,604,000)
Adjusted Note Receivable	6,896,000
Reserve for estimated potential claims	(2,892,000)
Long-term note receivable, estimated net realizable value	$	4,004,000

Disposal Groups, Including Discontinued Operations

The carrying amounts of the classes of assets and liabilities from the Vensure Asset Sale included in discontinued operations are as follows:

	February 28, 2022		August 31, 2021
Cash	$	—	$	—
Accounts receivable and unbilled account receivable	—		—
Prepaid expenses and other current assets	—		—
Deposits – workers’ compensation	92,000		356,000
Total current assets	92,000		356,000
Fixed assets, net	—		—
Deposits – workers’ compensation	232,000		883,000
Total assets	$	324,000	$	1,239,000
Accounts payable and other current liabilities	$	—	$	—
Payroll related liabilities	—		—
Accrued workers’ compensation cost	—		1,516,000
Total current liabilities	—		1,516,000
Accrued workers’ compensation cost	—		3,765,000
Total liabilities	—		5,281,000
Net liability	$	324,000	$	(4,042,000)

Schedule of Disposal Groups Including Discontinued Operations Income Statement

Reported results for the discontinued operations by period were as follows:

	For the Three Months Ended				For the Six Months Ended
	February 28, 2022		February 28, 2021		February 28, 2022		February 28, 2021
Revenues	$	—	$	—	$	—	$	—
Cost of revenue	18,000		221,000		151,000		1,535,000
Gross profit	(18,000)		(221,000)		(151,000)		(1,535,000)
Operating expenses:
Salaries, wages and payroll taxes	—		—		—		—
Commissions	—		—		—		—
Total operating expenses	—		—		—		—
(Loss) income from discontinued operations	$	(18,000)	$	(221,000)	$	(151,000)	$	(1,535,000)

XML

Stockholders' Equity (Tables)

6 Months Ended

Feb. 28, 2022

Equity [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes the changes in the Company’s common stock and Prefunded  Warrants from August 31, 2021 to February 28, 2022.

	Number of shares	Weighted average remaining life (years)	Weighted average exercise price
Warrants outstanding, August 31, 2021	9,592,085	4.7	$	3.87
Issued	22,470,104	4.7	1.58
(Cancelled)	—	—	—
(Exercised)	(4,948,453)	4.3	1.2
Warrants outstanding, February 28, 2022	27,113,736	4.7	2.83
Warrants exercisable, February 28, 2022	16,840,654	4.2	$	0.95

The following table summarizes the Company’s warrants outstanding as of February 28, 2022:

	Warrants Outstanding	Weighted average Life of Outstanding Warrants in years	Exercise price
Jan 2022 Common Warrants(1)	9,896,906	5.4	$	1.55
Sep 2021 Common Warrants	7,523,511	4.5	1.60
Sep 2021 Prefunded Warrants(2)	4,673,511	4.5	N/A
Sep 2021Underwriter Warrants (3)	376,176	4.5	1.75
May 2021Underwriter Warrants	247,423	4.2	2.43
October 2020 Common Warrants	2,300,000	3.6	3.30
October 2020 Underwriter Warrants	200,000	3.6	3.30
February 2021 Common Warrants	1,277,580	3.2	5.40
February 2021 Underwriter Warrants	111,108	3.2	5.40
March 2020 Exchange Warrants	423,669	3.6	10.17
Amended March 2019 Warrants	66,288	2.0	40.00
March 2019 Services Warrants	3,366	2.0	70.00
June 2018 Warrants	6,276	1.8	40.00
June 2018 Services Warrants	5,422	1.8	99.60
2017 PIPE Warrants	2,500	0.3	276.00
	27,113,736	4.7	$	2.22

(1)The January 2022 Common Warrants are exercisable commencing on July 28, 2022 and terminate on July 28, 2027..

(2)The September 2021 Prefunded Warrants were sold as part of a Prefunded Warrant Unit as described above at a nominal price of $0.0001 per share.

(3)The September 2021 Placement Agent Warrants become exercisable six months from issuance and expire four years from the effective date (which has not yet occurred) of the registration statement covering the resale of the underlying shares.

XML

Stock Based Compensation (Tables)

6 Months Ended

Feb. 28, 2022

Share-based Payment Arrangement [Abstract]

Share-based Payment Arrangement, Option, Activity

The following table summarizes option activity during the six months ended February 28, 2022:

	Options Outstanding and Exercisable
	Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance Outstanding, August 31, 2021	1,776,115	8.90	$	6.80
Granted	120,000	9.76	0.76
Exercised	—	—	—
Forfeited	(126,618)	8.66	(3.70)
Balance Outstanding at February 28, 2022	1,769,497	8.61	$	6.98
Balance Exercisable at February 28, 2022	1,769,497

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable

Option vesting activity from August 31, 2021, through February 28, 2022 was as follows:

Options Vested	Number of Options	Weighted Remaining Contractual Life	Weighted Average Exercise Price
		(In years)
Balance, August 31, 2021	309,257	8.63	$	16.92
Vested	218,077	8.57	4.88
Exercised	—	—	—
Forfeited	(8,011)	7.87	7.97
Balance, February 28, 2022	519,323	8.28	$	12.14

Summarizes of Stock Options Outstanding

The following table summarizes information about stock options outstanding and vested at February 28, 2022: 

	Options Outstanding				Options Vested
Exercise Prices	Number of Options Exercisable	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number of Options	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
		(In Years)				(In Years)
$0.75 - 10.00	1,730,808	8.6	$	4.27	483,756	8.4	$	4.93
$10.01 - $40.00	2,000	7.3	18.95		1,453	7.3	19.01
$40.01 - $80.00	13,100	7.1	51.21		11,066	7.1	51.21
$80.01 - $120.00	10,271	6.2	102.91		9,862	6.2	102.93
$120.01 - $160.00	12,193	5.5	155.36		12,060	5.5	155.39
$160.01 - $391.60	1,125	5.4	391.60		1,125	5.4	391.60
	1,769,497	8.6	$	6.64	519,322	8.3	$	12.14

XML

Commitments (Tables)

6 Months Ended

Feb. 28, 2022

Commitments and Contingencies Disclosure [Abstract]

Lease, Cost

The components of lease expense is as follows:

	Three Months ended February 28, 2022		Six Months ended on February 28, 2022
Operating Lease Cost	$	334,251	$	788,203

Lessee, Operating Lease, Liability, Maturity

Future minimum lease and licensing payments under non-cancelable operating leases at February 28, 2022, are as follows:

	Minimum lease commitments
2022	$	731,000
2023	1,739,000
2024	1,737,000
2025	1,532,000
2026	1,275,000
Thereafter	1,515,000
Total minimum payments	$	8,529,000
Less: present value discount	1,164,000
Lease Liability	$	7,365,000
Weighted-average remaining lease term - operating leases (months)	54
Weighted-average discount rate	5.54		%

XML

Summary of Significant Accounting Policies - Additional Information (Details)			3 Months Ended		6 Months Ended		12 Months Ended
	Oct. 22, 2021 USD ($) $ / shares shares	Oct. 21, 2021 shares	Feb. 28, 2022 USD ($) plan shares	Feb. 28, 2021 USD ($)	Feb. 28, 2022 USD ($) plan shares	Feb. 28, 2021 USD ($)	Aug. 31, 2020 segment	Oct. 19, 2021 shares	Sep. 01, 2021 USD ($)	Aug. 31, 2021 USD ($) shares	Dec. 31, 2020	Jan. 01, 2020
Concentration Risk [Line Items]
Contract with customer, term					12 months
Contract with customer, cancellation period					30 days
Unbilled accounts receivable			$ 2,615,000		$ 2,615,000					$ 2,741,000
Number of reportable segments | segment							1
Cash, uninsured amount			3,507,000		3,507,000
Capitalized computer software, net			0		0					0
Research and development expense			1,900,000	$ 1,400,000	3,900,000	$ 2,800,000
Capitalized computer software, additions			0	0
Operating lease, liability			7,365,000		7,365,000
Workers' compensation, claim responsibility per occurrence			500,000		500,000
Workers' compensation asset, current			36,000		36,000					155,000
Workers' compensation asset, noncurrent			91,000		91,000					386,000
Workers' compensation liability, current			597,000		597,000					663,000
Workers' compensation liability, noncurrent			1,260,000		1,260,000					$ 1,646,000
Disposal group, including discontinued operation, workers' compensation asset, current			100,000		100,000
Disposal group, including discontinued operation, workers' compensation liability, current			1,300,000		1,300,000
Disposal group, including discontinued operation, workers' compensation asset, noncurrent			200,000		200,000
Disposal group, including discontinued operation, workers' compensation liability, noncurrent			3,200,000		3,200,000
Advertising expense			$ 435,000	$ 719,000	$ 897,000	921,000
Number of stock-based compensation plans | plan			1		1
Class of warrant or right, outstanding (in shares) | shares			27,113,736		27,113,736					9,592,085
Common stock, shares, transferred (in shares) | shares		15,000
Temporary equity, carrying amount, attributable to parent			$ 116,725,000		$ 116,725,000					$ 0
Excess of proceeds from the sale of private placement warrants to Sponsor	$ 13,000,000				13,270,000
Deferred offering costs – SPACs (See Note 5)			$ 0		0					48,261,000
SPAC related offering costs paid					$ 3,502,000	$ 0
IHC
Concentration Risk [Line Items]
Deferred offering costs – SPACs (See Note 5)	$ 9,500,000									$ 9,800,000
Accounting Standards Update 2018-11
Concentration Risk [Line Items]
Operating lease, liability									$ 7,700,000
IHC
Concentration Risk [Line Items]
Variable interest entity, qualitative or quantitative information, ownership percentage					15.00%
Common stock, shares, owned (in shares) | shares	2,110,000	2,125,000	2,110,000		2,110,000
Excess of proceeds from the sale of private placement warrants to Sponsor					$ 38,000,000
SPAC related offering costs paid	$ 3,500,000				$ 3,500,000
IPO | IHC
Concentration Risk [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares					11,500,000
Proceeds from initial public offering of IHC	115,000,000
Assets held-in-trust	$ 1,725,000		$ 1,675,000		$ 1,675,000
Sale of stock, price per share (in dollars per share) | $ / shares	$ 10.00
Sale of stock, number of common shares issued per unit (in shares) | shares	1							1
Sale of stock, number of warrants issued per unit (in shares) | shares	1
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares	1							1
Exercise price of warrants (in dollars per share) | $ / shares	$ 11.50
Business combination, initial business combination consummation period	12 months
Redeemable noncontrolling interest, equity, common, redemption percentage	100.00%
IPO | IHC | Placement Warrants
Concentration Risk [Line Items]
Exercise price of warrants (in dollars per share) | $ / shares	$ 11.50
Class of warrant or right, outstanding (in shares) | shares	4,639,102
Sale of warrants, price per share (in dollars per share) | $ / shares	$ 1.00
Aggregate purchase price	$ 4,639,102
Measurement Input, Discount Rate
Concentration Risk [Line Items]
Note receivable, measurement input							0.15				0.15	0.10
Minimum
Concentration Risk [Line Items]
Capitalized software development, useful life					3 years
Maximum
Concentration Risk [Line Items]
Capitalized software development, useful life					5 years
Four Clients | Customer Concentration Risk | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage					100.00%

XML

Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
Disaggregation of Revenue [Line Items]
Revenues	$ 10,437	$ 2,419	$ 19,378	$ 4,922
Gross billings		17,900
Worksite employee payroll cost		15,500
HCM
Disaggregation of Revenue [Line Items]
Revenues	1,600	2,400	3,300	4,900
Gross billings	12,600		25,500	37,600
Worksite employee payroll cost	11,000		22,200	32,700
Staffing
Disaggregation of Revenue [Line Items]
Revenues	$ 8,800	$ 0	$ 16,100	$ 0

XML

Summary of Significant Accounting Policies - Revenue from External Customers by Geographical Areas (Details) - Revenue from Contract with Customer Benchmark - Geographic Concentration Risk	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
California
Concentration Risk [Line Items]
Concentration risk, percentage	53.00%	67.00%	54.00%	68.00%
Washington
Concentration Risk [Line Items]
Concentration risk, percentage	13.00%	10.00%	13.00%	10.00%

XML

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment (Details)	6 Months Ended
	Feb. 28, 2022
Equipment:
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Furnitures & Fixtures: | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Furnitures & Fixtures: | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	7 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years

XML

Summary of Significant Accounting Policies - Weighted Average Dilutive Common Shares (Details) - shares	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
Total potentially dilutive shares (in shares)			28,883,233	6,218,382
Options (See Note 8)
Total potentially dilutive shares (in shares)		1,822,173	1,769,497	1,822,173
Warrants
Total potentially dilutive shares (in shares)	27,113,736	4,396,209	22,440,225	4,396,209

XML

Discontinued Operations - Narrative (Details) - Disposal by sale - USD ($) $ in Thousands		6 Months Ended	12 Months Ended
	Jan. 03, 2020	Feb. 28, 2022	Aug. 31, 2020	Mar. 12, 2021
Overall business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percentage of business sold	88.00%
Working capital assets transferred	$ 1,500
Gross proceeds	19,200	$ 19,166
Proceeds from divestiture of businesses	9,700
Gross note receivable	$ 9,500	9,500
Period for payment of gross proceeds (in years)	4 years
Customer retention period (in years)	12 months
Working capital adjustment		2,604		$ 10,700
Disposal group, including discontinued operations, additional reserve for estimated potential claims		2,892
Discontinued operation, gain (Loss) on disposal of discontinued operation, net of tax			$ 15,600
Disposal group, including discontinued operation, consideration receivable, notes receivable, working capital adjustments		2,600
Lower net assets transferred at closing		88
Disposal group, including discontinued operations, consideration receivable, notes receivable, working capital adjustments for cash remitted to bank account by former client		$ 2,500
Disposal group including discontinued operations, estimated lower percentage of gross wages		90.00%
Disposal group including discontinued operations, contingent consideration		$ 1,400
PEO business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percentage of business sold	100.00%

XML

Discontinued Operations - Reconciliation of Gross Proceeds to Net Proceeds From Sale Transaction (Details) - USD ($) $ in Thousands	Feb. 28, 2022	Aug. 31, 2021	Mar. 12, 2021	Jan. 03, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Long-term note receivable, estimated net realizable value	$ 4,004	$ 4,004
Overall business | Disposal by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gross proceeds	19,166			$ 19,200
Cash received at closing – asset sale	(9,500)
Cash received at closing – working capital	(166)
Gross note receivable	9,500			$ 9,500
Less:  Transaction reconciliation – estimated working capital adjustments	(2,604)		$ (10,700)
Adjusted Note Receivable	6,896
Reserve for estimated potential claims	(2,892)
Long-term note receivable, estimated net realizable value	$ 4,004

XML

Discontinued Operations - Carrying Amounts of Assets and Liabilities (Details) - USD ($) $ in Thousands	Feb. 28, 2022	Aug. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Deposits – workers’ compensation	$ 100
Total current assets	92	$ 356
Deposits – workers’ compensation	200
Accrued workers’ compensation cost	1,300
Total current liabilities	1,291	1,516
Accrued workers’ compensation cost	3,200
Disposal by sale | Overall business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash	0	0
Accounts receivable and unbilled account receivable	0	0
Prepaid expenses and other current assets	0	0
Deposits – workers’ compensation	92	356
Total current assets	92	356
Fixed assets, net	0	0
Deposits – workers’ compensation	232	883
Total assets	324	1,239
Accounts payable and other current liabilities	0	0
Payroll related liabilities	0	0
Accrued workers’ compensation cost	0	1,516
Total current liabilities	0	1,516
Accrued workers’ compensation cost	0	3,765
Total liabilities	0	5,281
Net liability	$ 324	$ (4,042)

XML

Discontinued Operations - Reported Results for the Discontinued Operations (Details) - Disposal by sale - Overall business - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	$ 0	$ 0	$ 0	$ 0
Cost of revenue	18	221	151	1,535
Gross profit	(18)	(221)	(151)	(1,535)
Operating expenses:
Salaries, wages and payroll taxes	0	0	0	0
Commissions	0	0	0	0
Total operating expenses	0	0	0	0
(Loss) income from discontinued operations	$ (18)	$ (221)	$ (151)	$ (1,535)

XML

Special Purpose Acquisition Company ("SPAC") Sponsorship (Details)		3 Months Ended	6 Months Ended
	Oct. 22, 2021 USD ($) $ / shares shares	Feb. 28, 2022 USD ($) shares	Feb. 28, 2022 USD ($) shares	Feb. 28, 2021 USD ($)	Oct. 19, 2021 shares	Aug. 31, 2021 USD ($) company shares	Apr. 29, 2021 USD ($) company
Investments in and Advances to Affiliates [Line Items]
Other commitments, number of special purpose acquisition company sponsorships | company						4	4
Other commitments, capital investment sought, per acquisition company							$ 150,000,000
Other commitments, percentage of outstanding shares, per acquisition company							15.00%
Class of warrant or right, outstanding (in shares) | shares		27,113,736	27,113,736			9,592,085
Temporary equity, carrying amount, attributable to parent		$ 116,725,000	$ 116,725,000			$ 0
Excess of proceeds from the sale of private placement warrants to Sponsor	$ 13,000,000		13,270,000
SPAC related offering costs paid			3,502,000	$ 0
Investment income, interest			7,000
IHC
Investments in and Advances to Affiliates [Line Items]
Excess of proceeds from the sale of private placement warrants to Sponsor			38,000,000
Payment of deferred offering costs			274,000
SPAC related offering costs paid	$ 3,500,000		3,500,000
TechStackery
Investments in and Advances to Affiliates [Line Items]
SPAC related offering costs paid		0
Vital Human Capital
Investments in and Advances to Affiliates [Line Items]
SPAC related offering costs paid		0
Firemark Global Capital
Investments in and Advances to Affiliates [Line Items]
SPAC related offering costs paid		0
IHC SPAC Sponsorship
Investments in and Advances to Affiliates [Line Items]
Other commitments, interest rate	1.50%
IPO | IHC
Investments in and Advances to Affiliates [Line Items]
Sale of stock, number of common shares issued per unit (in shares) | shares	1				1
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares	1				1
Proceeds from initial public offering of IHC	$ 115,000,000
Assets held-in-trust	$ 1,725,000	$ 1,675,000	$ 1,675,000
IPO | IHC | Placement Warrants
Investments in and Advances to Affiliates [Line Items]
Class of warrant or right, outstanding (in shares) | shares	4,639,102
Sale of warrants, price per share (in dollars per share) | $ / shares	$ 1.00
Aggregate purchase price	$ 4,639,102

XML

Deferred Offering Costs - SPACs - Narrative (Details)			3 Months Ended		6 Months Ended
	Oct. 22, 2021 USD ($)	Apr. 22, 2021 USD ($) year $ / shares shares	Feb. 28, 2022 USD ($)	Feb. 28, 2021 USD ($)	Feb. 28, 2022 USD ($)	Feb. 28, 2021 USD ($)	Mar. 18, 2022 company	Aug. 31, 2021 USD ($) company	Apr. 29, 2021 company
Noncontrolling Interest [Line Items]
Other commitments, number of special purpose acquisition company sponsorships | company								4	4
Deferred costs, noncurrent			$ 0		$ 0			$ 48,261,000
Accrued professional fees								789,000
Deferred offering costs, excluding fees			38,000,000		38,000,000			47,472,000
Excess of proceeds from the sale of private placement warrants to Sponsor	$ 13,000,000				13,270,000
Deferred offering costs, increase (decrease)					38,500,000
Expensed SPAC offering costs			515,000	$ 0	515,000	$ 0
Subsequent Event
Noncontrolling Interest [Line Items]
Other commitments, number of special purpose acquisition company sponsorships withdrawn from | company							3
IHC
Noncontrolling Interest [Line Items]
Excess of proceeds from the sale of private placement warrants to Sponsor					$ 38,000,000
TechStackery
Noncontrolling Interest [Line Items]
Deferred offering costs, increase (decrease)			0
Vital Human Capital
Noncontrolling Interest [Line Items]
Deferred offering costs, increase (decrease)			0
Firemark Global Capital
Noncontrolling Interest [Line Items]
Deferred offering costs, increase (decrease)			$ 0
IHC
Noncontrolling Interest [Line Items]
Deferred costs, noncurrent	$ 9,500,000							$ 9,800,000
Measurement Input, Discount Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input | year		0.488
Measurement Input, Consummation Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input | year		0.20
Measurement Input, Special Acquisition Company Completion Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input | year		0.20
Measurement Input, Concession Rate
Noncontrolling Interest [Line Items]
Noncontrolling interest, measurement input | year		0.21
IHC, TechStackery, Vital And Firemark | Third Party Representative | Special Acquisition Company
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares		10,000,000
Sale of stock, consideration received on transaction		$ 47,472,000
Sale of stock, price per share (in dollars per share) | $ / shares		$ 4.7472
Sale of stock, stock and warrant price per share (in dollars per share) | $ / shares		10
Sale of stock, price per warrant (in dollars per share) | $ / shares		0.75
Sale of stock, unit price per common share (in dollars per share) | $ / shares		$ 9.25
IHC | Third Party Representative | Special Acquisition Company
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares		2,000,000
TechStackery | Third Party Representative | Special Acquisition Company
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares		2,000,000
Vital Human Capital | Third Party Representative | Special Acquisition Company
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares		2,000,000
Firemark Global Capital | Third Party Representative | Special Acquisition Company
Noncontrolling Interest [Line Items]
Sale of stock, number of shares issued in transaction (in shares) | shares		4,000,000

XML

Going Concern - (Details) - USD ($) $ in Thousands		1 Months Ended					6 Months Ended
	Jan. 26, 2022	Sep. 30, 2021	May 31, 2021	Oct. 31, 2020	Jul. 07, 2020	May 31, 2020	Feb. 28, 2022	Feb. 28, 2021	Aug. 31, 2021
Going Concern [Line Items]
Cash							$ 3,300
Working capital deficit							(14,900)
Net cash provided by (used in) operating activities							(10,333)	$ (10,430)
Retained earnings (accumulated deficit)							(166,940)		$ (149,338)
Proceeds from issuance of private placement, net of offering costs							4,183	0
Proceeds from warrant exercises	$ 5,900
Proceeds from warrant exercises, net of offering costs	$ 5,400						$ 5,409	$ 10,701
Underwritten Public Offering
Going Concern [Line Items]
Proceeds from issuance of common stock				$ 12,000		$ 12,000
Proceeds from issuance of common stock, net of offering costs				$ 10,700		$ 10,300
Overallotment
Going Concern [Line Items]
Proceeds from issuance of common stock					$ 1,350
Proceeds from issuance of common stock, net of offering costs					$ 1,240
Private Placement
Going Concern [Line Items]
Proceeds from issuance of private placement		$ 12,000	$ 12,000
Proceeds from issuance of private placement, net of offering costs		$ 11,100	$ 11,100

XML

Stockholders' Equity - Additional Information (Details) - USD ($)						1 Months Ended		3 Months Ended		4 Months Ended	6 Months Ended
	Jan. 26, 2022	Oct. 22, 2021	Aug. 13, 2021	Jun. 05, 2020	Jun. 04, 2020	Sep. 30, 2021	May 31, 2021	Feb. 28, 2022	Feb. 28, 2021	Nov. 30, 2020	Feb. 28, 2022	Feb. 28, 2021	Aug. 31, 2021	Jun. 04, 2021	May 17, 2021	Jan. 31, 2020	Sep. 30, 2016
Class of Warrant or Right [Line Items]
Preferred stock, par or stated value per share (in dollars per share)								$ 0.0001			$ 0.0001		$ 0.0001				$ 0.0001
Convertible preferred stock, shares issued upon conversion (in shares)																	1
Stock options exercised (in shares)											0
Share-based compensation arrangement by share-based payment award, options, forfeitures in period (in shares)											126,618
Preferred options outstanding (in shares)								1,769,497			1,769,497		1,776,115
Share-based compensation arrangement by share-based payment award, expiration period											10 years
Common stock, par or stated value per share (in dollars per share)								$ 0.0001			$ 0.0001		$ 0.0001	$ 0.0001
Warrants exercised (in shares)											4,948,453
Payments of stock issuance costs											$ 3,502,000	$ 0
Change in fair value due to warrants modification											13,728,000	0
Adjustments to additional paid in capital, warrant issued											6,861,000
Additional paid-in capital								$ 146,716,000			146,716,000		$ 142,786,000
Deemed dividend from change in fair value from warrants modification								$ 7,731,000	$ 0		$ 7,731,000	$ 0
Class of warrant or right, outstanding (in shares)								27,113,736			27,113,736		9,592,085
Existing Warrants
Class of Warrant or Right [Line Items]
Warrants to acquire shares of common stock (in shares)															4,948,453
Common stock, par or stated value per share (in dollars per share)															$ 0.0001
Exercise price of warrants (in dollars per share)															$ 2.425
Change in fair value due to warrants modification	$ 639,000
Investor Warrants
Class of Warrant or Right [Line Items]
Exercise price of warrants (in dollars per share)	$ 1.20
Warrants exercised (in shares)	4,948,453
Jan 2022 Common Warrants
Class of Warrant or Right [Line Items]
Warrants to acquire shares of common stock (in shares)	9,896,906
Exercise price of warrants (in dollars per share)	$ 1.55
Proceeds from issuance of warrants	$ 5,900,000
Payments of stock issuance costs	461,000
Change in fair value due to warrants modification	12,590,000
Adjustments to additional paid in capital, warrant issued	5,477,000
Additional paid-in capital	5,500,000
Deemed dividend from change in fair value from warrants modification	$ 7,731,000
Sep 2021 Underwriter Warrants
Class of Warrant or Right [Line Items]
Warrants term								4 years			4 years
Warrants and rights outstanding, requisite exercise period								6 months			6 months
Chief Executive Officer | Scott W Absher
Class of Warrant or Right [Line Items]
Preferred stock, par or stated value per share (in dollars per share)			$ 0.0001
Share-based compensation arrangement by share-based payment award, fair value assumptions, exercise price (in dollars per share)			$ 0.0001														$ 0.0001
Share-based compensation arrangement by share-based payment award, expiration period			24 months
Share-based compensation arrangement by share-based payment award, assets or earning power threshold for option exercise			50.00%
Convertible preferred stock, shares issuable upon conversion per preferred share (in shares)			1
Preferred Stock Issued
Class of Warrant or Right [Line Items]
Stock options exercised (in shares)										294,490
Preferred options outstanding (in shares)								37,570			37,570
Preferred Stock Issued | Chief Executive Officer | Scott W Absher
Class of Warrant or Right [Line Items]
Stock options exercised (in shares)					12,500,000
Number of options available for grant to founder shareholders (in shares)			12,500,000		12,500,000												12,500,000
Proceeds from issuance of preferred stock					$ 1,250
Number option additionally available for grant to founder shareholders (in shares)				12,500,000
Preferred Stock Issued | Founding Shareholder | J Stephen Holmes
Class of Warrant or Right [Line Items]
Share-based compensation arrangement by share-based payment award, options, forfeitures in period (in shares)		11,790,000
Stock Option | Chief Executive Officer | Scott W Absher
Class of Warrant or Right [Line Items]
Number of options available for grant to founder shareholders (in shares)																	25,000,000
Stock Option | Preferred Stock Issued
Class of Warrant or Right [Line Items]
Convertible preferred stock (in shares)																24,634,560
Common Share Units
Class of Warrant or Right [Line Items]
Shares issued upon conversion (in shares)										294,490
Common shares lock up period										6 months
Common Share Units | Chief Executive Officer | Scott W Absher
Class of Warrant or Right [Line Items]
Shares issued upon conversion (in shares)				12,500,000
Common shares lock up period				24 months
Warrants
Class of Warrant or Right [Line Items]
Exercise price of warrants (in dollars per share)								$ 2.22			$ 2.22
Class of warrant or right, outstanding (in shares)								27,113,736			27,113,736
Warrants | Jan 2022 Common Warrants
Class of Warrant or Right [Line Items]
Exercise price of warrants (in dollars per share)								$ 1.55			$ 1.55
Class of warrant or right, outstanding (in shares)								9,896,906			9,896,906
Warrants | Sep 2021 Underwriter Warrants
Class of Warrant or Right [Line Items]
Exercise price of warrants (in dollars per share)								$ 1.75			$ 1.75
Class of warrant or right, outstanding (in shares)						376,176
Private Placement
Class of Warrant or Right [Line Items]
Payments of stock issuance costs						$ 900,000
Proceeds from issuance of private placement						$ 12,000,000	$ 12,000,000
Shares of common stock issued (in shares)						2,850,000
Sale of stock, placement fee						7.00%
Private Placement | Common Stock Warrants
Class of Warrant or Right [Line Items]
Warrants to acquire shares of common stock (in shares)						2,850,000
Exercise price of warrants (in dollars per share)						$ 1.595
Number of share of common stock per warrant (in shares)						1
Sale of stock, stock and warrant price per share (in dollars per share)						$ 1.595
Warrants term						5 years
Private Placement | Pre-Funded Warrant
Class of Warrant or Right [Line Items]
Exercise price of warrants (in dollars per share)						$ 0.0001
Number of share of common stock per warrant (in shares)						1
Class of warrant or right, outstanding (in shares)						4,673,511
Sale of stock, stock and warrant price per share (in dollars per share)						$ 1.5949
Private Placement | Common Stock And Pre-Funded Warrants
Class of Warrant or Right [Line Items]
Warrants to acquire shares of common stock (in shares)						7,523,511
Private Placement | Placement Warrants
Class of Warrant or Right [Line Items]
Exercise price of warrants (in dollars per share)						$ 1.7545
Warrants term						4 years
Warrants and rights outstanding, requisite exercise period						6 months

XML

Stockholders' Equity - Summary of Warrants Outstanding (Details)	6 Months Ended
	Feb. 28, 2022 $ / shares shares
Number of shares
Number of shares outstanding, beginning balance (in shares) | shares	9,592,085
Issued (in shares) | shares	22,470,104
Cancelled (in shares) | shares	0
Exercised (in shares) | shares	(4,948,453)
Number of shares outstanding, ending balance (in shares) | shares	27,113,736
Number of shares exercisable (in shares) | shares	16,840,654
Weighted average remaining life (years)
Weighted remaining life (years), beginning	4 years 8 months 12 days
Issued	4 years 8 months 12 days
(Cancelled)	0 years
(Exercised)	4 years 3 months 18 days
Weighted remaining life (years), ending	4 years 8 months 12 days
Weighted remaining life (years) exercisable	4 years 2 months 12 days
Weighted average exercise price
Weighted average exercise prices, beginning (in dollars per share) | $ / shares	$ 3.87
Issued (in dollars per share) | $ / shares	1.58
Cancelled (in dollars per share) | $ / shares	0
Exercised (in dollars per share) | $ / shares	1.2
Weighted average exercise prices, ending (in dollars per share) | $ / shares	2.83
Weighted average exercise price exercisable (in dollars per share) | $ / shares	$ 0.95

XML

Stockholders' Equity - Summary of Information About Warrants Outstanding (Details) - $ / shares	6 Months Ended
	Feb. 28, 2022	Jan. 26, 2022	Sep. 30, 2021	Aug. 31, 2021
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	27,113,736			9,592,085
Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	27,113,736
Weighted average Life of Outstanding Warrants in years	4 years 8 months 12 days
Exercise price (in dollars per share)	$ 2.22
Jan 2022 Common Warrants
Class of Warrant or Right [Line Items]
Exercise price (in dollars per share)		$ 1.55
Jan 2022 Common Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	9,896,906
Weighted average Life of Outstanding Warrants in years	5 years 4 months 24 days
Exercise price (in dollars per share)	$ 1.55
Sep 2021 Common Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	7,523,511
Weighted average Life of Outstanding Warrants in years	4 years 6 months
Exercise price (in dollars per share)	$ 1.60
Sep 2021 Prefunded Warrants | Private Placement
Class of Warrant or Right [Line Items]
Sale of warrants, price per share (in dollars per share)	$ 0.0001
Sep 2021 Prefunded Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	4,673,511
Weighted average Life of Outstanding Warrants in years	4 years 6 months
Sep 2021 Underwriter Warrants
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, requisite exercise period	6 months
Warrants term	4 years
Sep 2021 Underwriter Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)			376,176
Weighted average Life of Outstanding Warrants in years	4 years 6 months
Exercise price (in dollars per share)	$ 1.75
May 2021Underwriter Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	247,423
Weighted average Life of Outstanding Warrants in years	4 years 2 months 12 days
Exercise price (in dollars per share)	$ 2.43
October 2020 Common Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	2,300,000
Weighted average Life of Outstanding Warrants in years	3 years 7 months 6 days
Exercise price (in dollars per share)	$ 3.30
October 2020 Underwriter Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	200,000
Weighted average Life of Outstanding Warrants in years	3 years 7 months 6 days
Exercise price (in dollars per share)	$ 3.30
February 2021 Common Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	1,277,580
Weighted average Life of Outstanding Warrants in years	3 years 2 months 12 days
Exercise price (in dollars per share)	$ 5.40
February 2021 Underwriter Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	111,108
Weighted average Life of Outstanding Warrants in years	3 years 2 months 12 days
Exercise price (in dollars per share)	$ 5.40
March 2020 Exchange Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	423,669
Weighted average Life of Outstanding Warrants in years	3 years 7 months 6 days
Exercise price (in dollars per share)	$ 10.17
Amended March 2019 Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	66,288
Weighted average Life of Outstanding Warrants in years	2 years
Exercise price (in dollars per share)	$ 40.00
March 2019 Services Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	3,366
Weighted average Life of Outstanding Warrants in years	2 years
Exercise price (in dollars per share)	$ 70.00
June 2018 Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	6,276
Weighted average Life of Outstanding Warrants in years	1 year 9 months 18 days
Exercise price (in dollars per share)	$ 40.00
June 2018 Services Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	5,422
Weighted average Life of Outstanding Warrants in years	1 year 9 months 18 days
Exercise price (in dollars per share)	$ 99.60
2017 PIPE Warrants | Warrants
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	2,500
Weighted average Life of Outstanding Warrants in years	3 months 18 days
Exercise price (in dollars per share)	$ 276.00

XML

Stock Based Compensation - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021	Aug. 31, 2021	Jul. 01, 2021	Jun. 04, 2021	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock issuable (in shares)						3,000,000	3,000,000	250,000
Common stock, par or stated value per share (in dollars per share)	$ 0.0001		$ 0.0001		$ 0.0001		$ 0.0001
Share-based compensation arrangement by share-based payment award, expiration period			10 years
Compensation expense	$ 339,000	$ 423,000	$ 747,000	$ 919,000
Share-based payment arrangement, noncash expense			747,000	$ 863,000
Share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value	1,415		$ 1,415
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition			2 years 9 months 7 days
Share-based payment arrangement, nonvested award, cost not yet recognized, amount	3,002,000		$ 3,002,000
Board of Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, noncash expense	$ 81,000		$ 205,000
Options Granted on or After July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting period			4 years
Share-based payment arrangement, tranche one | Granted Prior to July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage			25.00%
Share-based compensation arrangement by share-based payment award, award vesting period			12 months
Share-based payment arrangement, tranche one | Options Granted on or After July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage			25.00%
Share-based compensation arrangement by share-based payment award, award vesting period			1 year
Share-based payment arrangement, tranche two | Granted Prior to July 1, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting period			36 months

XML

Stock Based Compensation - Summary of Option Activity (Details) - $ / shares	6 Months Ended	12 Months Ended
	Feb. 28, 2022	Aug. 31, 2021
Number of Options
Beginning balance (in shares)	1,776,115
Granted (in shares)	120,000
Exercised (in shares)	0
Forfeited (in shares)	(126,618)
Ending balance (in shares)	1,769,497	1,776,115
Weighted Average Remaining Contractual Life
Outstanding	8 years 7 months 9 days	8 years 10 months 24 days
Granted	9 years 9 months 3 days
Exercised	0 years
Forfeited	8 years 7 months 28 days
Weighted Average Exercise Price
Outstanding (in dollars per share)	$ 6.98	$ 6.80
Granted (in dollars per share)	0.76
Exercised (in dollars per share)	0
Forfeited (in dollars per share)	$ (3.70)

XML

Stock Based Compensation - Schedule of Option Vesting Activity (Details) - $ / shares	3 Months Ended	6 Months Ended
	Nov. 30, 2021	Feb. 28, 2022	Aug. 31, 2021
Number of Options
Options vested, beginning balance (in shares)	309,257	309,257
Vested (in shares)		218,077
Exercised (in shares)		0
Forfeited (in shares)		(8,011)
Options vested, ending balance (in shares)		519,323
Weighted Remaining Contractual Life
Outstanding	8 years 7 months 17 days	8 years 3 months 10 days
Vested		8 years 6 months 25 days
Exercised		0 years
Forfeited		7 years 10 months 13 days
Weighted Average Exercise Price
Outstanding (in dollars per share)		$ 12.14	$ 16.92
Vested (in dollars per share)		4.88
Exercised (in dollars per share)		0
Forfeited (in dollars per share)		$ 7.97

XML

Stock Based Compensation - Stock Options Outstanding and Vested (Details)	6 Months Ended
	Feb. 28, 2022 $ / shares shares
Exercise Prices One | Minimum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	$ 0.75
Exercise Prices One | Maximum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	10.00
Exercise Prices Two | Minimum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	10.01
Exercise Prices Two | Maximum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	40.00
Exercise Prices Three | Minimum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	40.01
Exercise Prices Three | Maximum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	80.00
Exercise Prices Four | Minimum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	80.01
Exercise Prices Four | Maximum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	120.00
Exercise Prices Five | Minimum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	120.01
Exercise Prices Five | Maximum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	160.00
Exercise Prices Six | Minimum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	160.01
Exercise Prices Six | Maximum
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Prices (in dollars per share)	$ 391.60
Options Outstanding One
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable (in shares) | shares	1,730,808
Weighted Average Remaining Contractual Life	8 years 7 months 6 days
Weighted Average Exercise Price (in dollars per share)	$ 4.27
Options Outstanding Two
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable (in shares) | shares	2,000
Weighted Average Remaining Contractual Life	7 years 3 months 18 days
Weighted Average Exercise Price (in dollars per share)	$ 18.95
Options Outstanding Three
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable (in shares) | shares	13,100
Weighted Average Remaining Contractual Life	7 years 1 month 6 days
Weighted Average Exercise Price (in dollars per share)	$ 51.21
Options Outstanding Four
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable (in shares) | shares	10,271
Weighted Average Remaining Contractual Life	6 years 2 months 12 days
Weighted Average Exercise Price (in dollars per share)	$ 102.91
Options Outstanding Five
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable (in shares) | shares	12,193
Weighted Average Remaining Contractual Life	5 years 6 months
Weighted Average Exercise Price (in dollars per share)	$ 155.36
Options Outstanding Six
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable (in shares) | shares	1,125
Weighted Average Remaining Contractual Life	5 years 4 months 24 days
Weighted Average Exercise Price (in dollars per share)	$ 391.60
Options Outstanding
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Exercisable (in shares) | shares	1,769,497
Weighted Average Remaining Contractual Life	8 years 7 months 6 days
Weighted Average Exercise Price (in dollars per share)	$ 6.64
Options Vested One
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Vested (in shares) | shares	483,756
Weighted Average Remaining Contractual Life	8 years 4 months 24 days
Weighted Average Exercise Price (in dollars per share)	$ 4.93
Options Vested Two
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Vested (in shares) | shares	1,453
Weighted Average Remaining Contractual Life	7 years 3 months 18 days
Weighted Average Exercise Price (in dollars per share)	$ 19.01
Options Vested Three
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Vested (in shares) | shares	11,066
Weighted Average Remaining Contractual Life	7 years 1 month 6 days
Weighted Average Exercise Price (in dollars per share)	$ 51.21
Options Vested Four
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Vested (in shares) | shares	9,862
Weighted Average Remaining Contractual Life	6 years 2 months 12 days
Weighted Average Exercise Price (in dollars per share)	$ 102.93
Options Vested Five
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Vested (in shares) | shares	12,060
Weighted Average Remaining Contractual Life	5 years 6 months
Weighted Average Exercise Price (in dollars per share)	$ 155.39
Options Vested Six
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Vested (in shares) | shares	1,125
Weighted Average Remaining Contractual Life	5 years 4 months 24 days
Weighted Average Exercise Price (in dollars per share)	$ 391.60
Options Vested
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options Vested (in shares) | shares	519,322
Weighted Average Remaining Contractual Life	8 years 3 months 18 days
Weighted Average Exercise Price (in dollars per share)	$ 12.14

XML

Related Parties (Details) - USD ($)					1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Nov. 18, 2021	Oct. 22, 2021	Aug. 01, 2021	Feb. 22, 2021	Mar. 31, 2022	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021	Aug. 31, 2021	Aug. 31, 2019
Related Party Transaction [Line Items]
Professional fees						$ 1,677,000	$ 1,006,000	$ 3,414,000	$ 1,713,000
Subsequent Event
Related Party Transaction [Line Items]
Payments of discretionary bonus					$ 250,000
Chief Executive Officer
Related Party Transaction [Line Items]
Payments to employees										$ 750,000
Salaried compensation, amount		$ 1,000,000
One-time incentive payment										170,000
Discretionary bonus, amount		$ 500,000
Employee compensation, discretionary bonus, percent of tranche one		50.00%
Employee compensation, discretionary bonus, percent of tranche two		50.00%
One-time bonus payment										240,000
Chief Executive Officer | Subsequent Event
Related Party Transaction [Line Items]
Employee compensation, discretionary bonus, percent of tranche one					50.00%
Amanda Murphy | Affiliated Entity
Related Party Transaction [Line Items]
Payments to employees										240,000
Salaried compensation, amount		$ 500,000
One-time incentive payment										80,000
J Stephen Holmes | Affiliated Entity
Related Party Transaction [Line Items]
Payments to employees								$ 120,000
Professional fees										750,000
Mark Absher | Affiliated Entity
Related Party Transaction [Line Items]
Payments to employees											$ 276,951
Salaried compensation, amount	$ 240,000
David May | Affiliated Entity
Related Party Transaction [Line Items]
Payments to employees										125,000
One-time incentive payment										103,000
Jason Absher | Affiliated Entity
Related Party Transaction [Line Items]
Salaried compensation, amount			$ 120,000	$ 75,000
Phil Eastvold | Affiliated Entity
Related Party Transaction [Line Items]
Payments to employees										200,000
One-time incentive payment										111,000
Connie Absher, Elizabeth Eastvold, and Hannah Absher | Affiliated Entity
Related Party Transaction [Line Items]
Payments to employees										183,000
Hannah Absher | Affiliated Entity
Related Party Transaction [Line Items]
One-time incentive payment										$ 18,000

XML

Commitments - Narrative (Details)		3 Months Ended		4 Months Ended	6 Months Ended
	Oct. 22, 2021 USD ($) $ / shares shares	Feb. 28, 2022 USD ($) shares	Feb. 28, 2021 USD ($)	Feb. 28, 2022 USD ($) shares	Feb. 28, 2022 USD ($) shares	Feb. 28, 2021 USD ($)	Oct. 19, 2021 shares	Aug. 31, 2021 USD ($) company shares	Jun. 21, 2021 ft²	Jun. 07, 2021 ft²	Apr. 29, 2021 USD ($) company	Oct. 01, 2020 ft²	Aug. 13, 2020 ft²	Apr. 01, 2020 USD ($)	Apr. 15, 2016
Operating Leased Assets [Line Items]
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]		Accounts payable and other accrued liabilities		Accounts payable and other accrued liabilities	Accounts payable and other accrued liabilities			Accounts payable and other accrued liabilities
Defined contribution plan, age requirement					21 years
Defined contribution plan, service requirement					3 months
Multiemployer plan, employer contribution, cost		$ 0	$ 0		$ 0	$ 0
Other commitments, number of special purpose acquisition company sponsorships | company								4			4
Other commitments, percentage of outstanding shares, per acquisition company											15.00%
Class of warrant or right, outstanding (in shares) | shares		27,113,736		27,113,736	27,113,736			9,592,085
Payments for other commitments not expected to be repaid		$ 625,000		$ 625,000	$ 625,000
Repayments from other commitments					183,000
IPO | IHC
Operating Leased Assets [Line Items]
Sale of stock, number of common shares issued per unit (in shares) | shares	1						1
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares	1						1
Proceeds from initial public offering of IHC	$ 115,000,000
Exercise price of warrants (in dollars per share) | $ / shares	$ 11.50
IPO | IHC | Placement Warrants
Operating Leased Assets [Line Items]
Class of warrant or right, outstanding (in shares) | shares	4,639,102
Sale of warrants, price per share (in dollars per share) | $ / shares	$ 1.00
Aggregate purchase price	$ 4,639,102
Exercise price of warrants (in dollars per share) | $ / shares	$ 11.50
Shiftpixy Founders
Operating Leased Assets [Line Items]
Other commitments, percentage of outstanding shares, per acquisition company											15.00%
Special Purpose Acquisition Company, 1
Operating Leased Assets [Line Items]
Other commitment											$ 25,000
Special Purpose Acquisition Company, 2
Operating Leased Assets [Line Items]
Other commitment											25,000
Special Purpose Acquisition Company, 3
Operating Leased Assets [Line Items]
Other commitment											25,000
Special Purpose Acquisition Company, 4
Operating Leased Assets [Line Items]
Other commitment											$ 25,000
Special Purpose Acquisition Company, Maximum Amount Per Individual Loan
Operating Leased Assets [Line Items]
Other commitment	$ 500,000
Special Purpose Acquisition Companies
Operating Leased Assets [Line Items]
Other commitment	$ 2,000,000
Payments for other commitments				820,000
Irvine Facility
Operating Leased Assets [Line Items]
Operating lease term															5 years
Operating lease, monthly expense					35,000
Finance lease, liability														$ 33,030
Finance lease, liability, monthly payment														$ 756
Principal balance of finance lease		$ 23,391		$ 23,391	23,391			$ 26,260
Miami Office Space Facility
Operating Leased Assets [Line Items]
Operating lease term													7 years
Operating lease, monthly expense					57,000
Area of real estate property | ft²													13,246
ShiftPixy Labs Facility
Operating Leased Assets [Line Items]
Operating lease term												64 months
Operating lease, monthly expense					34,000
Area of real estate property | ft²												23,500
Miami Verifone Facility
Operating Leased Assets [Line Items]
Operating lease, monthly expense					26,000
Area of real estate property | ft²										8,000
Sublease term										3 years
Sunrise Facility
Operating Leased Assets [Line Items]
Operating lease, monthly expense					$ 27,000
Area of real estate property | ft²									13,418
Operating lease, lease not yet commenced, term									77 months

XML

Commitments - Lease, Cost (Details) - USD ($)	3 Months Ended	6 Months Ended
	Feb. 28, 2022	Feb. 28, 2022
Commitments and Contingencies Disclosure [Abstract]
Operating Lease Cost	$ 334,251	$ 788,203

XML

Commitments - Lessee, Operating Lease, Liability, Maturity (Details) $ in Thousands	Feb. 28, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2022	$ 731
2023	1,739
2024	1,737
2025	1,532
2026	1,275
Thereafter	1,515
Total minimum payments	8,529
Less: present value discount	1,164
Lease Liability	$ 7,365
Weighted-average remaining lease term - operating leases (months)	54 months
Weighted-average discount rate	5.54%

XML

Contingencies (Details) - USD ($)					1 Months Ended		5 Months Ended	70 Months Ended
	Mar. 19, 2021	Mar. 12, 2021	Dec. 18, 2020	Jan. 03, 2020	Apr. 30, 2019	May 31, 2016	Aug. 31, 2021	Feb. 28, 2022	Nov. 04, 2021
Disposal by sale | Overall business
Loss Contingencies [Line Items]
Gross proceeds				$ 19,200,000				$ 19,166,000
Gross note receivable				$ 9,500,000				9,500,000
Period for payment of gross proceeds (in years)				4 years
Everest Litigaton
Loss Contingencies [Line Items]
Loss contingency, damages sought, value			$ 600,000
Sunz Litigation
Loss Contingencies [Line Items]
Loss contingency, damages sought, value	$ 10,000,000
Vensure Litigation
Loss Contingencies [Line Items]
Loss contingency, damages sought, value		$ 1,519,991
Discontinued operation, proposed adjustments period				90 days
Discontinued operation, negotiation period				30 days
Vensure Litigation | Withdrawn Claim
Loss Contingencies [Line Items]
Loss contingency, damages sought, value							$ 1,500,000
Vensure Litigation | Pending Litigation
Loss Contingencies [Line Items]
Gain contingency, unrecorded amount									$ 9,500,000
Vensure Litigation | Disposal by sale | Overall business
Loss Contingencies [Line Items]
Gross proceeds				$ 19,000,000
Gross note receivable				$ 9,500,000
Period for payment of gross proceeds (in years)				48 months
Software Development | Kadima Litigation
Loss Contingencies [Line Items]
Software development cost						$ 2,200,000
Revised development costs						7,200,000
Software modules cost						11,000,000		$ 11,000,000
Additional software modules cost demanded						$ 12,000,000
Loss contingency, damages sought, value					$ 11,000,000